









McDonald, Marie Therese (2021) Level of, and factors affecting adherence to 






Copyright and moral rights for this work are retained by the author 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
When referring to this work, full bibliographic details including the author, 













Level of, and Factors Affecting, 
Adherence to Prescribed Exercise in 




Marie Therese McDonald BSc (Hons) 
 
Submitted in fulfilment of the requirements for the degree 
of Doctor of Philosophy 
 
School of Medicine, Dentistry and Nursing 
College of Medicine, Veterinary and Life Sciences 






Background: Spondyloarthritis is a group of chronic inflammatory 
musculoskeletal diseases for which exercise is considered an essential part of 
their management. Adherence is a primary determinant of the effectiveness of 
any intervention and can be influenced by multiple factors. The World Health 
Organisation proposes that when studying adherence, an approach where 
adherence is determined by interplay of factors relating to five construct; 
socioeconomic, healthcare, condition, treatment and patient-related can be 
used. Currently the level of adherence and factors affecting adherence to 
prescribed physiotherapy programmes in people with SpA is unknown. 
Objectives: The aim of the research within this thesis was to investigate the 
level of, and factors affecting, adherence in people with SpA.  
 
Methods: Three studies were undertaken. Firstly, a systematic review of the 
current literature investigating adherence to prescribed exercise in SpA. 
Secondly a cohort study to investigate the level of, and factors affecting, 
adherence to a web-based physiotherapy programme in patients with axial SpA 
(axSpA), the prototypic SpA condition. Finally, a survey of physiotherapists in the 
United Kingdom (UK) delivering prescribed exercise programmes to people with 
SpA, investigating the factors they perceive as affecting adherence and barriers 
to adopting methods to improve adherence. 
 
Results: The systematic review identified and included ten studies with a total 
of 690 participants. Rates of adherence ranged from 51% to 95%, and in the main 
were poorly reported. The interventions and measurement of adherence varied 
across studies, making comparisons difficult. Two studies identified that 
adherence was improved following educational programmes and one study 
indentified that higher disease severity and longer diagnostic delays were 
associated with higher adherence rates. One study indicated supervised group 
exercise increased adherence to HEP whilst another found no difference. Three 
linked studies by the same authors with the same participants demonstrated that 
adherence reduced over time. No study within the systematic review measured 
adherence to a web-based physiotherapy programme.  
ii 
 
The cohort study found adherence to web-based physiotherapy exercise in 
people with axSpA was 27.6% of all sessions for all participants over 12-months. 
When participants started a session, they were likely to complete all the 
individual exercises within the session (74% versus 26% of the time). Adherence 
reduced over the course of the intervention. No quantitative factors were found 
to influence adherence, however participant interviews found that disease 
symptoms, getting into a routine and support have an important role in 
influencing adherence.  
 
The online survey identified that physiotherapists believe that adherence to 
prescribed exercises can be low. There were high levels of agreement of the 
factors affecting adherence to exercise. Within the WHO-proposed healthcare- 
related construct, good access to physiotherapy and effective medication for 
symptom control were perceived to improve adherence. Within the disease- 
related construct, concurrent mental health problems, high disease symptoms 
and multiple co-morbidities were consided to reduce adherence. Within the 
socio-economic domain, support increased adherence, while social deprivation 
reduced adherence. Within the person related construct, the belief the exercise 
would help and being physically active improved adherence, whilst lack time, 
interest or confidence and low self-efficacy reduced adherence. Within the 
treatment related construct, several strategies such as individualising the 
intervention, including goal setting, providing patient education, could increase 
adherence. Time was the most common barrier to physiotherapists implementing 
strategies to improve adherence. 
 
Conclusions: This thesis has provided data that adherence to prescribed exercise 
in people with SpA can be variable, often low and reduces over the course of 
interventions. This thesis has identified multiple interacting factors within the 
five constructs suggested by the WHO adherence model which may influence 
adherence. When prescribing exercise, physiotherapists should consider which 
factors are potentially affecting adherence within each WHO domain and address 
key modifiable factors in order to optimise adherence for that individual. 
Further research is required to compare rates of adherence across different 
modes of programmes, identifying which factors are most important in 
influencing adherence on a group level. Finally improving and standardising the 
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1 Chapter: Introduction  
1.1 Introduction & Problem Statement 
This chapter introduces Spondyloarthritis and provides an introduction to 
rationale for the body of work contained within this thesis. This chapter presents 
the overarching aim and investigations central to the thesis. The organisation of 
the thesis and the original contribution of the work to existing knowledge will be 
presented. 
Spondyloarthritis (SpA) is a group of chronic inflammatory musculoskeletal 
diseases. The prevalence of SpA varies across countries and is estimated to be 
between 0.4-2.4% with an incidence rate of 1-16.4/100000 within Europe 
(Sieper., et al. 2006). The aetiology of SpA is unclear, however, interactions 
between genetic, immune and environmental factors are thought to contribute 
to the development of SpA (Dougados and Baeten, 2011). 
SpA is characterised by inflammation of the joints and spine, resulting in 
progressive musculoskeletal damage, enthesitis, dactylitis and extra-articular 
manifestations such as uveitis, psoriasis, and cardiovascular (CV) disease (van 
der Horst-Bruinsma and Nurmohamed, 2012). The physical limitations of SpA are 
known to affect employment, leisure activities, mood and interpersonal 
relationships (Strand and Singh, 2017). People with SpA suffer from joint pain, 
swelling, stiffness, loss of bone density, fatigue, and functional limitations in 
performing daily tasks. The economic impact of work limitations related to SpA 
is substantial. As symptoms commonly start when a person is young, normally 
within the second or third decade of life, and continue over a person's lifetime, 
work productivity is affected over the long term (Strand and Singh, 2017). SpA is 
associated with an increase in all-cause mortality compared with the general 
population. This is predominantly related to osteoporotic  fractures and CV 
disease (Molto & Nikiphorou, 2018).  
SpA can be classified as axial or peripheral SpA depending on the dominant 
clinical musculoskeletal manifestation (Rudwaleit et al., 2009). Axial 
spondyloarthritis (axSpA) predominantly affects the spine and/or sacroiliac 
joints. Whilst peripheral SpA predominantly involves the peripheral joints. 
Subtypes of SpA include ankylosing spondylitis (AS), psoriatic arthritis (PsA), non-
2 
 
radiographic axSpA (nr-axSpA), reactive arthritis (reA), enteropathic arthritis, 
and historically undifferentiated spondyloarthropathy (uSpA) (Dougados and 
Baeten, 2011, Reimold and Chandran, 2014). AxSpA itself is a spectrum, 
incorporating AS and nr-axSpA. AS is the most commonly described of the SpA 
conditions and is considered the most severe and potentially disabling of the SpA 
group (Zochling and Smith, 2010). Apart from when referring to the specific 
condition, AS and axSpA are used interchangeably throughout this thesis.   
 
The optimal management of SpA requires a combination of pharmacological and 
non-pharmacological treatments. Pharmacological treatment of SpA includes 
non-steroidal anti-inflammatory medicines (NSAIDs), disease-modifying anti-
rheumatic drugs (DMARDs) and biologic drugs including tumor necrosis factor 
(TNF) blocking agents (Zochling et al., 2006). NSAIDs can be effective in reducing 
symptoms such as pain, and morning stiffness as well as potentially reducing 
structural damage associated with SpA. However, gastrointestinal toxicity is a 
well-known adverse effect of NSAIDs and can contribute to co-morbidities within 
SpA (Wanders et al., 2005). NSAIDs alone are not sufficient or effective therapy 
for a significant number of people with more severe disease. Conventional 
synthetic DMARDs, such as sulfasalazine and methotrexate, are less studied and 
potentially less effective in SpA compared with rheumatoid arthritis (RA) (van 
der Horst-Bruinsma et al., 2002). They are generally not considered effective for 
spinal disease (Haibel et al 2007). Biologic therapy is indicated in cases of 
persistent high disease activity and when insufficient response to NSAIDs or 
conventional DMARDs are recorded (Braun et al., 2011). Biologic therapies used 
in SpA include the TNF inhibitors infliximab, etanercept, adalimumab, 
certolizumab and golimumab. They have demonstrated efficacy in the control of 
disease activity in 60–70% of patients with axSpA (van der Heijde et al., 2005, 
2006, Inman et al., 2008). Secukinumab, a biological DMARD that targets IL-17A, 
has also been shown to be effective for axSpA and is included in recently 
published treatment recommendations (van der Heijde et al., 2017, NICE 2017). 
Although drug management continues to evolve, people with SpA still experience 
impaired health-related quality of life due to the symptoms and clinical 
manifestations of SpA, and a significant percentage of people do not respond to 
any currently available medications (Strand and Singh 2017). 
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Non-pharmacological strategies include exercise therapies, education, lifestyle 
and behavioural changes and self-management. Physiotherapy treatment 
includes prescribed exercise programmes, which are important aspects of the 
care for people with SpA (NICE 2017). Physiotherapists prescribe exercises to 
improve and/or maintain clinical outcomes and symptoms. The existing 
literature suggests that exercise can be effective in improving physical function, 
disease activity, pain, stiffness and CV fitness. However, the majority of 
published literature has examined exercise in AS populations so generalising to 
SpA should be done with caution (O’Dwyer et al., 2014a, NICE 2017). Exercise 
programmes require to be individualised taking into consideration assessment 
findings, goals and lifestyle (Dagfinrud et al., 2004, O’Dwyer et al., 2014a, 
2014b, Reimold and Chandran, 2014, Millner et al., 2016, Regel et al., 2017). 
Prescribed exercise programmes are predominantly provided as home exercise 
programmes (HEPs) or in supervised sessions. These programmes commonly 
include flexibility, CV fitness, strengthening and balance exercise. The chronic 
nature of SpA requires ongoing, regular exercise throughout the person’s 
lifetime (Millner et al., 2016, Nice 2017, Regel et al., 2017).   
Due to the life-long, chronic nature of SpA, adhering to prescribed exercise 
programmes is challenging for individuals with SpA and the professionals 
supporting them. Adherence refers to the extent to which a person’s behaviour 
corresponds with the recommendations from a healthcare provider (HCP) 
(Sabete et al., 2003). A person's adherence to their prescribed exercise 
programme can determine the efficacy of the programme (Sabete et al., 2003). 
Improved clinical outcomes are reported in other conditions in those who adhere 
to their exercise programmes in comparison to those who do not (Pisters et al., 
2010, Peek et al., 2016). The extent to which people with SpA adhere to 
prescribed exercise programmes is currently not known. 
Adherence to physiotherapy prescribed exercise programmes is determined by 
the interplay of multiple factors. The World Health Organisation (WHO) proposes 
that when studying adherence, a multidimensional approach could be 
undertaken where adherence is determined by the interplay of factors relating 
to five constructs; socioeconomic, healthcare, condition, treatment and patient-
related (Sabate et al., 2003). The WHO (2003) suggest this approach could be 
used as a starting point to study factors within these constructs; however, the 
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factors within these constructs relating to the behaviour of adherence to 
prescribed exercise within SpA are currently unknown. 
Delivering physiotherapy using a web-based approach may be a feasible 
alternative to traditional physiotherapy for people with SpA. Web-based 
physiotherapy programmes can be individualised, with progressive exercise 
programme provided online with the physiotherapist remotely contactable. 
Physiotherapy programmes delivered in this manner, may help support people 
over the longer term who may struggle to engage with traditional physiotherapy 
due to travel or lifestyle (Laver et al., 2020). People with SpA are commonly 
diagnosed in the second or third decade of their life, when employment and 
family commitments have the potential to be demanding. Web-based 
programmes have the advantage of being flexible and available 24 hours per day 
and so may be a more feasible alternative intervention to traditional face to 
face physiotherapy and support adherence in the long term (Paul et al., 2014).  
 
1.2 Overall aim and investigations central to this thesis 
The overall aim of this research was to investigate the level of, and factors 
affecting, adherence to prescribed exercise programmes in people with SpA. 
 
1.3  Organisation of thesis 
This thesis comprises three studies. First, a systematic review was conducted to 
assess adherence to prescribed exercise in people with SpA (Chapter 3). 
Secondly, a cohort study assessed adherence over one year to a prescribed web-
based combined physiotherapy-led and patient choice programme and measured 
a range of factors affecting adherence in people with axSpA (Chapter 4). Finally, 
an online survey of physiotherapists delivering prescribed exercise programmes 
to people with SpA in the United Kingdom (UK) was conducted to investigate the 
factors they perceived as affecting adherence and barriers to adopting methods 
to improve adherence (Chapter 5). Overall conclusions and recommendations for 
each study and the collective body of work are presented in Chapter 6. 
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The three studies (Chapters 3-5) form a coherent and progressive programme of 
work. The systematic review found no studies had investigated adherence to an 
online physiotherapy programme, thus, a cohort study measuring adherence to 
online physiotherapy was devised. The cohort study and systematic review 
identified limited information on the factors affecting adherence, thus a survey 
of physiotherapist was devised.   
Individually the three studies may be of interest to a number of specific 
audiences including health professionals, academics, service providers and users, 
third sector organisations and exercise scientists. To help facilitate this, the first 
study, the systematic review, has already been published (McDonald et al., 
2019); however, this thesis will offer greater detail than presented in the 
published work.  
 
1.4  Original contribution of work to knowledge 
Each of the studies in this body of work has contributed original knowledge to 
the current literature of physiotherapy for people with SpA. The systematic 
review was the first to evaluate the level of adherence and factors affecting 
adherence in people with SpA. The cohort study addressed a gap in the 
literature, as it was the first study to measure the level of adherence to a web-
based programme and investigate new factors affecting adherence in people 
with axSpA. This study was part of, and extended the work of the Web-based 
Physiotherapy for people with axSpA (WEBPASS) study, which was funded by 
Versus Arthritis (previously Arthritis Research UK) (20874). The PhD student 
(MTM) was a qualified physiotherapist, who specialised in rheumatology. The PhD 
student was a grant applicant, and was involved in the design of the study, 
recruitment, provision of the physiotherapy, data analysis and write up of the 
study. This PhD study extended the work of the Versus Arthritis study by 
completing a more in-depth study and analysis of adherence. 
Finally, the online survey was the first to explore what physiotherapists 
perceived as the factors which affected adherence and the interventions for 







2 Chapter: Literature Review 
This chapter will present the epidemiology of SpA. It will then go on to outline 
the different subsets of the disease, the pathophysiology, and the diagnostic 
criteria. The clinical features and symptoms of SpA and pharmacological 
treatments available will be discussed. The effect of SpA on employment and 
the economy will next be presented.  Physiotherapy interventions and treatment 
will be discussed in relation to SpA, with particular focus on prescribed exercise 
programmes. Adherence will be defined and examined in the context of 
adherence to physiotherapy prescribed exercise programmes and the aims and 
objectives of this thesis will be outlined. An individual justification for each of 
the three studies undertaken in this PhD will be at the start of each of the 
respective chapters. 
 
2.1  Spondyloarthritis 
SpA describes a group of interrelated inflammatory arthritides which share 
common genetic, pathophysiological and clinical features (Dougados & Baeten 
2011, Bengtsson et al., 2017). SpA conditions include AS, nr-axSpA, reA, 
enteropathic arthritis, PsA and historically uSpA (Dougados & Baeten 2011, 
Reimold & Chandran 2014).  
 
2.2  Epidemiology & Prevalence of Spondyloarthritis 
SpA as a group are as common a diagnosis as RA (Haglund et al., 2011) with 
approximately 1 in every 200 people in the UK having an axSpA (Hamilton et al., 
2015). A systematic review investigated the epidemiology of SpA from 16 studies 
worldwide and reported the prevalence varied from 0.01% in Japan to 2.5 % in 
Alaska (Stolwijk et al., 2012). In western Europe the prevalence is estimated to 
be between 0.3 and 2.5% with an incidence of 1-16.4/100000 (Sieper et al., 
2006). However, there are variable definitions and delays in the diagnosis of SpA 
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which impact on the reported prevalence for SpA and potentially account for the 
variation between studies, in addition to geographic variation. It is anticipated 
that with better recognition and diagnosis of SpA the reported prevalence will 
increase. There is a need for further studies into the prevalence of axial and 
peripheral SpA in the general population, and to estimate the prevalence of SpA 
in developing countries (Stolwijk et al., 2012).  
 
2.3 Pathophysiology of SpA 
The pathogenesis of SpA is not fully elucidated. However, it is believed SpA is 
the result of a complex interaction between genetic risk factors and 
environmental triggers that leads to the activation of an auto inflammation 
response (Reveille and Arnett, 2005). 
Susceptibility to SpA can be partially attributable to genetic factors, with 
documented familial aggregation and a concordance rate in identical twins 
(Reveille and Arnett, 2005). The gene HLA-B27 is an important genetic factor in 
the development of SpA (Dougados and Baeten, 2011).  HLA-B27 is found in up to 
95% patients of European ancestry with AS, as well as  in 70% with reA, 60% with 
psoriatic spondylitis, 25% with peripheral PsA (although no association with 
cutaneous psoriasis itself), 70% with spondylitis associated with inflammatory 
bowel disease (IBD) (but no association with IBD itself), and 50% with acute 
anterior uveitis occurring without other stigmata of SpA (Serrano et al., 2017). 
However, HLA-B27 is also present in the general population. With geographic 
variation, only 7–8% of HLA-B27 carriers go on to develop AS. Therefore, HLA-B27 
can only explain part of the risk for SpA, other genes alongside environmental 
triggers may play a role, but are not yet fully understood (de Koneing et al., 
2018). Genome-wide association studies have identified a number of non-HLA 
susceptibility genes, several of which implicate the IL-23/IL-17 cytokine pathway 
(Reveille & Arnett, 2005). In common with other inflammatory rheumatic 
conditions, inflammatory cytokines have been implicated in the pathogenesis of 
SpA. The focus in SpA, and related extra-articular conditions such as psoriasis 
and IBD, has increasingly been on the key role of the IL-23/IL-17 axis, leading to 
numerous therapeutics targeting this (Siebert et al., 2020).  
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The role of abnormal intestinal microbiota and infections in the development of 
SpA have been suggested. In reA, symptoms typically develop a short-time after 
a gastrointestinal or genitourinary infection (Carter and Hudson, 2009). Evidence 
that gut bacteria are important in SpA includes findings in animal models of SpA. 
Seminal work reports that rats and mice develop SpA-like clinical and pathologic 
features when housed in a regular laboratory environment, but not when raised 
in a germ-free environment (Taurog., et al 1994). Findings on changes in gut 
microbiota in humans with SpA are emerging, with much unknown, such as how 
and when the microbiome influences disease. However, there appears to be a 
general expectation that abnormal intestinal microbiota and infections play a 
role, which may allow for therapeutic intervention in future (de Koneling et al., 
2018). 
The role of mechanical stress in inflammation and bone formation is increasingly 
recognised as associated with the pathogenesis of SpA but remains poorly 
understood (Ronneberger et al., 2011) The ‘synovio-entheseal complex’ 
represents an integration between ligament or tendon insertions and the 
adjacent synovium. Fibrocartilage at these insertions is prone to micro damage 
and in people who are susceptible, tissue repair can produce tenosynovitis or 
synovitis due to the synovium being rich in immune cells and able to undergo 
hyperplasia and vessel ingrowth (Schett et al., 2017). While acute lesions may 
resolve with chronic inflammatory lesions, resolution of the process results in fat 
metaplasia and bone formation. In axSpA this leads to bony bridges within the 
spine called syndesmophytes which limit spinal mobility, or boney projections at 
entheseal sites called enthesiophytes  (Vieira-Sousa et al., 2015).  
2.4 Clinical Features of SpA 
Common shared clinical features of SpA include inflammatory back pain, 
sacroiliitis, peripheral arthritis, enthesitis, dactylitis. Non-articular 
manifestations such as uveitis, psoriasis, IBD and CV disease are also reported 
(van der Horst-Bruinsma and Nurmohamed, 2012).  These clinical features are 




2.4.1 Enthesitis  
The enthesis is the site of insertion of ligaments, tendons, joint capsule, or 
fascia into bone. Enthesitis is defined as the inflammation of the enthesis origin 
and is the hallmark of SpA (Taniguchi et al., 2013, Sen et al., 2020). The most 
common site of enthesitis is the Achilles tendon insertion into the heel (see fig 
2-1) but iliac crests, cost chondral junctions at the sternum, the greater 
trochanters, and the tibial plateaus can also be affected. Enthesitis produces 
tenderness on palpation of these sites and occasionally also swelling of 
superficial sites such as the Achilles tendon insertion (Rudwaleit et al., 2011).  
 
Figure 2-1. Enthesitis at insertion of Achilles Tendon into calcaneus in right heel (arrow). 
Reproduced from ASAS http://slides.asas-group.org/app/slides/search?q= 
 
2.4.2  Inflammatory Back Pain & Sacroiliitis 
Inflammatory back pain is a major symptom of axSpA (Braun and Inman, 2010). It 
is distinct from mechanical back pain as it is characterised by persistent back 
pain that worsens with periods of immobility, such as during the night, but 
improves with light exercise. It is associated with morning stiffness and pain can 
radiate to the dorsal spine or pelvis. Sacroiliitis can manifest as alternating left-
right gluteal region pain. The cervical spine, and less frequently the thoracic 
spine, can also be affected, especially in AS, with loss of range of motion 
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(Deodhar et al., 2016). Spinal enthesitis has been suggested as the cause of 
inflammatory back pain and sacroiliitis (Braun, et al., 2000) 
 
2.4.3 Peripheral Arthritis  
Peripheral arthritis is a common characteristic of SpA. This often involves the 
lower extremities, especially knees and ankles, and is associated with pain, 
stiffness and joint swelling. The pattern is normally acute, non-erosive, 
asymmetrical, and oligoarticular (Fragoulis et al., 2019). 
 
2.4.4 Dactylitis  
Dactylitis is the global inflammation of fingers and toes, which can make them 
look like sausages (Figure 2-2) (Olivieri et al., 2006). It can be acute, with 
inflammatory signs, or chronic and often not painful. Dactylitis can affect one or 
more fingers and/or toes asymmetrically (van der Horst-Bruinsma and 
Nurmohamed, 2012).
 
Figure 2-2.  Dactylitis of the third digit (arrow) on right hand. 




2.4.5  Extra-Articular Features  
Acute unilateral anterior uveitis is a common symptom of SpA, especially in HLA-
B27 positive patients, and may be the presenting feature (Gupta, 2018). Uveitis 
is an eye condition where inflammation affects the uveal tract such as the iris, 
ciliary body, and/or choroid. Anterior uveitis is the most frequently observed 
extra-articular manifestation of SpA and can be seen affecting up to 40% of 
patients (Gupta, 2018). Approximately 10% of people with SpA have concurrent 
IBD, such as Crohn's disease and ulcerative colitis (van der Horst-Bruinsma and 
Nurmohamed, 2012). Psoriasis is an inflammatory skin condition which causes 
skin to become red, scaly and crusty and is present in 10-20% of people with SpA 
and characteristic of PsA (van der Horst-Bruinsma and Nurmohamed, 2012).  
Other less common non-articular features include aortic insufficiency, nerve 
conduction abnormalities, neurological manifestations secondary to spinal 
fractures or atlantoaxial subluxation, amyloidosis, and osteoporosis (Sieper et 
al., 2006). 
 
2.4.6  Symptoms  
Individuals with SpA commonly complain of fatigue, stiffness, and frequent 
flares. These symptoms are variable but for a proportion of individuals with SpA 
these will be intense, frequent and disabling (Sieper et al., 2006, Atzeni et al., 
2014, Jacquemin et al., 2017). As a result of clinical features and new bone 
formation, people with axSpA suffer with spinal immobility, pain and loss of 
function (Jacques and McGonagle, 2014). 
 
2.5 Types of Spondyloarthritis  
SpA conditions include AS, nr-axSpA, reA, enteropathic arthritis, PsA and 
historically uSpA (Figure 2-3) (Dougados & Baeten 2011, Reimold & Chandran 
2014). SpAs can be classified according to their clinical presentation as 
predominantly axial or peripheral SpA, with some overlap between these two 
subtypes (Rudwaleit et al., 2009) (Figure 2-3). AxSpA is characterised by 
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predominant involvement of the spine and/or sacroiliac joints. AS, nr-axSpa, 
certain forms of PsA and reA with axial involvement, and enteropathic arthritis 
can present as axSpA. These conditions are all part of the same spectrum of 
axSpA and, apart from when referring to the specific condition, AS and axSpA 
are used interchangeably throughout this thesis. In peripheral SpA, peripheral 
joint arthritis, enthesitis and/or dactylitis dominate in the clinical presentation 
(Rudwaleit et al., 2011). ReA, PsA, enteropathic arthritis and certain forms of 
undifferentiated SpA can present as a peripheral SpA (Figure 2-3). 
 
 
Axial Manifestations   Peripheral Manifestations 
Figure 2-3. Family of Spondyloarthritis conditions.  
Modified from Proft et al., 2018. Therapeutic Advanced Musculoskeletal Disorders. 
 
The following sections describe the clinical features of each specific condition in 
more detail. 
 
2.5.1 Ankylosing Spondylitis (AS)                  
AS (also known as radiographic axSpA) is the prototypic and best described of 
the axSpA conditions, and is considered the most severe and potentially 
disabling of the SpA group (Zochling and Smith, 2010). AS is traditionally 
distinguished from nr-axSpA by the presence of radiographic changes of the 
sacroiliac joints, fulfilling the modified New York criteria (van der Linden et al., 
1984), although both conditions fall on the axSpA spectrum. People with AS 











suffer from inflammatory back pain, which is worse in the morning and is 
associated with stiffness but improves as the day continues (Rudwaleit et al., 
2006). Inflammatory back pain is present in 70–80% of patients with axSpA, is 
chronic (present > 3 months) and typically has insidious onset before the age of 
45 years.  Inflammation in AS typically occurs at the entheseal sites, the spine 
and sacroiliac joints.  Persistence of disease leads to progressive joint and 
structural changes throughout the spine, mainly as a result of new bone 
formation (Zochling and Smith, 2010). This includes the ossification of spinal 
ligaments and the appearance of bony outgrowths, known as syndesmophytes, 
which are classic radiographic features of AS. In the most severe cases, this 
ultimately results in complete fusion of the vertebrae (ankylosis, often referred 
to as “bamboo spine”), which causes limited spinal mobility, and fixed curvature 
of the spine which gives the individual the characteristic posture and gait (Figure 
2-4) (Braun and Sieper 2007). There can also be peripheral joint involvement, 
particularly of the hips, and extra-articular manifestations, including uveitis, 
psoriasis and IBD.  
 
Figure 2-4. Schematic of changes in the spine in Ankylosing Spondylitis. 




2.5.2 Non-Radiographic SpA 
Nr-axSpA and AS are part of the spectrum of axSpA, with similar burden of 
disease (Rudwaleit et al., 2009). The clinical features of nr-axSpa are the same 
as, with people presenting with chronic inflammatory back pain and stiffness 
predominantly of the pelvis and the lower back which improves with movement. 
Peripheral arthritis and enthesitis of the lower limbs are the most common 
peripheral manifestations. In nr-axSpA there is spinal inflammation on magnetic 
resonance imaging (MRI) and/or evidence of inflammation (eg raised CRP) but no 
new bone formation on x-ray, whereas in AS radiographic changes have occurred 
in the sacroiliac joints (Ludwaleit et al., 2009). Modern imaging modalities 
especially MRI have allowed earlier diagnosis of axial inflammation in patients 
who suffer from inflammatory back pain (Rudwaleit et al., 2009, Poddubnyy and 
Sieper, 2018). However, nr-axSpA is not considered as a precursor to AS the 
majority of patients will not develop radiographic progression despite clinical 
and MRI imaging of spinal inflammation (Poddunbnyy et al., 2011). 
 
2.5.3 Reactive Arthritis 
ReA is an inflammatory arthritis that arises after certain types of gastrointestinal 
or genitourinary infections (Carter and Hudson, 2009). Musculoskeletal symptoms 
begin a few days to 6 weeks after infection. The typical pattern of ReA is an 
asymmetric, mono- or oligoarthritis, predominantly of the lower extremities 
including knees, ankles and feet. In addition, inflammatory back pain, sacroiliitis 
and enthesitis can occur. Non-articular manifestations include conjunctivitis and 
urethritis (Kim et al., 2009). This type of SpA is self-limiting over 2-3 months in 
the majority of patients but a proportion of people, as high as 40%, will develop 
chronic ReA, with a small number going on to develop AS (Kaavela et al., 2009). 
 
2.5.4 Psoriatic Arthritis 
PsA is a heterogeneous condition associated with cutaneous psoriasis. People 
with PsA may have a number of musculoskeletal presentations, including 
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peripheral polyarthritis, mono/oligoarthritis, dominant enthesitis, dactylitis or 
sacroiliitis/spondylitis (Akgul, 2011). 
 
2.5.5 Enteropathic Arthritis 
Enteropathic arthritis is an SpA which occurs in people with IBD such as Crohn’s 
Disease or ulcerative colitis (Peluso et al., 2013). Similar to other subtypes of 
SpA, people with EA can have axial symptoms and/or peripheral arthritis, 
enthesitis or dactylitis (Peluso et al., 2013).  
 
2.5.6 Undifferentiated SpA 
Undifferentiated SpA is a poorly described subgroup that fulfils SpA criteria but 
cannot be classified in one of the other subtypes (Paramarta et al., 2013). uSpA 
may develop into other forms of SpA such as AS or PsA (Paramarta et al., 2013) 
and has largely fallen out of favour and been replaced by nr-axSpA with the 
availability of MRI imaging allowing identification of sacroiliitis. 
 
2.6 Diagnosis and Classification Criteria for SpA 
Traditionally AS was the most commonly diagnosed subtype of SpA and 
classification was based on the modified New York criteria, which required the 
presence of both clinical and radiographic features (van der Linden et al., 1984). 
However, structural changes identified on conventional radiographs can often 
take up to 10 years to develop, while it was clear that a large proportion of 
patients with classic symptoms and clinical features did not fulfil the imaging 
criteria required for AS (Feldtkeller et al., 2000). The modified New York criteria 
therefore excluded the possibility of diagnosing nr-axSpA within the axSpA 
spectrum. The advent of MRI scanning, which can detect both acute 
inflammation and chronic damage within the spine and sacroiliac joints, has 
provided a means for the better detection of inflammatory changes.  
To classify the whole spectrum of SpA, not only axSpA, the European 
Spondyloarthropathy Study Group (ESSG) and Amor criteria were developed in 
the early 1990s (Amor et al., 1990; Dougados et al., 1991). They both cover the 
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whole spectrum of SpA including axial and peripheral manifestations and gave 
weighted scores to non-articular features associated with SpA. However, it has 
been suggested that these criteria lack sensitivity (Collantes et al., 2000). To 
facilitate the diagnosis of nr-axSpA the new Assessment of the SpondyloArthritis 
international Society (ASAS) classification criteria for axSpA was introduced 
(Rudwaleit, 2010). The ASAS, incorporates the use of MRI evidence of sacroiliac 
inflammation, with criteria for both axial and peripheral forms of SpA (Figure 2-
5). (Rudwaleit et al., 2009a, Rudwaleit et al., 2009b). Furthermore, some 
patients do not have obvious x-ray or MRI changes, so the ASAS classification 
criteria includes a clinical arm, although in clinical practice, c-reactive protein 
test (CRP) is the main non-imaging feature used to support a diagnosis of nr-
axSpA. This relatively new criterion was studied in a population of 975 and 
reported a sensitivity of 79.5% and a specificity of 83.3%, which overall in terms 
of sensitivity is superior to the Amor which reports sensitivity of 59% and 
specificity of 86% and ESSG criteria which reports sensitivity of 58% and 
specificity of 90%.  Therefore the ASAS classification criteria are now commonly 
used in SpA research and also to support clinical practice, although classification 
criteria on their own are not intended for diagnostic purposes (Rudwaleit et al., 
2011). By enabling the identification of patients with nr-axSpA, patients may 




ASAS Classification Criteria for Spondyloarthritis (SpA) 
  AxSpA:     Peripheral SpA 
In patients with ≥ 3 months back pain   In patients with peripheral 
(with/without peripheral manifestations)  manifestations ONLY: 
and age at onset <45 years: 
          
          
 
Sacroiliitis on imaging     OR    HLA-B27 plus  Arthritis or enthesitis or dactylitis 
plus ≥ 1 SpA feature   ≥ 2 other SpA    plus 




SpA features:      ≥1 SpA feature 
- inflammatory back pain       - uveitis 
- arthritis        - psoriasis 
- enthesitis        - crohn’s/colitis 
- uveitis        - preceding infection 
- dactylitis        - HLA-B27 
- psoriasis        - sacroiliitis on imaging 
- good response to NSAIDs        OR 
- family history for SpA 
- HLA-B27      ≤2 other SpA features 
- Elevated CRP        - arthritis 
         - enthesitis 
         - dactylitis 
         - IBP ever 
         - family history of SpA 
  
Figure 2-5. ASAS classification criteria for axSpa (left column) and peripheral SpA (right 
column).  
Adapted from Rudwaleit et al., (2011) 
 
2.7 Disease course of SpA 
With the exception of some forms of ReA, SpA is a chronic long-term condition 
with no known cure. The clinical course of SpA is characterised by periods of 
remission and flare-ups of the disease. Identification and treatment of SpA at an 
early stage can affect disease course and outcomes although it still remains 
unclear within axSpA whether this will translate to reduced radiographic 
progression (Baraliakes et al., 2014). Furthermore, not all patients with axSpA 
develop radiographic changes; in those that do develop new bone formation at 
the spine and sacroiliac joint, this can progress to spinal fusion or ankylosis of 
the spine, reducing spinal mobility and function (Dougados and Baeten, 2011) 
(Figure 2-4).  








Plus ≥1 SpA features  
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There is an increase in all-cause mortality in SpA compared with the general 
population predominantly related to osteoporotic fractures and CV disease 
(Bremander et al., 2011). CV disease is consistently found as the leading cause 
of mortality in patients with SpA, ranging from 30 to 50% of all-cause mortality 
in this population (Moltó and Nikiphorou, 2018). 
 
2.8 Employment in Spondyloarthritis 
Participation in employment with a long term chronic condition such as 
Spa/axSpA can be challenging, compounded by the fact that the symptoms of 
axSpA commonly start when a person is in their 20-30s when people are 
establishing their careers and work productivity is high (Strand and Singh, 2017). 
The physical limitations, such as reduced spinal mobility, and high disease 
activity leading symptoms such as pain, stiffness and fatigue of SpA can affect 
the ability to carry out certain tasks and therefore may negatively affect 
employment (Strand and Singh, 2017).  Employment levels among people with 
SpA may be lower than the general population. A study in the Netherlands found 
that people with AS were 14.4% less likely to be employed in comparison to the 
general population after adjustment for age, gender and education (Webers et 
al., 2018). People with AS can struggle to meet the various demands of their 
job, which can lead to higher rates of withdrawal from employment, sick leave 
(absenteeism) and impairment while at work (presenteeism) compared with the 
general population (Booneen et al., 2001). 
Furthermore, individuals in work may experience work instability, which is a 
mismatch between an individual’s functional abilities and the demands of their 
job (Fabreguet et al., 2012). If the mismatch is not resolved, it can threaten 
continued employment. Work instability within the working population of SpA is 
common. A study evaluated work instability in 156 patients with SpA, the mean 
age of participants was 41 (SD 11) years and the mean disease duration 15 (SD 
11) years. The results demonstrated high or moderate work instability as 
assessed by the ankylosing spondylitis work instability scale in 40% of individuals 
(Fabreguet et al., 2012). To combat work instability, people with SpA may 
switch to a less physically demanding job, and/or retire early because of the 
condition (Fabreguet et al., 2012). Within the UK, survey data from 570 people 
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with AS found that, AS had a significant effect on their ability to work with 43% 
of people of working age either unemployed or retired early and ≥70% citing AS 
as the cause (Cookey et al., 2015) 
 
2.9 Economic Impact of Spondyloarthritis 
SpA incurs an economic burden to individuals diagnosed with the condition, their 
families, the health service and society. This burden includes medical costs, 
such as medications, visits to outpatient clinics, hospital admissions, 
physiotherapy, and care (Cooksey et al., 2015). Indirect costs can also be 
incurred which includes reduced earnings, modifications to home or car, and 
transport. There are also societal costs with decreased tax receipt to the 
economy and increased receipt of disability benefits.  
Costs vary between countries and the majority of research has investigated the 
economic impact of AS. Within the UK the total cost of AS including indirect and 
medical costs in the UK is estimated at £19016 per patient per year. This was 
calculated to include GP attendance, administration costs and hospital costs 
derived from routine data records, plus patient-reported non-NHS costs, out-of-
pocket AS-related expenses, early retirement, absenteeism, presenteeism and 
unpaid assistance costs.  The majority of these costs (>80%) were work-related 
costs. (Cooksey et al., 2015).  
 
2.10 Pharmacological Management of SpA     
Pharmacological treatment options for people with SpA have broadened 
considerably over the past several years. Pharmacological treatments of SpA 
include; NSAIDs, DMARD and biologic agents including TNF and IL-17 inhibitors 
(Zochling et al., 2006).  
NSAIDs are the first-line therapy in axSpA, and can rapidly reduce pain and 
stiffness associated with inflammation in axSpA (Zochling and Smith, 2010). 
While two studies had suggested that continuous or high dose NSAID use in AS 
was associated with less radiologic progression (Wanders et al., 2005, Kroon et 
al., 2012), a subsequent randomised trial of continuous versus on-demand 
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diclofenac did not demonstrate a significant difference in radiographic 
progression (Sieper et al., 2016). Furthermore, potential long-term 
gastrointestinal and CV toxic effects of NSAID therapy remain a concern, 
especially in patients who are recognised as having more comorbidities than the 
general population (Dougados and Baeten, 2011).  
DMARDs, such as sulfasalazine are generally not considered to be effective for 
axial symptoms in axSpA (van der Horst-Bruinsma., et al 2002). However, 
DMARDs have a role in treating peripheral SpA, including in patients with axSpA 
peripheral joint involvement  (Sieper and Poddubnyy, 2016). The efficacy of 
DMARDs for enthesitis or dactylitis remains to be determined, with several 
studies within a review article suggesting no significant efficacy (Sieper and 
Poddubnyy, 2016), while other studies have indicated some efficacy in 
peripheral SpA, including PsA (Mease et al., 2019).  
Biologic therapy is indicated in cases of persistent moderate to high disease 
activity and insufficient response to NSAIDs (or conventional synthetic DMARD in 
cases of peripheral arthritis) (Braun et al., 2011). TNF and IL-17 inhibitors are 
the currently licensed for patients with active axSpA, including those with 
nr-axSpA. Improvements in clinical symptoms, inflammation levels and MRI-
detectable inflammation in the spine have been observed for infliximab, 
etanercept, adalimumab, golimumab and certolizumab pegol for AS and TNF 
blockers; adalimumab, certolizumab pegol, etanercept and golimumab in 
patients with nr-axSpA (Sieper and Poddubnyy, 2016).  Secukinumab, an IL-17A 
inhibitor, has been shown to be effective for both AS and nr-axSpa (Sieper, 
2016). The choice of treatment should be made after discussion between the 
clinician and the patient about the advantages and disadvantages of these 
treatments (van der Heijde et al., 2016, NICE 2017).  
Treatment options are likely to expand, with the development of other biologics 
and targeted synthetic DMARDs. However, people with SpA still experience 
significant impaired health-related quality of life and unmet need due to the 
symptoms and clinical manifestations of SpA, and a percentage of people do not 




2.11 Non-Pharmacological Management of SpA/axSpA 
The optimal management of SpA requires a combination of pharmacological and 
non-pharmacological treatments (Nice 2017).  The two most common non-
pharmacological managements are educational programmes, which aim to 
improve understanding of the condition and treatments and exercise 
programmes (Regel et al., 2017). Hydrotherapy is recommended as an adjunctive 
to manage pain and maintain or improve function in people with axSpA (NICE 
2017, McCrum, 2019). Less commonly used are manual therapy and 
electrotherapy, which may be due to the lack of evidence base for these 
interventions (Reimold and Chandran., 2014, McCrum, 2019).  
 
2.12 Exercise in SpA 
Exercise is a planned, structured, and repetitive bodily movement completed to 
improve or maintain physical fitness (Caspersen et al., 1985). Exercise 
programmes are an important part of non-pharmacological management of SpA 
and have been described as a cornerstone of management of axSpA (Dagfinrud et 
al., 2004). Within the UK, exercise programmes are a part of routine care for 
people with SpA where physiotherapists prescribe exercise programmes to 
improve or maintain symptoms and disease outcomes for individuals with SpA 
(O’Dwyer et al., 2014a, Poddubnyy and Sieper, 2018).  
 
2.12.1 Evidence for Exercise in SpA 
The majority of evidence for exercise programmes has focussed on AS 
populations and predates the ASAS classification criteria (Landewe & van 
Tubergen 2015, NICE, 2017). There is little evidence on physiotherapy 
management of peripheral SpA (McCrum, 2019).  
A systematic literature review examined the safety and efficacy of the non-
pharmacological management of axSpA (Regel et al., 2017). For the efficacy of 
exercise, this review focused on five papers which had an unclear or low risk of 
bias (Kjeken et al., 2013, Neidermann et al., 2013, Rodriguez-Lozano et al., 
2013, Dundar et al., 2014, Sveaas et al., 2014). Four papers considered exercise 
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interventions and one paper considered education in addition to exercise. The 
five RCTs included heterogeneous interventions including: aqauatic exercises 
versus land based exercises (Dundar et al., 2014), Nordic walking plus flexibility 
exercises compared to flexibility exercises and attention control (Neidermann et 
al., 2013), endurance exercises and strength training compared to no exercise 
(Sveaas et al., 2014), education and exercises (including flexibility, strength, 
deep breathing and advice for exercises in the pool) compared with standard 
care from a rheumatologist (Rodriguez-Lozano et al., 2013) and a rehabilitation 
programme versus standared care (Kjeken et al., 2013). The exercise 
interventions lasted between 3-12 weeks (Kjeken et al., 2013, Neidermann et 
al., 2013, Dundar et al., 2014, Sveaas et al., 2014), whilst the study which 
combined exercise and eduction lasted for 24 weeks (Rodriguez-Lozano et al., 
2013). Cohen’s effect sizes were calculated to determine the combined effect 
on disease activity, function, spinal mobility and pain. Cohen’s effect sizes are 
the mean change in score divided by the baseline standard deviation, with 
Cohen’s effect sizes <0 meaning worsening, 0–0.49 a small positive effect (i.e. 
an improvement), 0.5–0.79 a moderate effect and ≥0.8 a large effect (Cohen, 
1988).  
This review found for disease activity, as measured by the BASDAI, the majority 
of the effect sizes (n=3/6) fell into the small bracket (0–0.49). These small 
effect sizes were found in an intervention group which included flexibility 
exercises and Nordic walking and a control group of flexibility exercises and 
attention control (Neidermann et al., 2013), and an intervention group of 
education plus exercise (Rodriguez-Lorano et al., 2013). Two effect sizes were 
moderate (0.5–0.79), for an aquatic exercise intervention and the control group 
of land based exercise over 4 weeks (Dundar et al., 2014). A large effect size 
(1.43) was found for an intervention of a 12-week strength and endurance 
exercises (Sveaas et al., 2014). 
Regel et al., 2017, also considered effect sizes for function, as measured by the 
BASFI. A worsening Cohen’s effect size (-0.07) for the intervention group of 
Nordiac walking and flexibility exercises over 12 weeks was calculated 
(Neidermann et al., 2013). The majority of the effect sizes were small (n=4/6) 
(0-0.49). These small effect sizes were found in the control group of flexibility 
exercises and attention control (Neidermann et al., 2013), the intervention 
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group of aquatic execise and the control of land based exercise (Dundar et al., 
2014,) and the intervention group of education and exercise (Rodriguez-Lorano 
et al., 2013). A moderate effect size (0.5) for the intervention group of a 
strength and endurance intervention was calculated (Svaas et al., 2014). 
Regel et al (2017) also calculated effect sizes for spinal mobility as measured by 
the BASMI. Three RCTs found small positive Cohen’s effect sizes of between 0.07 
(Neidermann et al., 2013) and 0.48 (Dundar et al., 2014). The smallest effect 
size (0.48) was found within the flexibility control group of Neidermann et al., 
2013) and the largest in the aquatic exercise group of Dundar et al.,( 2014). 
Sveass et al 2014 also reported a small effect of their strength and endurance 
exercise intervention. 
Regel et al (2017) also calculated effect sizes for pain. They reported one small 
effect size for an intervention of exercise and education over 24 weeks (0.27) 
(Rodriguez-Lorano et al., 2013), one moderate effect size (0.57) for land based 
exercises over four weeks (Dundar et al., 2014) and one large effect size (0.96) 
for an aquatic exercise intervention over four weeks (Dundar et al., 2014).  
Overall, therefore, this review concluded that regular exercises can improve 
disease activity, pain, function and spinal mobility however, the effects were 
usually small (Regel et al., 2017). It is unclear from the evidence presented 
within this review if one particular type of exercise is superior to others. The 
review informed the European League Against Rheumatism (EULAR) guidelines 
and subsequently, exercise was identified as key and was incorporated in the 
EULAR/ASAS treatment recommendations which stated: 
‘Patients should be educated about axSpA and encouraged to exercise on a regular 
basis and stop smoking; physical therapy should be considered’. (van der Heijde et 
al., 2017).  
Although Regel et al (2017) focussed on non-pharmacological management it also 
included the safety and efficacy of NSAIDs, they did not compare exercise with 
NSAIDs. Regular exercise is considered to be of nearly the same importance as 
NSAIDs in the first-line therapy of axSpA (Braun et al. 2011). However, no study 
has directly compared the effect of NSAIDs with the effects of exercise.  
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Within SpA a systematic review was undertaken on the effectiveness of 
physiotherapy interventions including, exercise programmes in people with SpA 
and to inform the NICE guidelines, as previously the majority of the evidence 
relates to AS (NICE, 2017). Fourteen RCTs were included, these studies were 
divided into; unsupervised structured home exercises versus standard care, 
supervised individual structured exercise (inpatient) versus standard care, 
supervised structured group exercise versus unsupervised structured home 
exercise and supervised structured group exercise versus standard care. Quality 
was assessed using the GRADE tool: grading of recommendations, assessment, 
development and evaluations. The grade tool states RCTs are initially rated as 
high quality and then can be downgraded or not from this initial point. For non-
RCT evidence these are initially rated as low quality and the quality of the 
evidence can further downgraded or not from this point.   
When comparing unsupervised structured home exercise with standard care, 
NICE (2017) found high quality evidence for improved quality of life (1 RCT, 
n=756), reduced finger to floor distance (1 RCT, n=48), and improved BASFI score 
(5 RCTs, n=1034) favouring the unsupervised structured home exercise group and 
from low to moderate quality evidence, no significant difference in BASDAI score 
(5 RCTs, n=1034) and BASMI score (2 studies, n=104). 
NICE (2017) also compared supervised individual structured outpatient exercise 
with standard care. They reported from very low quality evidence that there was 
no significant difference in finger-floor distance (2 RCTs, n=80), or BASMI score 
(2 RCTs, n=68) or pain (2 RCTS, n=38). 
Supervised individual structured exercise (in-patient) were compared to 
standard care. NICE (2017) report, from moderate quality evidence (one RCT, n= 
95), that there was no significant difference in BASDAI, BASMI, and BASFI scores.  
NICE also compared supervised structured group exercise with unsupervised 
structured home exercise low to moderate quality evidence found no significant 
difference in BASFI score or stiffness (1 RCT, n=45), finger-floor distance, or pain 
(2 RCTs, n = 91). 
Furthermore, NICE (2017) found when supervised structured group exercise was 
compared with standard care, from low to moderate quality evidence, 2 RCTs, 
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(n=97) an improvement in BASDAI score and BASFI score in those receiving 
structured supervised group exercise compared with standard care. Very low to 
moderate quality evidence (2 RCTs, n=97) found no significant difference in 
BASMI score or quality of life in those receiving structured supervised group 
exercise compared with standard care.  
From this evidence, NICE (2017) recommended referring people with axSpA to a 
specialist physiotherapist to start an individualised, structured exercise 
programme. NICE (2017) did not specify if this should be within a group, or 
supervised. This programme should include stretching, strengthening, postural 
exercises, deep breathing, range of motion exercises for the spine and aerobic 
exercise (NICE, 2017). International guidelines similarly recommend exercise 
within the management of AS (Zochling, 2006; Ozgocmen et al., 2012; van den 
Berg et al., 2012; Rohekar et al., 2015) and SpA (Wendling., et al 2014).  A 
recent article published since these systematic reviews has found that high 
intensity exercises improved pain, fatigue and stiffness in people with axSpA in 
general (Sveaas et al., 2020). Furthermore, exercise may also have a role in 
attenuating a systemic anti-inflammatory response, and improving CV fitness 
(Millner et al., 2016).  
 
2.12.2 Content of Exercise Prescription 
Although the clinical guidelines and evidence support the use of exercise in 
axSpA, the optimum delivery strategy remains unclear. Traditionally, improving 
spinal mobility has been the focus of exercise programmes, however, there is an 
increasing recognition that exercise programmes should also aim to maintain or 
improve strength, CV health, function and quality of life (Reimold and Chandran, 
2014). Each exercise programme should be tailored for the individual that it is 
prescribed for, taking into account the physiotherapist’s assessment, and the 
goals and lifestyle of the patient (O’Dwyer et al., 2014a, Reimold and Chandran, 




2.12.3 Frequency, Duration and Course of Exercise Programmes 
There is a high level of variation in terms of the frequency and duration of 
prescribed exercise programmes for people with SpA in the published literature, 
with most studies limited to AS. Two systematic reviews reported that the 
frequency of exercise programmes in studies ranged from twice daily to once 
weekly (Dagfinrud et al., 2011, O’Dwyer, et al, 2014a). Recommendations from a 
consensus statement which used a modified Delphi technique from 11 
physiotherapists specialising in AS and a rheumatologist asked the question: ‘In 
adults with AS, what dosage of exercise is beneficial for pain, mobility, disease 
activity and function?’ and suggested aiming for long term maintenance and high 
frequency five or more times per week (Millner et al., 2016). Thirty minute 
sessions have been reported as being optimum in one paper (Santos et al. 1998), 
but exercise programmes should be tailored for each individual and therefore, 
30 minutes should be an aim but not compulsory. Therefore, people with SpA, in 
particular, axSpA should exercise frequently from diagnosis over the course of 
this life-long chronic condition (Millner et al., 2016). It is important to recognise 
long term participation in exercise programmes is likely to be challenging for 
people with SpA and the exercise professionals supporting them. 
 
2.12.4 Delivery of Exercise Programmes 
Exercise programmes can be done at home or supervised individually by a 
physiotherapist or within a group. Home-based exercise programmes have been 
shown to effectively improve clinical outcomes and health-related quality of life 
in people with AS (Yigit et al., 2013, Sollini et al., 2015). A Cochrane review 
reported that both home and supervised exercises were beneficial for people 
with AS, but concluded that supervised exercise programmes were more 
effective than home exercises (Dagfinrud et al., 2004).  More recently, it has 
been suggested that improvements from exercise undertaken in a supervised 
group setting are more likely to be due to higher adherence and higher exercise 
dosage rather than purely from the supervision alone (Millner et al., 2016). The 
authors conclude an exercise programme should be based on personal 
preference, local availability of physiotherapy and adequate dosage rather than 
only considering supervised exercise (Millner et al., 2016).  
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Participating in regular prescribed exercise over the longer term is important if 
the beneficial effects of the exercise are to be realised. For optimum clinical 
outcomes people with SpA then require regular (high frequency) life long 
exercise. Within finite resources and increasing patient numbers it is not feasible 
for people with SpA to receive ongoing physiotherapist supervised sessions 
through the NHS. In addition, for many it is not possible for them to attend face 
to face exercise sessions due to eg time, transport, caring responsibilities. 
Therefore, new approaches in the delivery of prescribed exercise programmes 
should be investigated in people with axSpA for efficacy and adherence. 
 
Web-based physiotherapy approaches are a newer form of delivery of 
physiotherapy exercise programme. In a web-based approaches the programme 
can be remotely monitored with the physiotherapist contactable if and/or when 
required and carried out asynochronously. These remotely delivered approaches 
may be an alternative to traditional HEP and/or supervised exercise programmes 
(Laver et al 2020). Web-based interventions are becoming a more feasible option 
due to the increasing number of people with access to the internet and the 
required computer skills. The Office of National Statistics (2018) reported that 
90% of the UK adult population used the internet, with most adults being regular 
users.  
 
Web-based tailored, individualised exercise programmes have been shown to be 
feasible for people with chronic conditions such as multiple sclerosis and spinal 
cord injury (Paul et al., 2014, Coulter et al., 2017). Furthermore, web-based 
interventions have demonstrated increased engagement, satisfaction and 
motivation to exercise in other long term health conditions including 
osteoarthritis (OA) and RA (Dahlberg et al., 2016, Brennan and Barker, 2008).  
They have the advantage of being available 24 hours a day, giving users 
flexibility to choose when and where to exercise, which may be particularly 
useful for the younger axSpA population, who are likely to be in employment and 
have family commitments. This flexibility may allow people with SpA to engage 
with the programme when is it suitable for them, for example in the evenings 
where work and family commitments may be less, improving adherence to the 
programme. Flexibility may improve adherence in the long-term as the 
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programme is available without the need for referral back to physiotherapy or 
group exercise programmes. Furthermore, for some people participating it is 
probable that exercise without social interaction like group exercise, or 
supervised exercise may be preferred. Web-based physiotherapy provision for 
people with SpA has not previously been examined. 
 
2.13 Adherence 
Adherence is defined as the extent to which a person’s behaviour corresponds 
with the recommendations from a HCP (Sabete et al., 2003). The term 
adherence takes into consideration that individuals have a choice about whether 
they act on the recommendations from a HCP. Traditionally the term 
‘compliance’ has been used to describe the extent a person’s behaviour 
corresponds to HCP recommendations; however, compliance implies that an 
individual does not have a choice (Taube, 2016). Therefore, compliance is a 
term to be used when there is no choice, such as laws or rules. When considering 
exercise prescription, physiotherapists recommend a structured exercise 
programme, and often prescribe the frequency, duration, and type of exercises. 
Individuals have a choice about whether to participate in these exercise 
programmes and therefore the correct term to use in this context is adherence 
(Segal 2007). Adherence is not a binary concept; individuals can adhere to only 
some of the recommendations or only some of the time. 
 
2.13.1 Level & Effect of Adherence  
The evidence presented in the above sections indicates that exercise improves 
clinical outcomes in axSpA. Even if the optimal dosage and frequency of exercise 
in SpA was known, the outcomes will also depend on how much of this 
recommended exercise the individual does. As it is an individual's choice 
whether they will follow the recommendations given by the physiotherapist, the 
level of adherence is important to consider.  
 
Adherence to exercise programmes helps realise the benefits from the exercise 
programme. Broadly, within long term conditions the WHO recognise poor 
adherence to long-term therapies compromises the effectiveness of treatment 
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(Sabete et al., 2003). The literature in other musculoskeletal conditions has 
reported better outcomes for those who adhere to exercise programmes, 
compared to those who do not (Pisters et al., 2010, Peek et al., 2016).  In 
addition to better treatment outcomes, increased adherence has been reported 
to reduce waiting times and the cost of care in long term conditions (Vermeire 
et al., 2001, Hayden et al., 2005).  
 
The level of adherence to physiotherapy prescribed exercises is unclear. A  
systematic review in a mixed population (musculoskeletal conditions, urinary 
incontinence, haemophilia, post orthopaedic surgery and chronic lung disease) 
reported an average rate of adherence to physiotherapy prescribed exercise 
programmes across 12 studies of 67% (Peek et al., 2016). Sluijs et al (1993) used 
questionnaires to ask 1,206 physiotherapy service users who had various 
pathologies including neck & back pain, about their adherence over a one-week 
period with and reported that adherence could be as low as 30%.  
 
The demands of the exercise programmes may be higher in people with SpA as 
programmes are likely to be prescribed in the long term and with high 
frequency. Therefore, it is possible adherence may be lower due to these high 
demands. Two quantitative cross-sectional surveys have gathered data on the 
extent of exercise participation in AS. Passalent et al (2010), surveyed 61 people 
in Canada finding that 34.4% of participants self-reported exercising on a daily 
basis, 57.4% 3 times per week and 26.2% less than once a week. More recently 
Sang et al (2020), surveyed 259 people in China finding only 20.5% of the sample 
exercised 30 minute, 5 times per week.  Neither Chan et al, or Passalent et al, 
provided an exercise intervention and therefore it was not clear if people 
participating in the study had previously seen a HCP and asked to adhere to 
exercise of specific parameters. Although these surveys suggest a gap between 
general recommendations to exercise and participation in exercise, without 
including recommendations from a HCP this cannot be defined as adherence.  
Therefore, there is a gap in the knowledge of the level by which people with 
SpA, and axSpA adhere to exercise interventions. The level of adherence to 




The literature investigating the effectiveness of exercise programmes on disease 
outcomes in axSpA, calls for more monitoring of adherence within research and 
further study to gain understanding (Dagfinrud et al., 2011, Millner et al., 2016, 
Passalent et al., 2010). Further study into the level of adherence to the 
recommended exercise would be of benefit, to gain a greater understanding of 
the extent of adherence in people with SpA.  
 
2.13.2 Measurement of Adherence 
Adherence to exercise has been measured using self-reported home diaries, self-
reported questionnaires, clinician reported questionnaires, and objective 
measures, such as accelerometers (Bollen et al., 2014, Hall et al., 2015, McLean 
et al., 2017, Newman-Beinart et al., 2017). The approach chosen depends on 
what aspect of adherence is being measured. For example, adherence to 
physical activity guidelines may be measured using electronic devices, such as 
accelerometers and pedometers, giving a measure of steps taken and sedentary 
time. However, these approaches would not capture whether the individual 
undertook specific exercises and therefore would not be suitable to measure 
adherence to HEPs (Newman-Beinart et al., 2017). A further measurement 
approach is for the clinician to assess adherence through direct behavioural 
observations, such as attendance at exercise sessions, or clinician-reported 
questionnaires such as the Sports Injury Rehabilitation Adherence Scale (Kolt et 
al., 2007). This approach may be suitable for measuring adherence to 
attendance at supervised exercise sessions but is not suitable or appropriate to 
measure adherence in an unsupervised HEP (Bollen et al., 2014). 
 
Researchers recognise that accurately measuring adherence to HEP is 
difficult  (Bollen et al., 2014, Hall et al., 2015, McLean et al., 2017). Self-
reported adherence questionnaires such as the Adherence to Exercise Scale for 
Older Patients (Hardage et al., 2007), the Community Health Activities Model 
Program for Seniors (Stewart et al., 2001), the modified Rehabilitation 
Adherence questionnaire (Shin et al., 2010) and the Rehabilitation over 
Adherence Questionnaire (Podlog et al., 2013) have been used. However, 
McLean et al (2017) found no evidence of content or face validity, precision and 
score interpretation for any of the above questionnaires. Therefore, adherence 
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to HEP is most commonly measured using a self-reported diary method, although 
there is currently no standardised diary used across research studies (Newman-
Beinart et al., 2017). Self-reported HEP diaries are far from ideal as they can be 
influenced by participants’ attitudes and beliefs, poor recall, and participants 
providing a perceived desired response rather than an accurate one (Bollen et 
al., 2014, Newman-Beinart et al., 2017).  
 
The issues of measuring adherence are recognised and acknowledged by the 
WHO (2003), who advised using the best measurement strategy to obtain an 
approximation of adherence appropriate for the specific setting. Researchers 
should also consider the convenience and acceptability of the method for the 
user (Vitolins et al., 2000).  
 
There is no gold standard for defining ‘good’ versus ‘satisfactory’ versus ‘poor’ 
adherence across health behaviours (Vitolins et al., 2000). Some exercise studies 
have defined good adherence as having completed or performed 50% (Wing et 
al., 1996) or 75% of all planned sessions (van Het Reve et al., 2014). Other 
studies have considered full adherence as 100% and partial adherence as 
approximately 67% (Jansons et al., 2016). 
 
2.13.3 World Health Organisation Five Interacting Dimensions 
Affecting Adherence 
Whether a person adheres or not to the recommendations from their HCP can 
depend on a number of factors. The WHO proposes that when studying 
adherence, a multidimensional approach should be undertaken where adherence 
is determined by the interplay of factors relating to five constructs; 
socioeconomic, healthcare, condition, treatment and patient related (Sabete et 
al., 2003). The WHO (2003) approach can be used to study factors within these 
dimensions to any regime for example taking medicine appropriately, obtaining 
immunisations and executing behavioural modifications that address personal 
hygiene, self-management, smoking, unhealthy diet and insufficient levels of 




Figure 2-6. The World Health Organization Five dimensions of Adherence, Sabete et al (2003) 
 
The factors which influence adherence to exercise programmes have been 
studied in other patient populations (Jack et al., 2010, Jordan et al., 2010, 
Beinart et al 2013, Picorelli et al., 2014, Kampshoff et al., 2014, Ezzat et al., 
2015, Peek et al., 2016, Nicolson et al 2017, Room et al 2017, Essery et al., 
2017).  
 
Six systematic reviews have investigated treatment-related factors related to 
exercise adherence (Jordan et al., 2010; Beinart et al 2013; Ezzat et al., 2015; 
Peek et al., 2016; Nicolson et al 2017; Room et al 2017). A Cochrane review in 
adults with chronic musculoskeletal pain reported interventions with supervised 
exercise components, individualised exercise programmes and self-management 
programmes had a positive effect on adherence to exercise (Jordan et al., 
2006). Peek et al (2016) found in a mixed population of adults (musculoskeletal 
conditions urinary incontinence, haemophilia, post orthopaedic surgery and 
chronic lung disease) that interventions which used activity monitoring and 
feedback, written instructions and booster sessions may be effective in 



















an arthritis population that patient education supported adherence.  Nicolson et 
al (2017) concluded that booster sessions could improve exercise adherence for 
those with osteoarthritis, and motivational approaches improved adherence for 
those with chronic low back pain. Beinart et al (2013), reviewed adherence to 
home based exercises in a chronic low back pain population, finding adherence 
was supported using motivational strategies and supervision. Room et al, (2017) 
reviewed effectiveness of interventions to improve adherence in older people 
finding that interventions which included feedback and monitoring techniques 
supported adherence but there was insufficient evidence to recommend their 
use. No participants with SpA were included within any of these reviews.  
Four systematic reviews investigated other factors such as patient-
related/socioeconomic and adherence to exercise (Jack et al., 2010, Picorelli et 
al., 2014, Essery et al., 2017, Kampshoff et al., 2014). Jack et al (2010) 
reviewed barriers to exercise adherence in a musculoskeletal population. There 
was evidence that poor treatment adherence was associated with low levels of 
physical activity at baseline or in previous weeks, low in-treatment adherence 
with exercise, low self-efficacy, depression, anxiety, helplessness, poor social 
support/activity, greater perceived number of barriers to exercise and increased 
pain levels during exercise. Picorelli et al (2014), reviewed older adults’ 
adherence to exercise programmes and found a number of factors were found to 
be associated with greater adherence rates. These included higher 
socioeconomic status, living alone, fewer health conditions, better self-rated 
health, taking fewer medications, better physical abilities, better cognitive 
ability, and fewer depressive symptoms.  Essery et al (2017) reviewed adults’ 
adherence to self-managed home based physical therapy and found evidence 
that intention to engage, self-motivation, self-efficacy, previous adherence to 
exercise-related behaviours and social support increased adherence. Kampshoff 
et al (2014) reviewed exercise adherence in people who previously had cancer 
and found that exercise adherence was supported when a person had previously 
exercised.  
There was no evidence of which health-care related factors affect adherence to 
physiotherapy exercise literature as noted by Jack et al 2010, and subsequently 
by Babatunde et al 2017. 
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An understanding of the factors in relation to these five WHO dimensions which 
influence adherence to prescribed exercise in SpA is important so that 
physiotherapists can assess who is most likely to benefit, explore with the 
individual how to change any modifiable factors and consider optimal 
interventions to improve adherence. The factors which influence adherence to 
exercise in SpA have not been reviewed, so there is no data about the condition-
related factors, while data for the other WHO domains is only available from 
other conditions. The characteristics of SpA and demographics of people with 
axSpA differ from other conditions and thus, while some factors which influence 
exercise adherence may be the same, it is likely that some of the factors will be 
different; this is currently unknown.   
 
2.14 Gaps in the Literature 
SpA is a group of common inflammatory arthritis conditions with no known cure 
(Rudwaleit et al., 2009). The evidence indicates that exercise improves clinical 
outcomes in axSpA. As part of their management, people with SpA, and axSpA in 
particular, are advised to perform lifelong regular exercise over the course of 
their condition, which commonly starts in their early 20s, making it difficult to 
adhere to this component of their management. It is therefore likely that the 
level of adherence with exercise will impact on clinical outcomes in axSpA. The 
main gaps in the literature when the work within this thesis started were: 
1. There was no systematic review of the level of adherence and factors 
affecting this adherence in people with SpA.  
2. Limited evidence existed in terms of measuring adherence to novel 
interventions such as online delivered physiotherapy for axSpA. 
3. There was no data on the views of physiotherapists who prescribe 
exercise programmes for people with SpA, regarding factors which 
influence adherence, strategies used to improve adherence and the 
barriers to implementing these strategies. 
2.15 Aim of the thesis 
The overall aim of this research was to investigate the level of, and factors 
affecting adherence to prescribed exercise programmes in people with SpA. This 
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was addressed by systematically evaluating the current literature to explore 
adherence to prescribed exercise programmes. Secondly, by conducting a cohort 
study measuring adherence to a 12-month five times per week web-based 
physiotherapy programme. And finally through a survey of physiotherapists 
delivering prescribed exercise programmes, investigating the perceived factors 
affecting adherence, the interventions and strategies to support adherence and 





























3 Chapter: Systematic Review  
This chapter presents the first study in the thesis, a systematic review of the 
level of adherence to prescribed physiotherapy programmes in people with SpA 
and investigated factors affecting this adherence. This study was published in 
Rheumatology International in January 2019 (McDonald et al., 2019). The 
published paper had five authors, Marie Therese McDonald (MTM), Stefan Siebert 
(SS), Elaine Coulter (EC), David McDonald (DM) and Lorna Paul (LP). LP and SS 
are the PhD students’ (MTM) supervisors. All authors contributed to the 
formation of the research question. MTM conducted the search, which was 
reviewed by DM. MTM extracted the data. EM, LP and MTM quality assessed the 
articles. MTM drafted the manuscript with all authors reviewing and commenting 
on the draft. This chapter also contains an update on the search summarising 
relevant papers published since the 2019 paper and a more detailed discussion 
on the findings of the review than the published article. 
 
3.1  Justification 
As described, SpA describes a group of inter-related but distinct inflammatory 
conditions  including AS, nr-axSpA, reA, enteropathic arthritis, PsA and 
historically uSpA (Dougados and Baeten, 2011, Reimold and Chandran, 2014).  
 
Exercise is essential in the management of SpA, and axSpA in particular, to 
maintain or improve mobility, strength, CV health, function, quality of life and 
to limit spinal deformity (Reimold and Chandran, 2014, Regel et al 2017) and is 
included in the ASAS-EULAR recommendations for the management of axSpA (van 
der Heijde et al 2017). It is recommended that people with axSpA should 
exercise frequently at every stage of their condition (Dagfinrud et al., 2011, 
Millner et al., 2016). Most of the literature evaluating exercise in SpA is in 
people with AS, the prototypic form of axSpA, and predates the ASAS 
classification criteria, so generalising to SpA as a whole should be done with 
caution (O’Dwyer, et al, 2014a, Landewé and van Tubergen, 2015). However, in 
order to capture the widest range of published literature on adherence to 
prescribed physiotherapy programmes, the search criteria for this systematic 




In order for any intervention like exercise to be successful, participants need to 
perform the required intervention. Adherence refers to the extent to which a 
person’s behaviour corresponds with the recommendations from a HCP (Sabete 
et al., 2003). The level of adherence to physiotherapy programmes in other 
conditions is reported to be as low as 30% (Sluijs., et al 1993, Peek et al., 2016). 
Survey data where no exercise interventions was provided, reports participation 
in exercise within an AS population may be as low as 20% (Passalent et al 2010, 
Sang et al 2020). 
 
Adherence to exercise programmes may be influenced by multiple inter-related 
factors (Sabaté et al., 2003). These factors have been studied in other patient 
populations including people with musculoskeletal complaints, OA, older people 
and people recovering from cancer (Jack et al., 2010, Jordan et al., 2010, 
Kampshoff et al., 2014, Picorelli et al., 2014, Ezzat et al., 2015, Peek et al., 
2016, Essery et al., 2017, Room 2017). However, the factors which influence 
adherence to exercise in SpA have not been reviewed.  
 
The aim of this systematic review was therefore to examine the rates of 
adherence to prescribed exercise and the factors reported to influence 
adherence in people with SpA conditions. The objectives of this review were to 
systematically review, appraise and synthesise quantitative literature in order to 
examine adherence levels and factors affecting adherence to prescribed exercise 
within studies. 
 
3.2  Methods 
3.2.1  Search Strategy 
The present systematic review follows the preferred reporting items for 
systematic reviews and meta-analyses (PRISMA) guidelines (Moher et al., 2009). 
A search was performed 1st of August 2018 by two reviewers MTM and DM using 
five databases: The Cochrane library, CINAHL (1982 to March 2018), EMBASE 
(1989 to March 2018), MEDLINE, and Web of Science Collections. The searches 
were saved on the database and updated on 1st of August 2020 by MTM alone. 
The search included specific keywords and combined Medical Search History 
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(MeSH) headings were exploded for greater depth (Table 3-1). Date of 

































Table 3-1. Keywords used for the literature search. 
 
1.  Enteropathic arthritis 
2.  Reactive arthritis 
3.  Seronegative spondyloarthritis 
4.  Ankylosing spondylitis 
5.  Axial Spondyloarthritis 
6.  Spondyloarthritis 
7.  Psoriatic arthritis 
8.  1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 
9.  Exercise 
10. Muscle Strength 
11. Flexibility exercise 
12. Physical therapy modalities 
13. Exercise therapy 
14. Physical activity 
15. Resistance training 
16. Physical fitness 
17. Sport 
18. Movement therapy 
19. Stretching 




24.   9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 
OR 20 OR 21 OR 22 OR 23 
25. Adherence OR patient adherence OR guideline adherence 
26. Concordance OR patient concordance OR guideline concordance 
27. Compliance OR patient compliance OR guideline compliance 
28.  25 OR 26 OR 27 





3.2.2 Inclusion/Exclusion criteria 
In order to assess the level of, and quantitative factors affecting adherence to 
prescribed exercise in adults with SpA, articles were included if they were 
quantitative papers with participants who were over 18 years old and had SpA or 
any of the specific SpA conditions, including AS, axSpA, ReA, PsA or enteropathic 
arthritis, or if the study had a mixed population where the data related to the 
SpA population could be extracted; they were published in English; the 
intervention involved a prescribed exercise or educational programme to 
increase exercise participation. Prior to the systematic review, a small scoping 
review by the PhD student (MTM) found little evidence of qualitative studies, 
therefore, due to insufficient literature to bring together in a review, qualitative 
studies were excluded from the search. 
 
There is no gold standard way of measuring adherence therefore any 
measurement of adherence to exercise, including self-report, was included. 
Articles were excluded if they were case studies, testimonies or editorial 
opinions in order to reduce an over estimation of the level of adherence and 
factors affecting adherence from single sources. Reviews, books or discussion 
papers, unpublished data, published theses and conference abstracts were also 
excluded as these were deemed lower level evidence (McAuley et al., 2000)  
 
3.2.3 Data Extraction and Synthesis  
For included studies the following data were extracted: study design, overall aim 
of the study, characteristics of participants, intervention details (duration and 
frequency of the exercise intervention), control group, measures of adherence, 
dropout rates, adherence data, other outcomes included in the studies, and 
overall conclusions of each study.  Where no % adherence rate to the 
intervention was provided, this was calculated by MTM where data were 
available to do so. Correlations of ≥ 0.3, ≥ 0.5, and ≥ 0.7 were considered small, 
moderate and large, respectively (Pett, 1997). Due to the heterogeneity of 
exercise interventions of the studies within the review, the data were 
synthesised using a descriptive narration (Higgins et al 2019). The descriptive 
narration synthesis grouped and compared the following; quality of studies, 
study design, characteristics of participants, characteristics of interventions, 
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measurement of adherence within the studies and level and factors affecting 
adherence; grouping together similar interventions where possible.  
 
3.2.4 Quality Assessment 
There is no one method for assessing methodological quality of articles within a 
systematic review. The quality of a study refers to measures of internal validity, 
external validity and statistical criteria, i.e whether calculations can be made 
and conclusions can be drawn (Higgins et al., 2019). There are several different 
quality assessment tools, however, there are no commonly used tools which 
allow different study designs, such as cohort studies and RCT studies, to be 
examined using one tool to give a single score. Therefore, a less commonly used 
quality assessment tool, consisting of 20 criteria, which has been developed and 
modified from previous tools and used within previous reviews proposed by 
Davie-Smith et al., (2017), was chosen (Table 3-2) (Scholten-Peeters et al., 
2003, Poorolajal el al., 2011, Davie-Smith et al., 2017). For this review, the 
quality criteria were based on representative study population, type of study, 
use of standard and validated outcome measures, appropriate statistical tests, 
control for confounding variables, consideration of non-response bias, and data 
presentation of relevant outcome measures. Davie-Smith et al (2017) also 
considered evidence of limitations, bringing the quality assessment in line with 
the Strengthening Reporting of Observational Studies in Epidemiology guidelines. 
The standard of information required to meet each criterion was set a-priori. 
The maximum quality assessment score is 38 points (100%), based on three sub-
categories: (1) the source population (11%), (2) study population characteristics 
(42%) and (3) methodological characteristics (47%). Each article was 
independently scored by two of three reviewers (LP, MTM, EC) and when 
agreement could not be met, the third assessor was consulted to ensure 









Table 3-2. Quality assessment criteria and scores used to rate the articles. 
Adapted from Davie-Smith et al., (2017).  
 
Category Criteria Scores 
(1) Source Population 
A Description of source population Not available (0) 
Ambiguous (1) 
Available (2) B Description of inclusion/ and or 
exclusion criteria 
(2) Study population characteristics 
C Age Not available (0) 




F Employment Status 
G Marital Status 
H Comorbidity 
I Economic Status 
J Data presentation of relevant O/M 
(3) Methodological characteristics 
K Representative population Not clear (0) 
Partially (1) 
Yes (2) 
L Study design/study type Not clear (0) 
Cross sectional design (1) 
Retrospective / mixed design (2) 
Prospective design (3)  
M Population selection Non randomised (0) 
Randomised / NA (1) 
N Instruments used Non validated (0) 
Partially validated (1) 
Validated (2) 
O Statistical methods for O/M Non appropriate (0) 
Partially appropriate (1) 
Appropriate (2) 
P Control for confounding variables Not considered (0) 
Partially considered (1) 
Fully considered (2) 
Q Response Rate vs. Drop outs <60%/not mentioned (0) 
60-80% (1) 
>80% (2)/ NA (2) 
R Characteristics of drop outs Not reported (0) 
Reported (1)/NA (1) 
S Relevant O/M Not well defined( 0) 
Well defined (1) 
T Limitations Not considered  (0) 
Partially considered (1) 





3.3.1 Outcome of the Search 
In August 2018 the literature search produced 813 articles, including 91 
duplicate articles which were removed (Figure 3-1). The titles and/or abstracts 
of articles were screened initially by two reviewers (MTM and DM) which resulted 
in a further 667 being excluded. The two reviewers (MTM and DM) then 
examined the full texts of the remaining 55 articles and a further 46 articles 
were excluded. Reasons for exclusion at each stage are provided in Figure 3-1. In 
August 2020 the search was updated and produced 189 further articles, including 
2 duplicate articles which were removed (Figure 3-2). The titles and/or abstract 
of articles were screened at this point by MTM which resulted in 184 being 
excluded. The full text of the three remaining articles were read by the MTM 
which resulted in a further 2 articles being removed. Reasons for exclusion at 
each stage are provided in Figure 3-2. This resulted in ten full text articles for 
review and assessment, nine from the august 2018 search and one from the 
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Figure 3-2. PRISMA flowchart of updated screening and inclusion process of included trials 
conducted in August 2020.  
 
 
3.3.2 Quality Assessment and Risk of Bias 
Quality assessment scores for the remaining ten papers ranged from 47% to 81%. 
The majority (n=7) of the included articles were rated as good quality, scoring 
greater than 60% (Hidding et al., 1993a, Hidding et al., 1993b, Hidding et al., 
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et al., 2013, Sveaas et al., 2020) (Table 3-3). Gross & Brandt (1981) had the 
lowest score (47%) due to a small convenience sample (n=18) and attribution bias 
with an average of only three participants attending the weekly intervention. 
Two studies scored 50% due to poor reporting of study population characteristics 
(Barlow & Barefoot 1996, Chimenti et al., 2014).   
 
Three studies ran consecutively using the same participants (Hidding et al., 
1993a, Hidding et al., 1993b, Hidding et al., 1994). This may have led to a 
repeated sample effect where a positive bias was created by the participants 
learning what was required in relation to the outcome measures. In the first 
study, participants (n=144) all received supervised exercise and a HEP for six 
weeks (Hidding et al., 1993a). For the second study, the participants were then 
randomised into two groups, an intervention group (n=68), who received 
supervised exercise and a HEP, and a control group, who received only a HEP 
(n=76) for nine months (Hidding et al., 1993b). In the third study, the 
intervention group from the second study (n=68) was divided further into two 
groups; one group undergoing group supervised exercise and a HEP while the 


















Table 3-3. Quality assessment of included articles, shown in descending order of overall quality score (based on the quality assessment tool proposed by Davie-Smith 
et al 2017) 
 
Study Source Population Study Population Characteristics Methodological Characteristics Quality Scores 
 A B Total % C D E F G H I J Total % K L M N O P Q R S T Total % Overall 
total 
% 
Hidding et al 
(1993a)  
2 2 4 100 2 2 2 1 2 0 2 2 13 81 2 3 1 1 2 1 2 0 1 1 14 78 31 81 
 
Svaas et al 
(2020) 
2 2 4 100 2 2 0 2 2 0 0 2 10 62 2 3 1 2 2 1 2 0 1 2 16 89 30 79 
Hidding et al 
(1993b)  
2 2 4 100 2 2 2 1 2 0 2 2 13 81 2 3 0 1 2 1 0 1 1 1 12 67 29 76 
Hidding et al 
(1994) 
2 2 4 100 2 2 2 1 2 0 2 2 13 81 2 3 1 1 2 0 2 0 1 0 12 67 29 76 
Niedermann 
et al (2013) 




2 2 4 100 2 2 0 0 0 0 0 2 6 37 2 3 1 2 2 0 1 0 1 2 14 78 26 68 
Sweeny et 
al (2002) 
2 1 3 75 2 2 0 0 0 0 0 2 6 37 2 3 1 2 2 0 1 0 1 2 14 78 23 61 
Chimenti et 
al (2014) 








1 0 1 25 2 2 0 0 2 0 0 1 7 44 2 3 0 0 2 0 2 1 0 0 10 56 18 47 
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3.3.3 Study Design & Characteristics 
The main findings of each of the ten included studies are presented in a 
summary table (Table 3-4). The majority of included studies were randomised 
control trials (RCTs) (n=6) (Niedermann et al., 2013, Hidding et al., 1993b, 
Hidding et al., 1994, Sweeney et al., 2002, Fernandez-de-Las-Penas et al., 2006, 
Sveaas et al., 2020), while the remaining trials were prospective cohort studies 
(n=2) (Hidding et al., 1993a, Chimenti et al., 2014,) and quasi-experimental 
studies (n=2) (Gross & Brandt 1981, Barlow & Barefoot 1996). Of the six RCTs; 
Svaeaas et al (2020) compared a combination of supervised and unsupervised 
high intensity exercise with usual care, Neidermann et al (2013) compared 
supervised Nordic walking and an unsupervised CV session with a discussion of 
mindfulness, Fernandez-de-las-Penas et al (2006) compared two different types 
of HEP for one year following a 12-week supervised exercise programme, Hidding 
et al (1993b) & (1994), compared supervised exercise plus a HEP with a HEP only 
and Sweeny et al (2002) compared a home based self-care programme, which 
consisted of an educational programme and a HEP, with no intervention. Of the 
two prospective cohort studies; Chimenti et al (2014) investigated a HEP only 
and Hidding et al (1993) supervised exercise and a HEP. The quasi-experimental 
studies compared self-management courses with no intervention (Gross & Brandt 
1981; Barlow & Barefoot 1996).  
 
3.3.4 Participant Characteristics 
A total of 690 individual participants (taking into account the three Hidding et al 
1993a, 1993b, 1994 used the same participants), of which 66% were male, with a 
mean age range of between 41-50 years were included across the ten studies.  
Eight trials included only participants with AS; 560 participants with a range of 
mean disease duration of between 4-28 years (Gross, Brandt 1981, Hidding et 
al., 1993a, Hidding et al., 1993b, Hidding et al., 1994,  Barlow & Barefoot 1996, 
Sweeney et al., 2002, Fernandez-de-Las-Penas et al., 2006, Niedermann et al., 
2013). One trial included 100 people with axSpA; with 70% of this axSpA 
population having AS (Sveaas et al 2020), and the remaining trial included 30% 
participants with PsA (Chimenti et al., 2014). Overall across all ten studies 
within this review AS participants made up 91% (630 participants), nr-axSpA 4.5% 
(30 participants) and PsA 4.5% (30 participants) of all participants (Gross, Brandt 
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1981, Hidding et al., 1993a, Hidding et al., 1993b, Hidding et al., 1994, Barlow & 
Barefoot 1996, Sweeney et al., 2002, Fernandez-de-Las-Penas et al., 2006, 
Niedermann et al., 2013, Chimenti et al., 2014, Sveaas et al 2020).  
 
3.3.5 Characteristics of Interventions 
Exercise duration ranged from six weeks (Hidding et al., 1993a) to 12 months 
(Fernandez-de-Las Penas et al., 2006) across the ten studies.  Frequency of 
exercise sessions varied from daily (Hidding et al., 1993a, Hidding et al., 1993b, 
Hidding et al. 1994) to once weekly (Fernandez-de-Las-Penas et al., 2006), with 
an individual session duration ranging from 30 minutes (Chimenti et al., 2014) to 
3 hours (Hidding et al., 1993b & Hidding et al., 1994). The exercise interventions 
included hydrotherapy, Nordic walking, supervised and unsupervised exercise 
programmes, aerobic and flexibility exercises (Gross, Brandt 1981, Barlow & 
Barefoot 1996, Hidding et al., 1993a, Hidding et al., 1993b, Hidding et al., 1994, 
Sweeney et al., 2002, Fernandez-de-Las-Penas et al., 2006, Niedermann, et al., 
2013, Chimenti et al., 2014, Sveaas et al., 2020). All but two studies Hidding et 
al., 1993b, Hidding et al., 1994,) used exercise interventions of varying length 
and frequency (Table 3-4). 
 
Educational programmes varied between two days to four weeks, with individual 
sessions ranging from 90 minutes (Gross & Brandt., 1981) to 12 hours (Barlow & 
Barefoot 1996).  
 
3.3.6 Measurement of Adherence 
Adherence to prescribed exercise was the primary outcome in three studies 
which all evaluated the effect of educational programmes that included advice 
on exercise (Gross & Brandt 1981, Barlow & Barefoot 1996, Sweeney et al., 
2002). The remaining studies recorded adherence as a measure of fidelity to the 
exercise intervention (Hidding et al., 1993a, Hidding et al., 1993b, Hidding et 
al., 1994, Fernandez-de-Las-Penas et al., 2006, Niedermann, et al., 2013, 
Chimenti et al., 2014, Sveaas et al., 2020). The main aim, included outcomes 




In three studies the supervised exercise component was recorded by attendance 
at the session (Hidding et al., 1993b, Hidding et al., 1994, Sveass et al., 2020). 
Seven studies measured adherence using patient-reported home exercise diaries 
with limited information provided about the diaries (Hidding et al., 1993a, 
Hidding et al., 1993b, Hidding et al., 1994, Sweeney et al., 2002, Niedermann et 
al., 2013, Chimenti et al., 2014, Sveaas et al., 2020). Four of these six reported 
the minutes of exercise per week, (Hidding et al., 1993a, Hidding et al., 1993b, 
Hidding et al., 1994, Sweeney et al., 2002). One study asked participants to tick 
a box to record that the prescribed exercises had been completed (Chimenti et 
al., 2014) and two studies provided no details of the home exercise diary 
(Niedermann et al., 2013, Sveaas et al., 2020). The three remaining studies 
measured adherence by asking participants to retrospectively record their 
adherence at different time periods; namely, whether they had completed their 
exercises the previous day (Gross & Brandt 1981), the frequency and volume of 
exercises in one week (Barlow & Barefoot 1996), and how often the exercises 
had been completed over the past year (Fernandez-de-Las-Penas et al., 2006). 
No study included the home exercise diary for closer evaluation. 
 
3.3.7 Level of, and factors affecting, adherence to Combined 
Supervised Exercise and HEP Interventions 
The summary adherence results for the studies are shown in Table 3-4. Five high 
quality studies combined supervised exercise and a HEP (Hidding et al., 1993a, 
Hidding et al., 1993b, Hidding et al., 1994, Niedermann et al., 2013, Sveaas et 
al., 2020). Sveaas et al (2020) reported adherence to a 3 times per week high 
intensity exercise programme over three months, finding 38 (76%) of participants 
followed more than 80% of prescribed sessions (≥29 of 36 sessions) while four 
participants (8%) discontinued after a few sessions. No data was provided for the 
remaining participants meaning a percentage adherence rate could not be 
calculated (Sveaas et al 2020). Nierdemann et al (2013) reported (calculated 
rate) 75% of sessions were completed of a three times per week intervention of 
which two sessions were supervised and one session was a HEP over 12 weeks 
(Niedermann et al. 2013). Hidding et al (1993a) combined a two weekly 
supervised session and daily HEP and reported 86% (calculated rate) to the daily 
30-minute HEP. No data was provided on adherence to the supervised sessions 
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(Hidding, et al. 1993a). In the follow-on studies, Hidding et al (1993b and 1994) 
reported mean adherence rates, reported as percentage of prescribed minutes 
of exercise, of 63% (calculated rate) and 51.4% (calculated rate) for the 
participants receiving a HEP over nine months with some of the participants 
receiving supervised exercise in addition to a HEP. Hidding et al (1993b) 
reported no difference between the groups but within Hidding et al (1994) the 
group with a supervised component spent significantly longer on their HEP (mean 
duration 1.9 versus 1.2 hours per week, p < 0.05). In addition to adherence rates 
for the HEP, Hidding et al (1993b) reported 74% and Hidding et al (1994) 
reported 62% of supervised sessions attended over nine-months.  
 
The three linked studies by Hidding et al demonstrated, from high quality 
evidence, that adherence to a HEP reduced over time, with 86% of prescribed 
minutes of exercise completed in the first six weeks (Hidding et al., 1993a), 
reducing to 63% over the following nine months (Hidding et al., 1993b), and 51% 
over the subsequent nine-month period (Hidding et al., 1994). Similarly, 
adherence to the once weekly supervised exercises reduced over time from 74% 
attendance at sessions in the first nine months to 62% in the second nine-month 
period studied (Hidding et al., 1993b; Hidding et al., 1994)  
 
3.3.8 Level of, and Factors Affecting, Adherence to Interventions 
of HEP only 
Two studies reported adherence to a HEP only. Fernandez-de-las-Penas et al 
(2006) reported 95% adherence (sessions completed, calculated rate) in 
participants with AS to a once weekly HEP for one year. Chimenti et al (2014), 
was considered poorer quality evidence and reported 100% adherence of 
completers with PsA to prescribed sessions and exercises during a 12 week, 
twice weekly HEP but reported that 23.3% of participants dropped out of the 
programme and so their overall calculated adherence for those starting the 
study was 76.7%. Chimenti et al (2014), also reported that adhering to a HEP in 
participants with PsA was not affected by age, gender, body mass index, blood 





3.3.9 Level of, and Factors Affecting Adherence to Exercise 
following an Educational Programme which includes Advice on 
Exercise 
The three remaining studies measured adherence to exercise, as primary 
outcome, following an educational programme which included advice on 
exercise or prescribed exercise but did not set the dose of exercise and 
therefore percentage adherence could not be calculated. Barlow and Barefoot 
(1996), reported an increase in the number of completed exercises (from 4.5 per 
week to 9 per week, p=0.004) and frequency (from 2.5 per week to 6 per week, 
p=0.002) of HEP three weeks after a 12-hour, two-day educational programme 
which included information on AS, exercises in the hydrotherapy pool, posture 
and exercise motivation sessions. The number and frequency of exercises 
significantly decreased at six months (9 per week -7 per week, p=0.04 and 6 per 
week to 1.5 per week, p=0.007 respectively). The authors also reported a 
moderate but statistically significant correlation of higher disease severity (as 
assessed by an earlier form of the BASDAI) with higher adherence to the number 
of exercises (r=0.35, p=<0.001) and weak but statistically significant correlation 
higher disease severity with frequency of therapeutic exercises (r=0.28, p<0.05), 
and longer diagnostic delay with adherence to a greater number (r=0.28, p<0.05) 
and frequency of home exercise activities (r=0.27, p<0.05).  
 
Gross & Brant (1981) reported no significant increase in exercise participation 
following a four week, once weekly, 90-minute educational session. However, 
they reported that four people improved their ‘compliance’ with exercise 
programmes, while compliance remained the same in five and one person had 
reduced compliance. Of note, the studies by both Gross & Brant (1981) and 
Barefoot & Barlow (1996) were considered poorer quality evidence. 
 
Sweeny et al (2002) found that participants who received an educational video 
with an exercise regime, a booklet and wall chart to encourage adherence to 
regular exercise did significantly more ‘AS exercise’ (p<0.05)  (55 mins/week  
before the intervention and 99 mins/week following the intervention,) and 
aerobic exercise  (67 mins/week before the intervention and 85 mins/week 
following the intervention p<0.001 than a control group which received no 
intervention (AS specific exercise increased by 5 minutes from 50 mins to 55 
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mins over the six month study duration and aerobic exercise reduced from 72 
mins to 55mins).  
 
3.3.10 Frequency of Exercise 
There was no clear relationship in the studies between the frequency of the 
exercise and adherence with 95% adherence reported for a once weekly 
intervention (Fernandez-de-las-Penas et al, 2006), 77% reported for twice 
weekly (Chimenti et al., 2014), 75% reported for three times per week 
(Niedermann et al., 2013) and 86% (Hidding et al., 1993a), 63% (Hidding et al., 
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n=7 (n=7 male) 
Mean age 49 
mean disease 
duration 19yrs 
n=0 yes Two groups; 
 
Intervention Group: 90-
minute educational support 
group which encouraged 
exercise. No details of the 
exercise programme given. 1 
x weekly for 4 weeks 
 
Control: no intervention 
Self-reported 
questionnaire at week 0 
and week 4 previous 
day recall of how often 
exercise. 
Adherence reported as 
the number of people who 
had changed adherence to 
exercise:  
Group 1 (no of people) 
Attendance at 
educational support 
group: mean 3 sessions 
Improved n=4/11,  
unchanged n=5/11, 
deteriorated n=1/11 
no data n=1/11 




no data n=2/7 
 












144 AS patients 
(n=31 F, n=113 
M) 
 
mean age 43 yrs 
 
median disease 
duration 4 years 
 
n=0 No One group: 
 
Individualised supervised 
exercise sessions: 30mins 2 
x per week for 6 weeks and 
daily 30 mins HEP 
Self-reported home 
exercise diary over 6 
weeks 
Average reported to HEP 
only: 3 hours on HEP *86% 
(adherence calculated by 
180 actual mins/210 
possible mins x 100 =86%) 
 
None reported 
Hidding et al 
1993b RCT  
N=144, AS 
patients’ 
Total N=9  No All participants:  Daily 30 
minute HEP 
Exercise class register 
of attendance for 




 continuation of 
Hidding 1993a 
Group 1: (group 
PT) n=68 (n=18F, 
n=50M) 




Group 2: (no 
group PT) 
n=76 (n=13F, n= 
63 M) 













Group 1: group 
physiotherapy 1 x week, 
3hours (1hour physical 
training, 1-hour sporting 
activities and 1-hour 
hydrotherapy) for 9 months 
 
Group 2: no group 
physiotherapy  
Group 1 for group 
exercise 
Self-reported home 
exercise diaries for 
both groups over 9 
months 
Average class attendance 
was 73.5% over 9 months 
 
During 9 months both 
group 1 & 2 spent 2.2 
hours (median 1.9 
reported with mean of 2.2 
reported in Hiding 1994)  
on HEP *63% adherence 
(calculated by 132 actual 




between groups.  






(follow up of 
group 1 of the 
Hidding 1993b 




Group 1: (group 
PT) 
n=30 (n=7 F & 23 
M) 





(no group PT) 
n=34 (n=10 F, n= 
24 M) 
mean age 44.3 
Total n=8  
Group 1 n=4 
Group 2 n=4 
No 
 
All participants HEP daily for 
30mins and assigned to two 
groups: 
 
Group 1: supervised group 
physiotherapy 1 X week, 3 
hours (1-hour physical 
training, 1hour sport and 1-
hour hydrotherapy) for 
9months 
 
Group 2: no group 
physiotherapy for 9 months 
Exercise class register 
for attendance of 
supervised group 
physiotherapy for Group 
1. 
 
Both Group 1 & 2 
adherence to HEP 
measured with self-
reported exercise diary 
over 9 months. 
 
Group 1: 
Mean 62% attendance at 
supervised group 
physiotherapy over 9 
months 
 
Both Groups: average 1.8 
hour of HEP per week 
*51.4% adherence to daily 
HEP over 9 months. 
(calculated by 30mins x 
7=210 possible minutes of 
exercise per week, 1.8 
hours = 108 actual 
minutes of exercise, 




duration of 1.9 
hours for supervised 
group and 1.2 hour 
per week for HEP 
group with 
supervised exercise 
versus group with 
































control n= 0 
yes 2 groups: 




Given a guidebook with 
exercise but no information 
on dose. 




the range in number of 
individual home 
exercise, and frequency 
of exercise sessions per 
week in the past week.  
At baseline, 3 weeks 
and 6 months 
Group 1:  
Median 
exercise frequency  
Baseline: 2.5x/week 
3 weeks: 6x/week 





3 Weeks: 9x/week 
6 Months: 7x/week 
 
Group 2:  
Exercise Frequency  
Baseline: 3x/week  
No 3 week data 





6 months 5.5x/week 
 
Rise in range home 
exercise activity: 
baseline- 3 weeks post 
intervention group 
(p=0.004) and increase in 
frequency of home 
exercise sessions 
(p=0.0023)   
 
Change in exercise range 
and frequency 3 weeks 
post intervention (p=0.04) 
Disease severity (an 
early form of 
BASDAI) positively 
associated with 
exercise range and 
frequency of 
exercise (r=0.35, 






of a great range 
(r=0.28, P<0.05) 







adherence in short 






6 months: decreased 
significance (p=0.007) 
 




























n= 25  
 
yes Two Groups 
 
Intervention: exercise video, 
exercise booklet, exercise 
progress wall chart and 
stickers. 
 




of exercise (AS specific 
exercise & aerobic 
exercise) at baseline 
and six months. 
Intervention 1: 
Baseline:  
55 mins per week AS 
exercise,  
67 mins per week aerobic 
exercise 
 
6 months:  
99 mins per week AS 
exercise, 





50 mins per week for AS 
exercise, 
72 mins per week for 
aerobic exercise 
 
6 months:  
55 mins per week each for 





group differences at 
6 months for 
aerobic (p≤ 0.001) 
and AS  p≤ 0.05) 












Group 1 n=20 (5 
F, 15 M) 






(n=4 F, n=16 M) 
Mean age 46 
n=0 No Two Groups: 
 
Group 1 
15 x 1 hour sessions of 
conventional supervised 
exercise over 4 months 
 
Group 2 
 15 x1 hour sessions of global 
posture re-education 
supervised over 4 months. 
 
Adherence measured 
for all participants 
exercising 
independently 
unsupervised for 1 year.  
Verbally asked 
participants at the end 
of the year follow up. 
80% of participants (n=32) 
had done every week for 
the year. 
20% of participants (n=8) 
did a mean of 3.25 
sessions per month. 
*95% adherence  
(total possible number of 
sessions for all 
participants over the 
year=2,080, 
32 people did each week 
for a year= 1,664 sessions. 







Both groups asked to 
continue regime individually 
unsupervised once per week 
for 1 year. 
8 people did 3.25 per 
month = over the year 
=312 sessions 
(312 +1664)/ 2080 x 100= 
95% adherence) 
 







n=53 (n=19 F, 
n=34 M) 
Mean age 50.1 
Mean disease 










Total n=7  
Group 1 n=4  





Group 1: 12 weeks, 30 
minute CV Supervised Nordic 
walking &, flexibility class, 
and one unsupervised CV 
activity such as Nordic 
walking or biking, 1 hour 
flexibility class 
 
Group 2:  Monthly (3 in total) 
X 2.5 hour psychology led 
discussion on mindfulness 
and 1 hour flexibility class 
Self-reported exercise 
diary over 12 week 
programme. 




n=40 did mean of 3 CV 
training per week 
n=8 did not perform at 
least 1 CV per week. 
 
*75% adherence rate 
(total available sessions 
12 X 3 X 53 = 1908 
completed sessions 40 x 
12 x 3 =1440 
1440/1908 x100 =75%) 
no factors reported 











mean age 50.8 
 
Total n=7  Yes One Group: 
HEP for 40 mins twice per 
week for 12 weeks. 
Patient reported 
exercise diaries over 
12-week programme. 
Frequency of individual 
exercise completed. 
23 participants completed 
100% of the programme 
7 participants who 
dropped out taken at 0% 
adherence. 
Overall adherence 76.6% 
Adherence to HEP 
not affected by 
age, gender, body 
mass index, blood 





Key: AS: Ankylosing Spondylitis, axSpA: Axial Spondyloarthritis, BASDAI: Bath Ankylosing Spondylitis Disease Activity Index, CV: Cardiovascular, F: female, HEP: Home Exercise 
















n=25 male, n=38 
with AS and n=12 
with nr-axSpA) 






n=50 (n=22 male, 
n=28 female, 
n=32 AS, n=18 
nraxSpA) 
Mean age 47.2 
Disease duration 
not reported 





no 12 weeks: 
Intervention Group: 3 X per 
week; 2 x weekly supervised 
high intensity 
cardiorespiratory & strength 




Control: standard care and 
instructed to maintain 






completed sessions and 
as self-reported 
exercise diary over 12 
weeks. 
Intervention Group: 
38 (76%) of participants 
followed more than 80% 
of the prescribed exercise 
protocol (more than 29 of 
36 sessions) 
 
4 (8%) of participants 
discontinued. 
 
No details given for the 
rest of the participants. 
 
Adherence rate not 
possible.  
No factors reported 
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Table 3-5. The overall aims, outcomes and conclusions of the studies included in the review. 
 
Author, date Overall aim of study All outcomes and time points Study conclusions 




To evaluate if a support group helps people cope 
with their disease and increases their knowledge 
and compliance with treatment 
Questionnaire on coping with AS, family 
relationships and knowledge of their condition, 
compliance (adherence). 0, 4 weeks 
Improvements in knowledge of disease. 
Compliance with prescribed exercise 
programmes improved but not significantly 
Hidding et al 
1993a, Cohort 
 
To study the relationship between disease 
duration and the effects of physical therapy 
Outcomes: Spinal mobility, physical fitness, 
function and pain. 0-6 weeks 
Short-term supervised individual therapy is 
effective in AS, improving mobility, fitness and 
function irrespective of disease duration 
Hidding et al 
1993b RCT  
 
To study the effects of adding supervised group 
physical therapy to unsupervised individual 
therapy in AS 
Outcomes: Spinal mobility, physical fitness, 
function, self-reported global health. 0,3,6,9 
months 
Group physiotherapy was superior to HEP in 
improving spinal mobility, fitness and self-
reported global health 




To evaluate if beneficial effects with supervised 
group physiotherapy continue when supervised 
group exercise is stopped 
Outcomes: Spinal mobility, physical fitness, 
function, self-reported global health. 0,3,6,9 
months 
Global health and function are sustained or 






To examine the effect of group education on 
self-efficacy, psychological well-being and 
performance of home exercise 
Outcomes: Self-efficacy, psychological well-
being, home exercise activities performed 
(adherence) 
Group patient education course improved self-
efficacy, psychological well-being at 6 months. 
Improvement in adherence to home exercises 
but not maintained at 6 months 




To evaluate the effect of a home based self-care 
package. 
Outcomes: function, disease activity, well-
being, self-efficacy. 0, 6 months 
An exercise intervention package to promote 
self-management significantly increases self-
reported levels of exercise, self-efficacy for 






To evaluate the long-term effect of two exercise 
interventions on function and mobility in AS 
Outcomes: Spinal Mobility, function, disease 
activity. 0, 4 months, 1 year 
Global posture re-education offers short and 
long term promising results in management of 
AS 




To evaluate moderate intensity CV training & 
flexibility programme on fitness and perceived 
disease activity in AS 
Outcomes: Disease activity, function, spinal 
mobility, global health, physical activity, 
anxiety and depression 
CV training and flexibility exercises increased 
fitness and reduced disease activity 
61 
 




To evaluate the effect of an exercise 
programme on disease activity and quality of 
life in people with PsA (no information if axial or 
peripheral symptoms) 
Outcomes: Disease activity, quality of life, 
physical activity, adherence 
Self-reported health outcomes improved in 
those who completed the study 
Sveaas et al 2020 
RCT 
 
To investigate the effectiveness of high intensity 
exercises on disease activity in patients with 
axSpA 
Outcomes: Disease activity, function, physical 
fitness, inflammation levels, muscle mass and 
body weight. 0, 3 months 
High intensity exercise reduced disease activity, 
inflammation and improved function and 
physical fitness 
 
Key: AS: Ankylosing Spondylitis, axSpA: Axial Spondyloarthritis,  CV: cardiovascular, F: female, HEP: home exercise programme, M: male, Mins: minutes, PsA: Psoriatic 




This is the first systematic review to explore the level of, and the factors 
affecting, adherence to prescribed exercise in people with SpA. Ten papers were 
identified that addressed adherence to prescribed exercise in SpA, of which 
eight studies included participants with AS, one study with axSpA participants 
where the majority of participants included had AS, and a single small study of 
participants with PsA. Adherence was not the primary outcome in the majority 
of studies. Adherence rates were reported, or able to be calculated, in six of the 
ten papers, finding percentage adherence rates to prescribed exercise 
interventions programmes ranging from 51 – 95% (Hidding et al., 1993a, Hidding 
et al., 1993b, Hidding et al., 1994, Fernandez-de-Las-Penas et al., 2006, 
Niedermann et al., 2013, Chimenti et al., 2014). The exercise interventions 
differed in terms of frequency, type, intensity, length and in the measurement 
of adherence. Therefore, any direct comparison should be interpreted with 
caution. While the majority of these studies did not report factors affecting 
adherence rates, inclusion of education programmes and supervision, disease 
severity and delays in diagnosis were identified in single studies, as affecting 
adherence there was no consensus across studies (Hidding et al., 1993a, Hidding 
et al., 1993b, Hidding et al., 1994, Niedermann et al., 2013, Chimenti et al., 
2014). There was general agreement however that adherence to prescribed 
exercise appeared declined over time.  
 
3.4.1 Level and Measurement of Adherence 
Adherence was poorly reported within the studies. The level of adherence 
reported in the studies varied from 51-95% in six papers (Hidding et al., 1993a, 
Hidding et al., 1993b, Hidding et al., 1994, Fernandez-de-Las-Penas et al., 2006, 
Niedermann et al., 2013, Chimenti et al., 2014). Three studies did not provide 
parameters for the exercise prescription therefore adherence could not be 
calculated (Gross & Brandt 1981, Barlow & Barefoot 1996, Sweeny et al., 2002).  
One study did not provide information on adherence for all participants (Svaas et 
al., 2020). No study provided full details of the adherence to each parameter of 
the prescribed exercise programme, instead reporting one aspect of adherence 
such as the number of sessions completed or the minutes of exercises 
completed. Better reporting of adherence within research studies investigating 
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physiotherapy prescribed exercise interventions studies would aid fuller 
understanding of the level of adherence to these programmes.  
 
Evaluating and improving adherence is limited by the absence of a gold standard 
measure of adherence to prescribed exercise programmes. Self-reported HEP 
diaries, used by six of the studies within this review, may be influenced by 
participants’ attitudes and beliefs, poor recall, and giving a perceived desired 
response rather than an accurate one (Stone et al., 2003, Prince et al., 2008, 
Bollen et al., 2014). The highest rate of adherence within the included studies 
was 95% for a once weekly HEP (Fernandez-de-Las-Penas et al., 2006).  Poor 
recall potentially influenced this rate as participants were asked about 
adherence after one year.  Class attendance registers, used in all supervised 
components within this review do not take into consideration adherence to the 
actual exercises within the attended exercise session (Hidding, et al., 1993b, 
Hidding et al., 1994,). Developing a standardised measure of adherence which 
addresses the limitations of self-reported measures and fully measures 
adherence such as minutes/sessions/intensity to prescribed components, would 
improve the ability to meaningfully assess adherence rates and make 
comparisons across studies.  
 
Two cross sectional surveys have gathered data on the extent of exercise 
participation in AS. Passalent et al (2010), surveyed 61 people with AS in Canada 
finding; 34.4% of the sample reported exercising on a daily basis, 26.2% 
exercised less than once a week, and 57.4% of patients reported engaging in at 
least 1 form of exercise 3 times per week. More recently Sang et al (2020), 
surveyed 259 people with AS in China finding only 20.5% of the sample exercised 
5 times per week for 30 minutes of exercise. It is unclear if participants within 
the study had been prescribed an intervention by a HCP at any point, and 
therefore were adhering to the recommendations of the HCP. The rates found in 
this review were mostly higher than those found by Passalent et al (2010), and 
Sang et al (2020). This might reflect adherence to the interventions (of lower 
frequency) and not general participation in exercise, however it should be noted 
that people who volunteer for research studies may be more motivated or 
interested. Therefore, adherence rates in research studies may be higher than 
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adherence rates within routine clinical practise. Measuring adherence rates as 
part of research studies limits generalisability. 
 
Due to the small sample within this review, and the poor quality of three of the 
studies (Gross & Brandt 1981, Barlow & Barefoot, 1996, Chimenti et al., 2014), it 
remains unclear as to the extent of adherence to prescribed exercise in people 
with SpA. However, no study within this review reported full adherence to a 
prescribed exercise programme. Therefore, HCPs should be aware that SpA 
patients, with the majority of evidence for people with AS, are unlikely to fully 
adhere to an exercise programme, impacting the effectiveness of the 
intervention. 
 
Future research should consider what level of adherence or dose of exercise is 
necessary for prescribed exercise in axSpA to be effective in terms of beneficial 
outcomes; for example, is there a minimum amount of exercise required to 
achieve outcomes? Is there a level of exercise beyond which additional gains are 
minimal or is it a linear relationship? Understanding this would enable more 
targeted focus on adherence to ensure the required levels of exercise are 
achieved.  
 
3.4.2 Factors Affecting Adherence 
As discussed in the previous chapter (Section 2.13.3), the WHO proposes that 
when studying adherence, a multidimensional approach should be undertaken 
where adherence is determined by the interplay of factors relating to five 
constructs; socioeconomic, healthcare, condition, treatment and patient related 
(Sabete et al., 2003). Adherence to prescribed exercise was the primary 
outcome in only three studies, therefore the majority of studies did not report 
on factors that influenced adherence rates. The review found two disease 
characteristics influenced adherence; severity of AS disease and delay in 
diagnosis. However, this was reported in only one study, with limitations and 
assessed as poorer quality, and the correlations were moderate to weak and thus 
this should be interpreted with caution (Barlow & Barefoot, 1996). A review and 
meta-analysis including 27 studies across a broad number of conditions and 
treatment regimens including medication, exercise and diet similarly found that 
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greater disease severity was reported to be associated with better adherence 
(DiMatteo et al., 2007). Prescribed exercises have the potential to reduce 
disability and/or improve function, and may increase motivation for people with 
higher disease severity, however on the other hand symptoms for people with 
high disease severity has the potential to reduce adherence. This issue needs 
further investigation. Longer diagnostic delays may increase adherence to 
adhere to recommended exercise interventions but again more information is 
required to explore why this might be the case.  
 
Patient-related factors are another domain of the WHO approach to studying 
adherence. One small study, with limitations, and assessed as poor quality, 
within this review found completing a HEP was not affected by age, gender, 
body mass index, blood pressure or heart rate (Chimenti et al., 2014). It is 
probable that other patient-related and condition characteristics influence 
adherence, for example those discussed in chapter 2 that have been found in 
other conditions in SpA (section 2.13.3) but no further information was found 
within this review.  
 
Treatment factors can also affect adherence (Sabete et al., 2003). This review 
found limited evidence that interventions which include supervised components 
and educational programmes increase adherence to exercise in SpA. Two of the 
three studies within this review, which included an educational component, 
found an increase in adherence following an educational programme 
incorporating exercise prescription (Barlow & Barefoot 1996, Sweeney et al., 
2002). The third found only a trend towards improvement, although poor 
participant attendance at the educational programme could account for this 
result (Gross & Brandt 1981). The three studies were rated poorer quality from 
the appraisal, which further reduces the conclusions that can be drawn from 
these studies. However, a review investigating adherence to medicine in chronic 
conditions similarly found support groups, which included educational support, 
increase adherence (Ganguli et al., 2016). Two linked studies within this review 
compared a combined a supervised component and HEP with HEP alone (Hidding 
et al., 1993b, Hidding et al., 1994), with the latter reporting that participants 
who were supervised for part of their programme spent significantly longer 
performing HEP. The magnitude of the influence of supervision and educational 
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programmes on adherence is unknown, but it is probable that they have some 
effect.  A Cochrane review found supervised programmes in people with chronic 
musculoskeletal pain reported better adherence to exercise programmes than 
unsupervised exercise (Jordan et al., 2006). A Cochrane review of physiotherapy 
interventions for people with AS has shown that supervised programmes improve 
spinal mobility and overall wellbeing more than individualised HEPs (Dagfinrud et 
al., 2008).  As these exercise programmes are otherwise similar, it is possible 
that improved adherence may in part account for this, although regular contact 
with the physiotherapist and possibly the group if the supervision is in a group 
setting, in the supervised programmes may also have additional benefits beyond 
the exercise intervention itself.  
 
There are likely more treatment factors which could facilitate adherence, but no 
more information was found within this systematic review. Designing 
interventions which are underpinned by behavioural change theory such as social 
cognitive theory, or which incorporate behavioural change techniques may have 
the potential to improve adherence (Jansons et al., 2017).  Self-efficacy refers 
to the magnitude of a person’s belief in their ability to undertake a task and 
achieve a desired goal (Room et al., 2017). Improving health knowledge and self-
efficacy are integral to initiating and maintaining behaviour change within social 
cognitive theory (DiMatteo et al., 2007).   
 
Intervention types within this review included hydrotherapy, nordic walking, 
aerobic and flexibility exercises. It was not possible to draw any conclusions in 
terms of the superiority of any particular type of exercise at improving 
adherence as there were no studies which compared exercise interventions on 
adherence rates. In addition, within the limited information found in this review 
there was no clear relationship between the frequency of the session and 
adherence.  Therefore, it could not be concluded whether the type of exercise 
prescribed or the frequency of the session affected adherence. Enjoyment and 
perceived benefit of types of exercise have been shown to be facilitators to 
regular exercise in middle aged women (McArthur et al., 2014). An individualised 
approach could be considered where the physiotherapist and person with SpA 
reflect on how often an individual realistically thinks they can carry out their 
prescribed exercises, which type of exercise they would prefer and prescribes 
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exercise on this basis (Taube, 2016). Furthermore, interventions which include 
agreed goals and explores barriers to change could help improve adherence on 
an individual basis and have been shown to improve adherence in other health 
conditions (Farrance et al., 2016, Hill et al., 2011). There was health-care 
related factors affecting adherence found within this review. 
 
3.4.3 Adherence over Time 
As axSpA is a lifelong condition, long term adherence to exercise is a crucial part 
of management. This review found adherence to exercise in axSpA generally 
declined over time following an educational programme, from one poor quality 
study (Barlow & Barefoot 1996), and declined following an exercise programme 
in three high quality studies (Hidding et al., 1993a, Hidding et al., 1993b, 
Hidding et al., 1994).  This concurs with the wider field of adherence literature 
(Pisters et al., 2010, Spink et al., 2011, Jansons et al., 2017). Continued 
adherence has been shown to depend on the ability to accommodate exercises 
within everyday life and the perception that exercise is effective in improving 
unpleasant symptoms (Campbell et al., 2001). Self-regulation is the ability to 
monitor and regulate behaviour, such as exercise. Self-regulatory skills could be 
improved through the use of goal setting, self-monitoring, self-reinforcement, 
stimulus control, and cognitive restructuring strategies which may help to 
maintain adherence to prescribed exercise over time. Previous systematic 
reviews in other conditions have found these strategies to be effective in 
maintaining adherence (Room et al., 2017, Jordan et al., 2006) but have not 
been investigated in SpA. 
 
3.4.4 Limitations 
This review has a number of limitations. Firstly, only papers available in English 
were included as there were no resources for translation. This potential 
publication bias may influence the generalisability of the review. It was also 
limited by the heterogeneity of the study designs included. As mentioned 
previously, adherence was not the primary outcome in the majority of studies, 
while interventions and measures of adherence varied. Due to the variety of 
outcome measures used, it was not possible to conduct a meta-analysis. Three 
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studies within this review used the same participants; this may have led to a 
repeated sampling bias effect. 
 
Only 4.5% of patients within this review were diagnosed with PsA & nr-axSpA 
with the 91% of participants diagnosed with AS.  No studies examined adherence 
to exercise programmes in people with the other specific SpA conditions or SpA 
in general. While nr-SpA is considered to be on the same spectrum as AS, with 
shared clinical and functional features, the results from AS cannot be assumed 
to apply to nr-axSpA as people with the latter are more likely to be younger or 
female (Wright et al., 2020). Therefore, the limited evidence base to date is 
predominantly in relation to people with AS.  
 
3.4.5 Future Research 
Future research should investigate a range of personal, condition (disease), 
socioeconomic, and healthcare that may influence adherence and consider 
which ones best predict adherence or which can be modified to increase 
adherence. Understanding who is likely to adhere to prescribed exercise can 
allow physiotherapists to predict who is most likely to benefit from their 
interventions and to ensure resources are targeted to those who require them 
most. 
 
A variety of treatment factors may support adherence and should be 
investigated. Interventions which include education to improve health 
knowledge, provide information and support at key points and/or in novel ways, 
such as through web-based exercise, could facilitate adherence, especially in 
the longer term when adherence declines and warrant further investigation (Paul 
et al., 2014). 
 
3.5 Conclusion 
The aim of this systematic review was to examine the rates of adherence to 
prescribed exercise and the factors reported to influence adherence in people 
with SpA. The review found adherence was poorly reported within the included 
studies and the heterogeneity of the studies included meant comparison 
between studies was difficult. Adherence rates were reported from 51%- 95% 
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suggesting that patients do not fully adhere. Treatment factors identified within 
single studies as possible influencers were supervision, inclusion of education 
programmes. Higher disease severity and delays in diagnosis were associated 
with higher adherence although these were within single, poor quality studies. 
The full picture of adherence levels and factors affecting adherence to 
prescribed exercise in SpA remains unclear. Future research should aim to 
measure adherence to prescribed exercise, including novel programmes such as 
web-based physiotherapy programmes over the longer term and consider 
multiple personal, disease, healthcare and treatment factors which could 





4 Chapter: Web-based Physiotherapy: A cohort study (WEBPASS) 
The role of exercise as an intervention in SpA is best characterised and 
established in axSpA, as seen in the systematic review in Chapter 3 and the 
clinical guidelines (Regel et al., 2017). This chapter reports a cohort study 
measuring adherence to a web-based physiotherapy programme over one year in 
axSpA. This study was part of, and extended the work of, the Web-based 
Physiotherapy for people with axSpA (WEBPASS) study, which was funded by 
Versus Arthritis (previously Arthritis Research UK, 20874) (Paul et al., 2016).  
 
4.1  Study Team and Role of the PhD Student 
The study research team consisted of Lorna Paul (LP) chief investigator (CI), and 
co-investigators Stefan Siebert (SS) clinical academic Rheumatologist, PhD 
student Marie Therese McDonald (MTM), Elaine Coulter (EC), Sara Cameron (SC), 
Debbie Cook (DC), Mhairi Brandon (MB), and Alex McConnachie (AM).  
 
The PhD student (MTM) was a qualified physiotherapist, who specialised in 
rheumatology in general and axSpA in particular. The PhD student was a co-
applicant on the grant, and was involved in the development and design of the 
study, and the application for ethical approval. The PhD student picked and 
filmed the exercises for the exercise catalogue. The PhD student was responsible 
for recruitment, assessing each individual at the baseline visit and providing 
them an individualised prescribed exercise programme. The PhD student 
monitored each participant and changed the exercise programme accordingly. 
The PhD student carried out all the semi-structured interviews and data analysis 
pertaining to the adherence of the study apart from the data analysis for 
adherence over time which was analysed by the Robertson Centre for 
Biostatistics at the University of Glasgow.   
 
The aim of the Verus Arthritis-funded study was to assess the feasibility of the 
web-based physiotherapy intervention, including efficacy and adherence over 
time. The work presented in this PhD extended this to a more detailed 





examination and analysis of overall sessions each participant engaged with, 
comparing patient choice and prescribed exercise components, analysing 
individual exercises within each prescribed session and explored associations of 
the overall sessions completed with participants’ baseline characteristics.  
 
4.2 Justification 
As described in Chapter 2, exercise programmes are essential in the 
management of axSpa and are prescribed to improve disease outcomes (Regel et 
al., 2017). Adherence refers to the extent to which a person’s behaviour 
corresponds with the recommendations from a HCP (Sabete et al., 2003). The 
level of adherence to an exercise programme will affect how successful exercise 
programmes are in achieving improved disease outcomes (Pisters et al., 2010). 
 
The systematic review described in Chapter 3 found the rates of adherence to 
supervised and unsupervised exercise interventions of hydrotherapy, nordic 
walking, aerobic and flexibility exercises ranged from 51-95% in people with SpA, 
with the majority of evidence in people with AS (Gross & Brandt 1981, Hidding et 
al., 1993a, Hidding et al., 1993b, Hidding et al., 1994, Barlow & Barefoot 1996, 
Sweeney et al., 2002, Fernandez-de-Las-Penas et al., 2006, Niedermann et al., 
2013, Chimenti et al., 2014, Svaas et al., 2020).  Interventions which 
incorporated supervision and an educational programme potentially improved 
adherence. Higher disease severity and delays in diagnosis were positively 
associated with adherence whilst age, gender, body mass index, blood pressure 
and heart rate were not found to affect adherence. These factors were found 
often in single, low-quality studies with minimal consensus between studies (fig 
4-1). Therefore, the majority of factors affecting the WHO model of adherence 
for exercise programmes in axSpA remain unknown (fig 4-1). Furthermore, the 
systematic review in Chapter 3 observed adherence reduced over time. Short 
term adherence appears higher than long-term adherence. However, long-term 
adherence to exercise is recommend and required in conditions such as axSpA 











Figure 4-1. WHO model of dimensions of adherence (Sabete et al., 2003) with possible factors 
identified in the systematic literature review in Chapter 3 (shown in shaded ovals). 
 
Furthermore, no study within the systematic review investigated and reported 
the level of, and factors affecting, adherence to a web-based based 
physiotherapy programme.  Web-based exercise programmes are becoming a 
more feasible option due to the increasing number of people with regular access 
to the internet and skills to use it (Laver et al., 2020). Web-based programmes 
can be individualised and progressed with the physiotherapist being remotely 
contactable and with digital interactions between therapist and user being 
incorporated. Advantages of web-based physiotherapy approaches include the 
flexibility of being available without the need for travel and having the ability to 
choose when and where to exercise. This can be useful for those who struggle to 
engage with traditional physiotherapy due to other commitments such as work 
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monitored therapies has also been highlighted by the coronavirus pandemic in 
2020. 
 
Web-based exercise may be a particularly beneficial strategy for people with 
axSpA. People with axSpA are commonly diagnosed with this chronic lifelong 
condition in the second or third decade of their life (Rojas-Vargas et al., 2009), 
so many will need to start exercise in young adulthood so this means exercising 
over the long term, which is likely to be hard to maintain. With the advent of 
effective drug therapies, the majority of people with axSpA remain in 
employment and also have family and lifestyle commitments which make it 
difficult for them to attend traditional, scheduled face to face physiotherapy 
sessions (Webers et al., 2018). Adherence has been shown to be adversely 
affected by exercise regimens which are inconvenient, or not tailored to a 
person’s situation or daily routine (Sluijs et al 1993). Therefore, investigating 
adherence to a web-based physiotherapy approach in axSpA is warranted. 
 
Investigating adherence to exercise is hampered by the lack of a standardised 
approach to measurement allowing limited comparisons to be made between 
studies (Bollen et al., 2014, Hall et al., 2015, McLean et al. 2017). In the 
systematic review (Chapter 3), adherence to HEPs was usually measured using 
patient-reported home exercise diaries (McDonald 2019). The majority of these 
studies measured only one aspect of adherence to the prescribed programme, 
for example the minutes of exercise or the number of sessions completed. 
Measuring more than one aspect of the prescribed exercise components, such 
as the number of sessions and the number of exercises completed within the 
session and over an extended time period, has the potential to give a more 
complete understanding of the adherence to HEPs in axSpa.   
 
Therefore, to address the issues outlined from the published literature, this 
second study within the PhD aimed to explore adherence to a 12-month web 
based programme. Focusing in detail on adherence levels through; sessions and 
exercises completed, comparing adherence to participant choice and 





factors which may affect adherence. In addition, qualitative data from semi 
structured interviews conducted as part of the WEBPASS study that specifically 
related to adherence were analysed. 
 
The following research questions were identified: 
 
At the individual level, what was the adherence to a 12-month programme web- 
based physiotherapy programme for people with axSpA. Specifically; 
1. How many sessions did each participant engage with (total number and 
percentage of maximum of 5 per week X 52 weeks)? 
2. How many participants had good adherence (pre-defined as engaging with 
at least 3 sessions per week)?  
3. Did participants adhere differently to the prescribed component or the 
patient-choice component. 
4. For each prescribed exercise session did participants complete all 
individual exercises presribed? 
5. What were the weekly adherence rates (sessions engaged with and 
percentage of participants with good adherence) to the 12-month 
physiotherapy programme and how did the weekly rates change 
throughout the 12-month period? 
6. Were there any associations between participants’ demographics, disease 
measures and adherence (in terms of number of sessions engaged with)? 
 
4.3 Research Methodology 
Within the field of research there are two main poles of research methodology; 
quantitative and qualitative, each with distinct epistemological paradigms with 
strong philosophical underpinnings (Crossan, 2003). From a quantitative 
perspective collecting objective data which are measurable and eliminating 
confounding variables allows the researcher to derive cause and effect or 
association from the relationship under investigation (Leavy et al., 2014). In 
contrast, qualitative research uses small, purposeful samples of respondents to 
provide important information, not because they are representative of a larger 





participant (Reid, 1996). Punch (2013) recommended careful consideration of 
the research questions and ensuring the correct and most appropriate 
methodology is used to answer the questions. It was determined that a 
predominantly quantitative methodology would best answer the research 
questions posed but an additional qualitative programme evaluation would add a 




4.4.1 Study Design and Ethical Approval  
A prospective, interventional cohort study was undertaken. The primary aim of 
WEBPASS study was the feasibility, including efficacy and adherence each week 
to a web-based physiotherapy programme. Favourable ethical opinion was 
obtained from the West of Scotland Research Ethics Committee (Ref: 
15/WS/0229) (see Appendix 1) and approval from NHS Greater Glasgow and 
Clyde (NHS GGC) Research and Development prior to any study related 
procedures being performed. The study sponsor was NHS GGC Health Board.  
 
4.4.2 Study population 
The population of interest were 50 adults with inclusion criteria of axSpA 
(diagnosed by a rheumatologist), with disease duration of longer than one year 
and who had access to the internet. There was no reliable data in the literature 
to inform sample size calculations for this study, so 50 was chosen as a 
convenience sample that was felt to be both feasible for recruitment and 
sufficiently large to assess adherence to the exercise programme. As adherence 
was the primary outcome, any drop outs during the study would be captured as 
part of this. The disease duration of longer than one year was chosen as the 
exercise programme was intended as a maintenance programme. Key exclusion 
criteria were already exercising regularly (three or more times per week), any 
joint replacement within the past six months and any other significant 






4.4.3 Description of the Intervention  
The intervention was a physiotherapy prescribed programme delivered using a 
web-based approach and a patient choice component. The website used was 
www.webbasedphysio.com (now www.giraffehealth.com). This consisted of a 
home page, exercise page, exercise diary and an axSpA-specific advice/ 
information section with links to relevant external websites. The website could 
be accessed via a personal computer, tablet, smartphone or television, via a 
personal login provided to each participant. This online platform had been used 
to deliver online exercise programmes in people with multiple scelorsis and 
spinal cord injury with promising results in terms of feasibility (Paul et al., 2014, 
2019, Coulter et al., 2015, 2017). 
 
The website contained a catalogue of exercises with different levels of 
difficulty, as well as a warm up and cool down. Each exercise was demonstrated 
using a video, text explaining the exercise, an audio description of the exercise 
and a timer (fig 4-2, fig 4-3). The exercise catalogue was expanded by the PhD 
student in conjunction with the wider research team to include axSpA-specific 
exercises based on the Back to Action programme (http://nass.co.uk/back-to-
action) developed by the National Ankylosing Spondylitis Society (NASS) in 
conjunction with specialist rheumatologists and specialist physiotherapists for 


















An exercise programme to maintain or improve spinal mobility, function, quality 
of life and CV fitness is recommended in axSpA (Dagfinrud et al. 2004, O’Dwyer 
et al. 2014a, O’Dwyer et al. 2014b, Reimold and Chandran 2014, Millner et al. 
2016, Regel et al., 2017). Exercise programmes should be tailored to the 
person’s assessment findings, goals and lifestyle (Milner et al., 
2016).  Therefore, in WEBPASS, participants were initially assessed by a 
physiotherapist (MTM, PhD student) and specific personal goals, including 
mobility, flexibility and CV goals, were agreed, between the physiotherapist and 
participant. Participants were then provided with a tailored, prescribed exercise 
programme based on the assessment findings and agreed goals. Although there is 
no agreed recommendation with regards to how often and for how long people 
with axSpA should exercise, the limited available research and consensus advises 
to aim for high frequency such as five or more times per week for around 30 
mins (Dagfinrud et al., 2004, O’Dwyer et al., 2014a, 2014b, Reimold and 
Chandran 2014, Millner et al., 2016). In WEBPASS the five exercise sessions per 
week were composed of the prescribed individualised exercise programme three 
times per weekly and, in order to enable participants the choice to incorporate 
other exercise and physical activities, participants were also asked to choose 
their own exercise twice per week. As part of these patient choice sessions, 
participants were encouraged to participate in a NASS run group class or a 
recreational swim, walk, or any other exercise of their choice. Participants were 
asked to record this as ‘other exercise’. The programme was amended 
throughout the year by the PhD student based on feedback from each 
participant as described in section 4.4.9.    
 
The website incorporated behaviour change techniques. Behaviour change 
techniques are observable and replicable components of interventions and can 
be used alone or in combination with other behaviour change techniques (Michie 
et al., 2011). The following behavioural change techniques were incorporated 
into WEBPASS; goals and planning, feedback and monitoring, shaping knowledge, 
natural consequences, comparison of behaviours, repetition, substitution and 





successful in promoting and maintaining exercise behaviour (Webb et al., 2010, 
Michie et al., 2011). Feedback was incorporated into the programme by 
displaying each individuals progress by the percentage of the programme they 
had completed. This was displayed using a graph, which users saw each time 




Figure 4-4. Screenshot of an example of a participant’s progress. 
 
4.4.4 Study Conduct 
All members of the research team undertook Good Clinical Practice training and 
these principles were adhered to throughout the study. A trial steering 
committee comprising an independent chair, independent clinical experts, the 
CI, grant co-applicants, a statistician and two patient representatives oversaw 
all aspects of the project to monitor progress and to help ensure the aims and 
objectives were achieved. All adverse events were recorded and discussed. For 








A convenience sample, of up to 50 people, of participants with axSpA were 
recruited from specialist axSpa clinics and related physiotherapy departments 
across NHS GGC between 1st of Dec 2015 and 1st of Dec 2016. The study was also 
promoted through local NASS branches, the NASS website and newsletter, the 
University of Glasgow website and social medial twitter account and using 
posters in the waiting areas of axSpA clinics. Rheumatology consultants and 
registrars, physiotherapists and other HCPs involved in the care of people with 
axSpA were informed about the study and they were asked to discuss the study 
with their patients and identify interested patients. The PhD student regularly 
attended these clinics and spoke directly with potential participants or ones who 
were referred by HCPs. The purpose of the study was explained to potential 
participants, each interested participant had the opportunity to ask questions, 
they were given the participant information sheet (PIS) and a week to consider 
the study before deciding whether to take part. The study PIS is shown in 
Appendix 2. 
 
4.4.6 Screening, consent and baseline assessment (Visit 1) 
The initial visit took place at the participants’ local hospital within NHS GGC. 
The purpose of the study was again explained to the participant and they were 
given an opportunity to ask any further questions. This first study visit was 
undertaken by the research assistant (SC). Participants provided written 
informed consent to participate in the study and for their GP to be informed of 
their participation; they then underwent screening for eligibility as per the 
inclusion and exclusion criteria (section 4.4.2). 
 
If the participant passed the screening, the following outcome measures were 
taken as baseline assessment; Bath ankylosing spondylitis functional index 
(BASFI), Bath ankylosing spondylitis disease activity index (BASDAI), the work 
productivity and impairment questionnaire (WPAI:AS, the ankylosing spondylitis 
quality of life questionnaire (ASQoL), the EuroQol 5 dimension scale (EQ5D-5L), 





index (BASMI), and the six minute walk test (6MWT). These outcome measures 
are validated, widely used in clinical and research practice and are explained in 
more detail in Section 4.5. If required, assistance was provided with scribing for 
the self-reported outcome questionnaires. The 6MWT and BASMI were supervised 
by the research assistant using standardised methodologies. Each participants 
weight and height was measured so a body mass index (BMI) could be calculated. 
 
Physical activity was measured with an activPAL activity monitor (PAL 
Technologies, Glasgow) which was attached to the participant’s thigh using a 
Tegaderm waterproof dressing and participants were asked to undertake their 
usual activity for seven days. The participant was asked to fill in a diary for the 
days on which they wore the activPAL, recording when they slept and woke each 
day, so that sleep time could be subtracted from sedentary time.  
 
Participants were informed that the programme was intended as a maintenance 
programme and that they could access any HCPs, including physiotherapists, as 
usual if any specific health care problems arose. There were no other changes to 
routine clinical care or treatment, which continued as per local practice.  
 
4.4.7 Randomisation and Blinding 
As this was a cohort study in which all participants received the intervention, 
randomisation and blinding were not relevant or required. 
4.4.8 Visit 2 
Participants were asked to return one week after the baseline visit for an 
appointment with the PhD student (MTM). The activPAL and sleep diary were 
returned. The participant was assessed by the physiotherapist by reviewing the 
outcome measures taken at visit 1. By using this information, and discussing 
each individual’s lifestyle and preferences, specific exercise goals (including 
mobility, flexibility, and CV health) were agreed between the physiotherapist 
and participant. An exercise programme was then devised by the physiotherapist 





programme was set up on the web platform. Participants were advised on how 
to use the website and taken through their personal online exercise programme.  
 
Participants were asked to tick a box on each exercise page when they had 
completed that exercise so that adherence to the programme could be recorded. 
Participants were informed that the online exercise diary should only be 
completed on the day on which the exercises were undertaken.  
 
4.4.9 Remote Monitoring and Programme Alterations 
After visit 2, participants received weekly phone calls from the PhD student 
(MTM) or the first two weeks of the programme. The purpose of these phone 
calls was to ensure the participant was able to log onto the website and to 
follow the exercise programme. Thereafter, the PhD student (MTM) reviewed the 
exercise diary of each participant remotely every two weeks and altered the 
participant’s exercise programme online, as appropriate, by changing any 
combination of exercises, level of difficulty and/or number of repetitions based 
on feedback from the participant. Participants were informed of any changes by 
email. Participants could also contact the PhD student (MTM) directly to request 
a change in their programme should they feel this was required or if a problem 
arose. 
 
4.4.10 Visit 3  
Visit three was undertaken 6 months (± two weeks) after the visit 2. All outcome 
measures done at the baseline visit were repeated under the direction of the 
research assistant (SC) or PhD student (MTM) and the participant was given the 
opportunity to ask any questions. A new activPAL was attached and, as at 
baseline, the participant was advised to undertake their normal activities for 
seven days. The participant was again asked to fill in the sleep diary and asked 
to return the diary and activPAL in the post after the seven days. Of note, the 







4.4.11 Visit 4  
Visit four was undertaken 12 months (± two weeks) after visit 2. All outcome 
measures were repeated under the direction of the research assistant (SC) or 
PhD student (MTM).  A new activPAL was attached and as before the participant 
was advised to undertake their normal activities for seven days. The participant 
was again asked to fill in the sleep diary and was asked to return the diary and 
activPAL in the post after a week. A visual summary of the participant journey 
through the trial is provided in Figure 4-5. Similar to visit 3, this PhD work does 

















•Screening and Informed Consent
•Baseline Assessment
•ActivPAL attached
Visit 2, week 0
•Goal Setting with PhD student (MTM) and exercise set up on Web-based Physio
•ActivPAL returned
Weeks 0-2
•Participant recieves weekly telephone calls
Weeks 3-26 
•PhD student reviews programme every 2 weeks and alters it remotely as required. 
Changes are communicated through email. Participant can contact physiotherapist to 
change their programme or if they encounter a problem. 
Visit 3 Week 24-
28
•Assessment. ActivPAL attached and participant asked to return this in a pre-paid 
envelope.
week 26-52
•PhD student reviews programme every 2 weeks and alters it remotely as required. 
Changes are communicated through email. Participant can contact physiotherapist to 
change programme or if any problems encountered.
•Telephone interviews undertaken with a subset of participants.
Visit 4
Weeks 50-54 






4.4.12 Telephone Interviews - Qualitative Data Evaluation 
To explore participants’ views and adherence to the programme, telephone 
interviews were conducted with participants between 6 months and 12 months 
of the study.  Telephone interviews were chosen as the CI found in previous 
studies that these were most convenient for the participants. A topic guide was 
developed, which contained the main and prompt questions (Appendix 3). The 
interview questions were piloted by the PhD student within the research team in 
order to determine the most logical order of the questions. 
 
A sample of 10 participants, 20% of all participants, was purposely selected to 
ensure data was collected from participants who did, and who did not, adhere to 
the programme, by looking at their total sessions adhered to, in order to gain a 
maximum variation sample. Participants were selected by the research assistant 
(SC) and the PhD student looking at the adherence data between 0-6 months, 
purposely selecting participants with different adherence rates, thereby 
attempting to collect data from participants across the adherence ranges. 
Selected participants were asked at their six-month assessment if they would be 
willing to participate in interviews and, if agreeable, a time of the participant’s 
choosing was arranged for the PhD student to phone the participant. The PhD 
student (MTM) performed the interviews using the previously developed 




As described in Chapter 2, there is no gold standard measurement of adherence, 
with adherence to HEPs most commonly measured using a self-reported diary 
method, although, even then, there is currently no standardised diary used 
across research studies (McLean et al., 2017). The World Health Organisation 
advises using the best measurement strategy to obtain an approximation of 
adherence appropriate for the setting (Sabete et al., 2003). Researchers should 





(Vitolins et al., 2000). Self-reported diaries are convenient and provide an 
approximation of adherence; therefore, self-reported exercise diaries were 
utilised in WEBPASS.  
 
Electronic diaries are thought to be more accurate than paper diaries as 
individuals using paper diaries may retrospectively fill multiple entries at one 
time, possibly recording their adherence inaccurately. Electronic diaries can be 
completed in real time and so have the potential to be more accurate (Stone et 
al., 2002). The web based physio platform also included an inbuilt electronic 
self-reported exercise diary which was felt to be the most convenient for the 
patient to record adherence as they would already be accessing their 
physiotherapy programme on the website.  In an attempt to improve accuracy 
participants were asked to complete this self-reported exercise diary on the day 
they completed their exercise programme. They were not able to retrospectively 
or prospectively complete exercise diaries. 
 
Participants logged onto www.webbasedphysiotherapy.com (now 
www.giraffe.com) and after each exercise ticked a box if the exercise was 
completed; participants were also able to leave a comment for the 
physiotherapist (Figure 4-6). A session of web-based physiotherapy was counted 
when the session of physiotherapy had been engaged with, with any of the 
individual exercises within the session completed. There was a maximum 
possible of 5 sessions per week. The exercise plan had two components; 
prescribed exercise sessions three times per week, and participant choice twice 
per week. To assess if the exercises within each session of prescribed exercise; 
the session was deemed as complete if all prescribed exercises had been ticked 
and was deemed incomplete if any prescribed exercise in that session was not 
ticked. For the participant-choice component, the participant was asked to tick 
‘other exercise’ and use the comment box to give further details on what 
exercise they had performed.  
 
The exercise diary for each participant was copied into an Excel spreadsheet and 





and recorded. For each session of the prescribed component, the ‘exercises 
completed’ were compared with the ‘total number prescribed’ and the session 
was deemed ‘completed’ if all exercises were completed or ‘incomplete’ if any 





Figure 4-6. Physiotherapist’s view of a participant’s exercise diary, showing comments from the 
participant and that all exercises have been completed 
 
4.5.2  Defining Good Adherence 
As described in Chapter 2 there is no gold standard for defining ‘good’, 
‘satisfactory’ or ‘poor’ adherence across health behaviours (Vitolins et al. 2000). 
In the absence of a consensus, good adherence was pre-defined in this study as 





week (i.e. 60%) or an average of three exercise sessions per week averaged 
across the programme. 
 
4.5.3 Outcome measures used for correlations  
4.5.3.1 Function 
Function was measured using the BASFI. The BASFI is a set of 10 questions 
designed to determine the degree of functional limitation in those with axSpA. It 
is measured using visual analogue scales (VAS) ranging from 0 (easy) to 10 
(impossible) with questions focused on the person’s ability to perform specific 
functional tasks over the past week (Calin et al., 1994). The first 8 questions 
consider activities related to functional tasks, such as putting on socks with or 
without help and climbing steps with or without using a handrail. The final two 
questions assess the patient’s ability to cope with everyday life. 
 
The BASFI has been shown to have high levels of validity and reliability when 
measuring functional ability in AS. Calin et al (1994) compared the BASFI to the 
Dougados Functional Index within a sample size of 163 AS patients. They 
demonstrated that the BASFI score covered 95% of the available range in 
contrast to 65% with the Dougdas Functional Index. Furthermore, superior 
sensitivity was noted with the BASFI over a three-week period when compared to 
the Dougdas functional index (p=0.004).  
The BASFI has become the standard functional questionnaire in clinical practice. 
The questionnaire was developed with patient input, ensuring the questions are 
relevant to those with AS (Calin et al., 1994). It is quick and easy to complete, 
reliable and sensitive to change across the whole spectrum of disease. A final 
total score out of ten is given by adding up the answer to each question and then 
dividing by ten. A higher overall score indicates more functional impairment. 
The minimal clinically important improvement of the BASFI is 0.6 (Kviatkovky et 






4.5.3.2 Disease Activity 
Disease activity was measured using the BASDAI (Garrett et al., 1994). The 
BASDAI uses a 10cm VAS to answer 6 questions pertaining to the 5 major 
symptoms of AS within the past week; fatigue, spinal pain, joint pain/swelling, 
areas of localised tenderness and morning stiffness. The VAS lines are anchored 
with the labels ‘none’ and ‘worst ever’ at either end of the first five questions, 
and with ‘0 hours’ and ‘two hours’ at either end of the additional question on 
duration of morning stiffness. The two scores for morning stiffness are added 
and divided by two, giving a single mean count for morning stiffness. The final 
score is the mean of the five items, giving a score between 0 and 10. A BASDAI 
score equal to or above 4 is considered to indicate active disease (Kviakovky et 
al., 2016). The BASDAI is a quick and simple validated index, taking between 30 
seconds and 2 minutes to complete and therefore widely used in routine clinical 
practice to assess disease activity. The minimal clinically important 
improvement of the BASDAI is 1.1 (Kviatkovky et al., 2016). Test–retest 
reliability was good when assessed for inpatients over a 24-hour period (r 0.93, P 
<0.001), and when assessed by postal survey in 162 AS patients who reported no 
change on an AS-specific health transition question over a 1-week period 
(intraclass correlation coefficient of 0.87 (95% confidence interval [95% CI] 0.83– 
0.91) (23). In terms of content validity, the measure was developed by experts 
in the field with patient input, reflecting items relevant to both patients and 
clinicians. For construct validity, the BASDAI correlated well with the earlier 
Bath Disease Activity Index, with no significant differences in score distribution, 
reproducibility, or sensitivity. There is good correlation with the ASQoL 
questionnaire (Pearson’s correlation coefficient 0.79) and BASDAI scores are 
significantly higher in AS patients unable to work due to ill health (P < 0.01) 
(Zochling 2011).  
 
4.5.3.3 Spinal Mobility 
In addition to pain and stiffness, axSpA is associated with reduced spinal 
mobility, especially in long-standing disease. Spinal mobility was measured using 





(Jenkinson et al, 1994). The index includes five clinical measurements:  cervical 
rotation, tragus to wall distance, lumbar side flexion, modified Schober Test, 
and intermalleolar distance. For cervical spine rotation, tragus to wall and 
lumbar spine flexion, the mean of the left and right measurements is taken, 
according to the instructions. The BASMI measurements take around 7 minutes to 
perform. 
 
There are two tables for calculating the BASMI scores from the measurements 
obtained. A table with three scores (0, 1, 2) for each measure was used in the 
original BASMI description by Jenkinson et al, (1994); this table was subsequently 
expanded to allow ten scores (0-10). This table is more sensitive to change and 
now more commonly used in research and practice (van der Heijde et al 2008).  
The 10-step table was used in WEBPASS. Each clinical measure has an individual 
score, which are then added together to give a total score out of 50, which is 
then divided by 5 to give a final score out of 10.  Scores range from 0 to 10 and 
the higher the BASMI score the more severe the patient’s limitation of spinal 
movement due to their AS. 
 
The BASMI is accurate, reproducible and sensitive to change.  Zochling et al 
(2011) report that comparisons between three physiotherapists showed good 
interrater reliability for cervical rotation of r 0.98, (P <0.001), tragus to wall of r 
0.99 (P < 0.001), lumbar side flexion of r 0.94 (P < 0.001), lumbar flexion as 
measured by the modified Schober’s method of r 0.99, (P <0.001), and 
intermalleolar distance r 0.98, (P < 0.001). Intraobserver reliability for the same 
three physiotherapists on consecutive days showed similarly high values: cervical 
rotation (r 0.99, P < 0.001), tragus to wall (r 0.99, P <0.001), lumbar side flexion 
(r 0.98, P < 0.001), lumbar flexion as measured by the modified Schober’s 
method (r 0.99, P < 0.00 1), and intermalleolar distance (r 0.99, P < 0.001) 
(Zochling et al., 2011). Inter and intra– rater operator reliability has been 
reported with repeated measurements differences of 1.0 or less are within the 
bounds of error (Martindale et al, 2012). In terms of content validity, the initial 
instrument development was based on an extensive literature review and a 





of construct validity, the BASMI has been shown to discriminate between 
patients with and without radiographic change due to AS. The BASMI does not 
correlate strongly with changes in functional outcomes, as measured by the 
BASFI (r 0.44, P < 0.001). Spinal mobility, as measured by the BASMI, correlates 
with radiographic change as measured by the Stoke Ankylosing Spondylitis Spine 
Score (Spearman’s 0.6). For criterion validity, the comparison between the five 
BASMI measures and total scores of 20 clinical measurements (total metrology 
score) was good (r 0.92, P< 0.001) (Zochling, 2011) 
  
4.5.3.4 Quality of Life 
Disease-related quality of life was measured using the ASQoL questionnaire 
(Doward et al 2003). This is a self-reported questionnaire which takes around 4 
minutes to complete. The ASQol has 18 items which address the physical and 
psychological impact of the disease, including items relating to mood, coping, 
relationships, social life and activities of daily living. Scores range from 0-18, 
with a higher score reflecting worse quality of life. This questionnaire has been 
shown to be valid and reliable in AS (Doward et al., 2003). The Spearman rank 
correlation coefficient for the test-retest reliability of the 18 item ASQoL was 
0.92 (n=129), indicating that the measure has excellent reliability, with low 
levels of random measurement error. Intraclass correlation coefficients were 
0.92. Evidence of construct validity was provided by examining the levels of 
association between the ASQoL and the comparator instruments. Moderate to 
high correlations were found between the ASQoL and all the comparator 
instruments (Doward et al., 2003). 
  
Health related quality of life was also measured with the EQ-5D-5L, which 
consists of a questionnaire and VAS (Brazier el al., 2016).  It is short and easy to 
use, encompassing both positive (well-being) and negative (illness) aspects. The 
EQ-VAS records the subject’s perceptions of their own current overall health 
status and can be used to monitor changes over time. The questionnaire is a 
self-reported description of the subject’s current health in 5 dimensions i.e., 





The participant is asked to grade their current level of function in each 
dimension into one of three degrees of disability (severe, moderate or none). 
The maximum score of 1 indicates the best health state (Brazier et al., 2016). 
The EQ_5D is commonly used across a number of health conditions. A cross-
sectional study investigated the validity and realiability of the EQ_5D in people 
with axSpA in an Asian tertiary hospital from 2017 to 2018 (Seng et al., 2020). 
Construct validity was evaluated by testing 22 a priori hypotheses with other 
patient-reported outcomes measures. Cronbach’s alpha was used to estimate the 
internal consistency of the EQ-5D-5L, while its test-retest reliability was 
assessed using weighted kappa and the intraclass correlation coefficient (ICC). 
The EQ-5D-5L demonstrated good internal consistency with a Cronbach’s alpha 
of 0.79. The test-retest reliability of the EQ-5D-5L was good, with a weighted 
kappa of ≥0.61 for mobility, self-care, usual activities, and anxiety/depression; 
the ICC was 0.92 and 0.99 for the EQ-5D-5L index and VAS scores, respectively. 
The weighted kappa for the EQ-5D-5L pain/discomfort was moderate [0.53, 95% 
CI: 0.41–0.60]. This study supports EQ-5D-5L as a valid and reliable instrument 




4.5.3.5 Employment and Productivity 
Employment and productivity were measured using the self-administered 
WPAI:AS which measures work productivity loss due to general health or a 
specified health problem. This questionnaire has been shown to be a valid, 
reliable and responsive tool for assessing work productivity for people with AS 
(Reilly et al., 2010). The WPAI:AS consists of six questions to determine 
employment status, hours missed from work due to AS and other reasons 
(absenteeism), hours actually worked, the degree to which AS affected work 
productivity while at work (presenteeism) and the degree to which AS affected 
activities outside of work. Four scores are derived: percentage of absenteeism 
(time off work), percentage of presenteeism (reduced productivity while at 





presenteeism and the percentage of impairment in activities performed outside 
of work. Higher scores indicate greater work impairment. Questions related to 
absenteeism and presentism are applicable to employed participants only. A 
study was carried out to determine the validity, reliability and responsiveness of 
the WPAI:SpA. Baseline and week-24 data from a randomized, double-blind study 
of adalimumab in patients with AS were used. The discriminative validity of 
WPAI:SpA absenteeism, presenteeism, overall work productivity loss and activity 
impairment scores was assessed relative to patient-reported outcomes: BASDAI, 
ASQOL, Short-Form 36 Health Survey, Physical and Mental Component Summaries 
and Health Utilities Index Mark 3. Responsiveness of the WPAI:SpA instrument 
was assessed for patients meeting the minimum clinically important differences 
for ASQOL and BASDAI (i.e. quality of life and clinical responders, respectively) 
and quantified with standardized response mean calculations. Two hundred and 
five people with AS were included. Patients with more severe AS (BASDAI > 
median) showed significantly greater impairment in work and daily activities 
than patients with lesser disease severity (P < 0.001). This trend was consistent 
for ASQOL, Short-Form 36 Physical Component Summary, Short-Form 36 Mental 
Component Summary and Health Utilities Index Mark 3. There were significant 
differences in WPAI:SpA scores for patients achieving BASDAI clinical response 
and ASQOL quality of life response compared with non-responders. For 
responders, standardized response mean calculation were large for work 
presenteeism, overall work impairment and activity impairment (0.86 to 1.29 for 
BASDAI; 0.89 to 1.18 for ASQOL) and small for absenteeism (0.25 for BASDAI; 
0.31 for ASQOL). Therefore, it was deemed the WPAI:SpA is a valid, reliable and 
responsive tool for assessing work productivity for patients with AS. 
  
4.5.3.6 Attitude to exercise 
The participants’ attitude to exercise was measured using the EAQ (Manigandan 
et al., 2004). This self-reported questionnaire contains three different 
components of attitude: affective, behavioural and cognitive. Each question is 
scored from 1 (‘don’t agree at all’) to 4 (‘agree very much’). A higher score 
indicates a positive attitude to exercise. This questionnaire was constructed 





therapists with a minimum of 2 years’ working experience at the Christian 
Medical College, Vellore (Manigandan et al., 2004). In terms of content validity, 
21 therapists took part in this phase of the study. Eighteen specific questions 
based on the experts’ opinion were selected. The questionnaire was also piloted 
on a small (no number given) group of patients. Therefore, the EAQ-18 was 
deemed a validated questionnaire which represents participants’ attitudes 
towards exercise (Manigandan et al., 2004). 
 
4.5.3.7 Exercise Capacity/Fitness 
Exercise capacity or fitness was assessed using the 6MWT which measures the 
total distance walked in six minutes on a hard flat surface (Enright, 2003)). The 
participant is instructed to walk around two cones positioned 10m apart for six 
minutes. They are permitted to slow down or rest when necessary and to use 
walking aids as required. Although not specific to axSpa, this test is a well-
recognised and validated outcome measure of exercise capacity across a range 
of chronic conditions (Enright, 2003).  The validity and reliability of the 6MWT 
has not been tested on people with axSpA. A study conducted by Pankoff et al., 
(2000) used the 6MWT as a tool to assess cardio-respiratory fitness in people 
with fibromyalgia. Twenty-six subjects (27–59 years of age) performed three 
walk tests over consecutive days before and after a 4-week treatment 
programme. Reliability was determined using a one-way repeated measures 
analysis of variance and the intraclass correlation coefficient (ICC2,1). 
Reliability of the 6MWT was excellent, both at program intake (ICC2,1 = 0.91) 
and programme completion (ICC2,1 = 0.98), and a significiant correlation 
between the 6MWT and VO2 max (P<0.001) was found.  
 
4.5.3.8 Physical Activity 
Physical activity level was measured with an activPAL activity monitor. The 
activPAL, is a small, single unit device that contains a tri-axial accelerometer 
that responds to gravitational acceleration as well as acceleration resulting from 
segmental movement (Edwardson et al., 2016).  From the inclination of the 





activPAL was attached at each assessment using a Tegaderm waterproof dressing 
and participants were asked to undertake their usual activities for seven days. 
 
Wearing an activPAL monitor for five consecutive days has been shown to be a 
valid and reliable method of measuring physical activity in a healthy population 
with this data being representative of an individual’s activity (Grant et al., 2006, 
Dahlgren et al., 2010). No study has measured the validity of the activPAL in 
axSpA; however, in rheumatoid arthritis it has been reported to be a valid 
measure of time spent in sedentary, standing/light activity and walking 
behaviours when compared to direct observation (Larkin et al., 2016). This study 
compared activPAL with direct observation of the time spent in sedentary, 
standing/light activity and walking behaviours, with correlation analysis 
revealing that activPAL step counts were strongly correlated with direct 
observation values (r=.94; 95% CI=.86, .98). However, paired t test revealed no 
significant difference (P=0.57) between the activPAL activity monitor and direct 
observation for time (total number of seconds) spent in sedentary behaviour or 
between the activPAL activity monitor and direct observation for time (total 
number of seconds) spent in standing or light activity behaviour for the total 
testing session (p=0.08) (Larkin et al., 2016). 
 
4.5.4 Handling of data 
Participants were assigned an individual study number with all information 
relating to their participation coded using this unique identifier. All study 
specific information and all subsequent data analysis, reports and potential 
publications were anonymised. Data were collected, managed and stored in 
accordance with the Data Protection Act (1998), which was the relevant Act at 
the time of the study. Data were entered into a database by the research 
assistant (SC) or physiotherapist (MTM). All participant data were anonymised 
and any data which identified a participant were stored separately in a locked 
filing cabinet in a locked room in the University of Glasgow. Anonymised data 
were stored on a secure password protected drive on a University server. Only 
the research team had access to the data collected. The data will be destroyed 






4.5.5 Statistical Analysis 
4.5.5.1 Quantitative data analysis 
Adherence data was calculated for each session and whether the exercise 
session was complete or incomplete. This data was inputted into Excel initially, 
as the exercise diaries could not be cut and pasted into SPSS and then 
transferred to SPSS by the PhD student.  Descriptive statistics were used to 
explore adherence to the number of sessions and exercises completed within the 
session. In addition, comparisons were made between the two components of 
the exercise programme; prescribed and participant choice.  
 
Participants who completed the study, i.e attended their 12-month appointment 
were divided into those who had good adherence, as defined by averaging at 
least three sessions per week over the course of the 12 months, or not good 
adherence, averaging less than three sessions per week over the course of the 
year, by counting all sessions throughout the year and dividing by 52.  
 
Data analysis for adherence over time was calculated by the Robertson Centre 
for Biostatistics, as part of the WEBPASS grant, but was also included within this 
PhD. This was recalculated by the PhD student, as one participant was 
subsequently removed from the analysis because she did not meet the criteria to 
be included in the study. 
 
All demographic and outcome data were tested for distribution using the 
Kolmogorov–Smirnov test (Razali and Wah, 2011). Where a normal distribution 
was noted, mean and standard deviation were used and where data were not 
normally distributed, median, range and inter quartile range were used. To 
compare the adherence rates between the prescribed and participant choice 
component of the programme, a Wilcoxon Signed Ranks statistical test was used 






The relationship between the total completed sessions of the intervention and 
age, duration of disease, BASFI, BASMI, BASDAI, ASQOL, PA data and 6MWT was 
assessed using Pearson correlation coefficient, if data were normally distributed, 
and Spearman’s Rho correlation, where data were not normally distributed. 
Correlations of ≥0.30, ≥0.50 and ≥0.70 were considered small, moderate and 
large, respectively (Pett et al 1997). For the correlation analysis, the Bonferroni 
correction was applied to control for type I error from multiple comparisons and 
the statistical significance was pre-defined as p<0.025.  
 
4.5.5.2 Qualitative data analysis 
The telephone interviews were recorded and transcribed. Data were analysed 
using thematic analysis according to the six-phase method of identifying and 
analysing patterns in qualitative data described by Clarke and Braun (2013) using 
a general inductive approach. Initially, the transcripts were read and re-read in 
order for the CI and PhD student to become familiar with the data. Observations 
were noted on the transcriptions, as appropriate, during this stage and relevant 
codes were generated along with appropriate data extracts. The next stage of 
analysis involved the CI and the PhD student independently considering and 
collating the codes by hand, and making note of meaningful patterns in the data 
that were relevant to the research questions.  Themes and sub-themes were 
generated and reviewed, discussed and agreed by the CI (LP) and the PhD 
student (MTM).  
 
Themes and subthemes were then presented using pseudonym quotes, with 
participant age and number of completed sessions from the prescribed number 
of exercises, to illustrate the participant view. 
 
Rigour was enhanced during the process by ensuring an audit trail of the process. 
The CI and PhD student (MTM) were involved in reviewing each of the themes 
and subthemes. The principles of credibility, transferability and dependability 
were followed throughout. Credibility was ensured by triangulating the themes 
from a number of participants. Dependability was ensured by having both the CI 





maximum variation sample of those who adhered and did not. Reflexivity was 
promoted by completing a reflexive diary and regularly meeting with the 
research team to try minimise the bias this would bring to interpretation of the 
data.  
 
4.6 Results of WEBPASS Cohort Study 
Within this section the results of the PhD work relating to adherence within the 
interventional WEBPASS cohort trial are presented. This work aimed to explore 
adherence to the 12-month web based physiotherapy programme in more detail 
than in the main Versus Arthritis funded WEBPASS study, focusing on adherence 
levels; sessions and exercises completed, good adherence (defined as adhering 
at least three times per week), comparing adherence in the participant choice 
and physiotherapy prescribed components, adherence over time and evaluating 
factors which may affect adherence. In addition, data from the WEBPASS 
interviews related to adherence were analysed. The CONSORT flow diagram 
(Moher et al (2010) of participants’ progress through the different phases of the 




In total, 166 people were invited to participate in the study, with 139 invitations 
made directly at dedicated axSpA clinics, 9 people expressed an interest in 
participating after seeing the project published on posters, twitter and the NASS 
newsletter and 18 participants were referred by a doctor or physiotherapist. Of 
these 166 people, 116 were excluded for the following reasons: not interested in 
the study (n=32), already exercising more than three times per week (n=23), no 
access to the internet (n=14), significant co-morbidity that precluded exercise 
(n=5), joint replacement surgery less than six months ago (n=5), axSpA diagnosis 
less than one year ago (n=5), no axSpa diagnosis (n=4) or no information/reason 






Fifty participants met the inclusion criteria, were willing to participate in the 
study, and underwent screening and baseline measurements. Four participants 
withdrew prior to the six-month assessment for the following reasons: health 
issues (n=2), work commitments (n=1) and unable to access the programme 
(n=1), while four participants did not attend for their six-month appointment 
and therefore were lost to follow up (LTF). Between the six month and 12-month 
visits, a further 5 participants were LTF, one of these participants lost to follow 
up subsequently contacted the PhD student to advise that her diagnosis was 
revised from axSpA to chronic non-specific low back pain, although this 
participant’s data is included in the baseline data her data was removed from 
the subsequent adherence analysis. Thirty-eight participants (76%) completed 



























































• Not interested (n=32) 
• Exercising ≥ 3times/week (n=23) 
• No access to internet (n=14) 
• Co-morbidity (n=5) 
• Joint replacement ≤ 6 months ago 
(n=5) 
• Diagnosis ‹ 1 year (n=5) 
• No axial SpA diagnosis (n=4) 
• No information/reason given (n=28) 
Invited to participate (n=166) 
• Direct invitations in dedicated axSpA clinics (n=139) 
• Project publicity (Poster, twitter feed, NASS newsletter) 
(n=9) 
• Referred by physiotherapist and/or doctor (n=18) 
6 Month Assessment (n=46) 
• Completed (n=34) 
• Did Not attended 
appointment (n=12) 
o Missing (n=8) 
o LTF (n=4) 
12 Month Assessment (n=41) 
• Completed (n=38) 
• Lost to follow-up (n=3) 
Withdrawn (n=4) 
• Health issues (n=2) 
• Work commitments (n=1) 
• Unable to access programme (n=1) 
Withdrawn (n=5) 
• LTF (n-4) 







4.6.2 Demographics and baseline characteristics 
The cohort of 50 participants comprised of 23 males (46%) and 27 females (54%) 
(Table 4-1). The mean age was 50 years (SD 11.7) and mean time since diagnosis 
was 16.2 years (SD 11.9). All participants had a diagnosis of axSpa at baseline, 
48 (96%) participants had a subset diagnosis of AS and only two (4%) participants 
had a subset diagnosis of nr-axSpA. The mean Body Mass Index (BMI) across the 
sample was 27.2 kg/m2 (SD 5.58) with a range of 17-42kg/m2; 19 participants 
were of normal weight (BMI 18.5-25kg/ m2,), 14 people were overweight (BMI 25-
30kg/m2) and 11 participants were obese BMI >30kg/m2,), with missing weight 
and hence BMI data for 6 participants (NICE 2014). Twenty-one participants 
(42.1%) had no co-morbidities, 18 participants (36%) had one co-morbidity, eight 
participants (16%) had two co-morbidities and three participants (6%) had three 
or more co-morbidities. The most common co-morbidity was hypertension.  
 
The majority of participants (68%) were currently employed, with 30 working 
full-time and 4 part-time. Three participants were unemployed, one was a 
student, two were off work and 10 were retired. Forty-six participants (92%) 
walked with no aids while four (8%) participants walked with the aid of a stick. 
 
The mean baseline disease activity (BASDAI) was 4.6 (SD 2.27; range 0.4-8.7), 
with 58% with a BADAI score ≥4, indicating high disease activity and 42% with 
BASDAI <4 indicating low disease activity. The mean baseline function score 
(BASFI) was 4.5 (SD 2.6), which is below the reported patient-acceptable 
symptom state for the BASFI for this age-group and disease duration (Kviatkovsky 
et al., 2016).  The mean spinal mobility for the cohort, as measured by the 
BASMI, was 3.7 with a higher score indicating more restricted spinal mobility. 
The mean baseline ASQoL (quality of life) score was 9.6 (SD 5.8) out of a possible 
18, with a higher score indicating poorer quality of life. Health related quality of 
life, as measured by the mean ED-5D was 0.7, where the maximum score of 1 
indicates the best health state. 
 
Exercise capacity was measured using the 6MWT, and participants walked for a 





which was reported for 444 health subjects (238 males) from seven countries (10 
centres) ranging 40–80 yrs of age (Casanova et al., 2011). The mean score for 
attitude to exercise at baseline was 60.9 out of a possible 72, with a higher 







Table 4-1. Participant baseline characteristics. 
 n (%) Mean ± SD (range) 
Demographics  
Age (years)  50 ± 11.7 
Gender (M:F) 23:27 
(46:54) 
 
Disease duration since diagnosis (years)  16.2 ± 11.9 
Weight (kg)  76.9 ± 18.2 
Type of axSpA   
   AS 48 (96%)  
   nr-axSpA 2 (4%)  
No of Co-morbidities   
   0 21 (42%)  
   1 18 (36%)  
   2 8 (16%)  
   3 3 (6%)  
Work status & Impairment 
WPAI  42.4 ±27.9 (0-100) 
Paid Employment 34 (68%)  
Retired/medically retired 10 (20%)  
Unemployed 3 (6%)  
Off work 2 (4%)  
Student 1 (2%)  
Disease activity/mobility/function 
BASDAI (0-10)  4.6 ± 2.3 (0.4-8.7) 
   Low disease activity (BASDAI <4)  21 (42%)  
   Active disease activity (BASDAI ≥4) 29 (58%)  
BASMI (0-10)  3.7± 1.76 (0.4-7.5) 
BASFI (0-10)  4.5 ± 2.6 (0.4-9.3) 
Exercise capacity 
6 minute walk test (m)  406.5 ± 112.2 (121-622) 
Mobility 
Mobility with aid (stick) 4 (8%)  
No aid required 46 (92%)  
Attitude 
Exercise Attitude Questionnaire (n=48)  60.9 ±11.4 
Quality of Life  
EQ-5D (n=50)  0.7 ± 0.35 
EQ-5D VAS (n=50)  65.5 ±15.7 
ASQoL (n=50)  9.6 ± 5.8 
Current Treatments 
Anti-TNF 25 (50%)  
NSAIDs 30 (60%)  
Analgesics 22 (44%)  







4.6.3 Characteristics of Participants Completing and Not 
Completing Study. 
In order to determine whether participants who completed the study (to 12 
months) were different to those who did not complete the study, baseline 
characteristics of these two groups were compared (Table 4-2).  Compeletors of 
the study were those participants who attended their 12-month appointment 
(n=38). Non completors were those participants who did not attend their 12-
month appointment (n=12). There was no statistically significant difference in 
terms of demographics, work status, disease activity/mobility/function, exercise 
capacity, exercise attitude and quality of life between those who completed or 





Table 4-2. Baseline demographics of participants completing or not completing 12-month follow-up. 
 n (%) Mean ± SD (range) Completers (n=38) Non-completers (n=12) p value 
Demographics  
Age (years)  50 ± 11.7 Mean 50.8 ± 11.31 Mean 47.5 ± 12.96 0.35 
Gender: Male  
             Female 
23 (46%)  
27 (54%) 





Disease duration since diagnosis (years)  16.2 ± 11.9 17 ± 12.4 13.5 ± 10.3 0.73  
Type of axSpA      
   AS 48 (96%)  36 12 1 
   nr-axSpA   2 (4%)  2 0  
No of Co-morbidities      
   0 21 (42%)  16  5  0.85 
   1 18 (37%)  14 4   
   2 8 (16%)  6  2  
   3 3 (5%)  2  1   
Work status & Impairment 
WPAI  42.4 ± 27.9 (0-100) 40.5 ± 30.9 48.3 ± 14.7 0.4 
Paid Employment 34 (68%)  25 9 0.75 
Retired/medically retired 10 (20%)  7 3  
Unemployed 3 (7%)  3 0  
Off work 2 (4%)  2 0  
Student 1 (2%)  1 0  
Disease activity/mobility/function 
BASDAI (0-10)  4.6 ± 2.3 (0.4-8.7) 4.9 ± 1.6 4.4 ± 2.45 0.53 
   Low disease activity (BASDAI <4)  21 (42%)     
   High disease activity (BASDAI ≥4) 29 (58%)     
BASMI (0-10)  3.7± 1.76 (0.4-7.5) 3.87 ± 1.74 3.6 ± 1.78 0.82 
BASFI (0-10)  4.5 ± 2.6 (0.4-9.3) 3.87 ± 1.74 3.6 ± 1.78 0.82 
Exercise capacity 
6MWT(m)  406.5 ± 112.2 (121-622) 406 ± 91 406 ± 119 0.86 
Motivation/ Attitude 
Exercise Attitude Questionnaire (n=48)  60.9 ±11.4 54.6 ± 8.2 62.6 ± 11.5 0.30 
Quality of Life 
EQ-5D VAS (n=50)  65.5 ±15.7 66.34 ± 16.4 62.91 ± 13.3 0.288 





4.6.4 Baseline Exercise Level 
Participants were only eligible for the study if they self-reported that they were 
not exercising ≥3 times per week. Twenty-eight participants (56%) self-reported 
that they did not exercise at all at baseline. Twenty-two participants (44%) self-
reported that they did some form of exercise; eight participants exercised once 
per week, eight participants exercised twice per week, four participants 
reported exercising three times a week and two participants initially reported 
exercised more than three times per week. On further questioning, the two 
participants who self-reported exercising three or more times a week, were in 
fact describing physical activity, such as walking to work, rather than exercise, 
so these participants were included in the study. The mean number of self-
reported exercise sessions for the cohort at baseline was 2.1 sessions per week 
(SD 1.4).  
 
4.6.5 Adherence to Number of Sessions over 12 months for all 
Participants 
To answer how many sessions of web-based physiotherapy individuals engaged 
with, adherence to the number of sessions in the exercise programme was 
assessed by calculating the number of sessions for each individual and then the 
percentage of exercise sessions over 12 months (number of sessions engaged in 
divided by maximum 260 based on five exercise sessions per week over 52 
weeks). The data for all participants is shown in Table 4-3. Note that totals only 
add up to 49 as the participant (study number 43) whose diagnosis changed 







Table 4-3. Adherence to prescribed sessions of exercise all participants (n=49) – shown in order 












48 260 0 0 no  
21 260 0 0 no  
15 260 0 0 yes 
30 260  0 0 no  
8 260 0 0 yes 
39 260 0 0 yes 
36* 260 0 0 yes 
27 260 1 0.4 yes 
29 260 1 0.4 yes 
20 260 2 0.8 no  
16 260 4 1.5 no  
3 260 8 3 no  
13 260 9 3.5 yes 
42 260 11 4.2 yes 
9 260 13 5 no  
44* 260 19 7.3 yes 
35 260 19 7.3 yes 
32 260 17 6.5 no  
25* 260 28 10.8 yes 
38 260 33 12.7 yes 
10 260 36 13.8 yes 
14 260 38 14.6 no  
28 260 42 16.1 yes 
17* 260 43 16.5 yes 
22 260 46 17.7 no  
18 260 46 17.7 yes 
23 260 46 18 no  
5* 260 52 20 yes 
19 260 78 30 yes 
50 260 80 30.8 yes 
4 260 92 35.4 yes 
49 260 96 36.9 yes 
11* 260 105 40.4 yes 
2* 260 106 40.8 yes 
24* 260 108 41.5 yes 
7 260 109 41.9 yes 
46 260 116 44.6 yes 
45 260 134 51.5 yes 
26 260 135 51.9 yes 
47 260 144 55.4 yes 
6 260 145 55.8 yes 
1* 260 151 58.1 yes 
41 260 168 64.6 yes 
34 260 169 65 yes 
37 260 176 67.7 yes 
33* 260 181 69.6 yes 
31 260 225 86.5 yes 
40 260 227 87.3 yes 
12 260 260 100 yes 
Total 12,740 3519 27.6%  





* indicates participants who participated in interviews.  
 
The percentage of sessions undertaken ranged from 0-100%. Overall 3519 out of 
a total of 12,740 potential exercise sessions (27.6%) were completed. Seven 
participants did not initiate their exercise programme, engaging in zero sessions. 
Only one participant engaged in all 260 sessions. 
 
4.6.6 Adherence to Sessions for Participants Who Completed and 
Did Not Complete the Study 
In order to illustrate differences in adherence rates between participants who 
completed the study, (as determined by attending their 12-month appointment) 
and did not complete the programme and also to compare participants who 
initiated the exercise programme and did not, Table 4.4 presents the adherence 
to sessions (number and percentage) as a group for participants who did and did 
not complete the study, and who did and did not initiate the exercise 
programme. 
Table 4-4. Adherence for participants who completed (completers) and did not complete (non-
completers) the study. 
 




Number of Sessions 
Percentage (SD) 
Completers (n=38) 9,880 3345 33.8 (± 28.6)% 
Completers removing 
those who did not start 
(n=34) 
8,840 3345 37.8(± 28.3)% 
Non-completers (n=11) 2869 174 6.1(+7.8)% 
Non-completers removing 
those who did not start 
(n=8) 
2080 174 8.3 (+7.2)% 
 
 
For those participants who completed the study (n=38), overall their percentage 
adherence was higher than those who did not complete the study (n=11), 33.8% 
versus 6.1%. Furthermore, for participants completing the study when removing 
those who did not initiate any sessions of web-based physiotherapy, the overall 






For participants who did not complete the study they represent low adherence 
rates overall, 6.1% which rises to 8.3% when removing those who did not initiate 
any sessions of the WEBPASS study. 
 
4.6.7 Adherence for Participants  
In order to illustrate the range of adherence to sessions over the 12-months for 
participants, the results are presented by box plots (Figure 4-8). 
 
 
Figure 4-8. Boxplots showing the number of sessions completed over the 52 weeks for all 49 
participants, and for completers and non-completers of the study.  
 
 
The maximum number of sessions was 260 over the year for each participant. 
The first box plot from the left represents participants (n=11) who did not 
complete the study. For these participants the range of sessions completed was 





percentile of 38 sessions. The second box plot represents participants who 
completed the study (n=38). For these participants the range of sessions was 
between 0-260 with a median of 86 sessions, 25th percentile of 19 sessions and 
75th percentile of 144 sessions. The final box plot represents all participants. 
For these participants the range of sessions was between 0-260, the median of 
46 sessions completed, the box indicates the 25th percentile of 8.5 sessions and 
75th percentile of 125 sessions.  
 
Although adherence overall to the exercise programme was low, for those 
completing the trial the adherence to sessions was much higher. 
 
4.6.8 Participants with Good Adherence 
Good adherence was defined as being met if the participant completed an 
average of at least three exercise sessions per week throughout the 12-month 
programme (at least 156 sessions out of the overall possible total of 260). 
Considering the 38 participants who completed the study, only seven 
participants (18.4%) met the pre-defined criteria for good adherence for the 
year. Thirty-one participants who completed the 12 months of the study adhered 
to less than 156 sessions overall (Table 4-3). 
 
4.6.9 Adherence to Prescribed and Participant Choice Components  
The participants’ weekly exercise programmes consisted of two components: a 
prescribed component (3 times per week, 156 possible sessions per participant, 
7,644 sessions for all participants) and a participant choice component (2 times 
per week, 104 possible sessions per participant, 5,096 sessions for all 
participants). In order to assess whether adherence differed, the adherence rate 
(percentage of completed sessions) was assessed for each component, for all 
participants (n=49) (Table 4-5). The adherence to each component for each 







Table 4-5. Adherence rates for the prescribed and participant choice components of programme 
(n=49).  


















19.7 (± 24.8)% 
 
 
Overall the participants’ adherence rate was higher for the prescribed 
component of the exercise intervention (32.9% of all sessions completed) than 
the patient choice component (19.7% of all sessions completed).  
 
A Wilcoxon signed ranks test found that adherence with the prescribed exercise 
component was significantly higher than the patient-choice exercise component 
in this study (p<0.001).  
 
4.6.10 Adherence to Content of Prescribed Component of Exercise 
Previous sections have described adherence across the programme and across 
exercise sessions as a whole. However, it is also important to consider adherence 
within each prescribed exercise session. If all prescribed exercises within an 
exercise session were carried out, the session was considered as “complete”, 
whereas if any prescribed exercise in the session was missed, the session was 
defined as “incomplete”. Table 4-6 below shows the summary of complete and 
incomplete prescribed exercise sessions. Only prescribed exercise sessions that 
were initiated (2515) were analysed to investigate whether all the exercises that 
were prescribed within the session were completed. Appendix 5 presents the 










Table 4-6. Number of initiated prescribed exercise sessions that were complete or incomplete. 
 
 Sessions Complete Sessions Incomplete 
Total Number of sessions 
(n=2515) 
1850 665 
Percentage of total sessions 74% 26% 
 
The data shows that when exercise sessions were initiated, the majority (74%) of 
these sessions were completed fully, with approximately a quarter (26%) of 
initiated sessions incomplete.  Once participants initiated an exercise session, 
most of the time they completed each exercise within the session.  
 
4.6.11 Adherence over Time 
Adherence to any activity or lifestyle programme is not constant but is likely to 
change over time. In order to evaluate how adherence to this exercise 
programme changed over time, adherence each week within the 12-month 
intervention was analysed.  
 
4.6.11.1 Adherence over time: Sessions 
Adherence over time was first calculated as the percentage of sessions for each 
week for all participants adjusting for when participants withdrew or were lost 
to follow up (Figure 4.9). Thirty-eight participants completed the trial (3 
participants were lost to follow up at the last (12 month) study visit, 8 






Figure 4-9. Percentage of Completed Exercise Sessions each Week for All Participants, adjusting for when withdrew and lost to 



























The weeks with the highest percentage of sessions engaged with were early in 
the study, with 47% and 49% of all sessions for weeks 2 and 3, respectively. 
These weeks coincided with when the PhD student contacted the participant by 
phone. A few participants had trouble logging on to their programme, which 
explains the relatively lower adherence in week 1 in comparison to week 2.  A 
general downward trend is observed from week 3 (49%) until week 19 (23%), 
apart from a small temporary increase in adherence at weeks 9 and 10 (40% and 
40.4% respectively).  
 
Around the six-month mark, the adherence level increased (from 23% in week 19 
to 39.1% in week 22), and was sustained above 34.8% until week 28. This 
increased adherence coincided with attendance for the third study visit (6 
months ± 2 weeks). A further gradual downward trend is then seen, with 
occasional spikes, from week 29 (29.5%) until week 36. After this, adherence 
plateaus between 17.1% and 27.1% until the end of the study, with the nadir at 
week 50 and peak at week 47, when the final study visit was being arranged. 
 
4.6.11.2 Adherence over Time: Good Adherence 
Good adherence was defined if participant engaged with an average of at least 
three exercise sessions per week throughout the programme. The percentage of 
participants who had good adherence for each week of the 12-month study 
period was calculated, again adjusting for participants who withdrew or were 































The overall trend for good adherence rates (Fig 4-10) was similar to that for 
adherence to weekly sessions (Fig 4-9). Good adherence was highest at the start 
of the study, peaking during weeks 2 and 3 with 49% and 55% of all participants 
achieving good adherence, respectively. The relatively lower adherence in week 
1 compared to week 2 is again likely due to difficulties logging on to the 
programme. Good adherence was lowest at the end of the trial, with only 15% of 
all participants achieving good adherence. Overall the first 10 weeks of the trial 
had higher rates of good adherence (35.4%- 55.1%of participants), with a second 
increase between weeks 22-29 (33%-41.3 %of participants), which coincided with 
the six-month assessment.   
 
4.6.12 Factors Associated with Adherence 
To determine which factors were associated with higher adherence, the 
associations between a number of baseline demographic and disease measures 
and the number of sessions of exercise completed were explored. These baseline 
measures were chosen, based on previous literature and plausible associations, 















































Category Variable  Sessions Completed  
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Attitude to exercise Attitude (total score from 
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(measured with six minute 








There were no significant associations (P>0.025) between baseline 
demographics, disease measures or any of the other measures and exercise 
sessions completed. 
 
4.6.13 Adverse events and complications 
While exercise is established as a key component in the management of axSpA 
and adherence with the web-based exercise programme was the primary 
outcome, the safety of this approach also needs to be considered. There were 4 
serious adverse events and 15 adverse events recorded during the study (Tables 
4-8 and 4-9). None of the serious adverse events were deemed to be related to 
the study intervention or any study procedures.  
 
In terms of adverse events, there were three adverse skin reactions due to the 
waterproof dressing used to attach the ActivPAL physical activity monitor. There 
were five musculoskeletal reactions (three axSpA disease flare ups and two with 
increased localised pain in neck/knee) that were considered possibly related to 
the exercise intervention. These axSpA flares ups occurred early in the study on 
commencing the exercise programme and, as there was some concern this was 
related to too rapid increases in exercise intensity, the exercise programmes 
were amended so that exercises were introduced more gradually for subsequent 
participants. There were also three episodes of axSpA flare ups that were not 
considered related to the study intervention as these occurred in people who 
were not exercising (not adhering) to the exercise regime, or who had been 
exercising at their current exercise level with no change in their programme and 
occurred during concurrent infections. An increase in hip pain was recorded but 
this was deemed not related to the trial as the participant was known to have an 
old hip replacement, which needed revision. There were three further adverse 
reactions of pins and needles, kidney stones and drug reaction, which were 






Table 4-8. Serious Adverse Events. 
Serious Adverse Events  Assessment of relationship to study  
Breast cancer (n=1)  Not related to intervention 
Fractured humerus (n=1)  Not related to intervention 
Lung Cancer (n=1) Not related to intervention 
Hospital stay for headache (n=1) Not related to intervention 
 
Table 4-9. Adverse Events. 
 
Adverse event Assessment of relationship to study 
Skin reaction to activity monitor 
waterproof dressing (n=3) 
Related to study procedure (activPAL) 
Generalised axSpA flare (n=3) Possibly related to intervention 
Infection and axSpA flare (n=3) Not related to intervention 
Increased neck pain (n=1) Possibly related to intervention 
Increased knee pain (n=1) Possibly related to intervention 
Increase hip pain (n=1) Not related to intervention 
Pins and needles (n=1) Not related to intervention 
Kidney stone (n=1) Not related to intervention 
Drug reaction* (n=1) Not related to intervention 





4.6.14 Telephone interview results 
Twenty percent of participants (10 out of 50) were interviewed as part of the 
qualitative component. There was an equal gender split with five male and five 
female interviewees, age range of 47-79 years. Eleven participants were invited 
to interview, with one participant (p12) unable to commit to the telephone 
interview due to work commitments. This participant was the only participant 
with full adherence (p12, p 103). The number of sessions adhered to by this 
group ranged between 0 and 181 sessions, as illustrated by * in Table 4-3. To 
allow comparison between responses from the same participant and between 
different participants, each participant was given a pseudonym. Participant 
demographics and pseudonyms are shown in Table 4-10. Only Sophie, met the 
criteria for good adherence. 







Total number of 
sessions engaged in 
Sophie 33 Female 55 181 
John 1 Male 79 151 
Mary 24 Female 60 108 
Laura 11 Female 50 105 
Robert 2 Male 54 106 
Fred 5 Male 52 52 
Gary 17 Male 47 43 
Fay 25 Female 79 28 
Peter 44 Male 49 19 
Hannah 36 Female 61 0 
 
4.6.14.1  Themes from Qualitative Data Evaluation 
From the qualitative programme evaluation, two key themes were identified 
from the data. The first theme was views on the web-based physiotherapy 
approach with three sub-themes identified; content, accessibility and usability. 
The second theme was adherence to the programme with four sub-themes; 








For the first theme identified: the participants’ views on the web-based 
physiotherapy approach, a sub-theme related the specific content of the web-
based physiotherapy programme emerged. This included aspects such as the 
behaviour change techniques incorporated into the programme. The most 
frequently reported aspect of the website that participants found helpful were 
the exercise videos. The behavioural technique of comparison of behaviours and 
repetition were provided in the form of exercise videos, which also included 
written and spoken instruction. Four participants commented that they used the 
exercise videos to compare their own exercise technique to the technique 
showed in the videos. This increased confidence levels that they were 
performing their exercise correctly. The exercise videos were felt to be superior 
to an exercise sheet or leaflet. 
 
‘(previously) a physio gave me some sheets to study and I found it difficult 
because I didn’t know if I was doing it properly and eh, lets be honest, you 
don’t always do it! So for me the web-based was very good because you could 
actually watch people doing it so you could follow and know how to do it..yeah I 
think for me watching somebody do something is much better than a leaflet’ 
(P2 Robert, age 54, 106 sessions) 
 
 ‘What I do find is the web-based one, em, you know exactly what to do because 
someone is doing it in front of you and you’re following it, copying them. So you 
know you’re doing the exercise correctly’ (P11 Laura, age 50, 105 sessions) 
 
‘Its good having the videos to go back to it check if you’re still doing it right’ 
(P33, Sophie, age 55, 181 sessions) 
 
‘I think it’s good because well you know you’ve, cos of the little video’ (P5 
Fred, aged 52, 52 sessions) 
 
The content sub theme within the views of the web-based programme also 




Each individual was assessed by a physiotherapist and the programme was 
prescribed based on assessment findings and relevant to their condition. This 
was reported to be of benefit, with two participants commenting on this aspect 
of the programme: 
 
‘The good thing is with this programme is that it’s recommended by you 
[physiotherapist], so you’re telling me what to do for my condition. So I’d hate 
to do something off YouTube or a DVD and discover that I’m doing it wrong or 
causing more damage’ (P2, Robert, age 54, adhered to 106 sessions) 
 
Another participant compared the programme to other apps and online 
resources:  
 
‘The unfortunate thing with that [other apps/resources] is that it’s not 
specifically for myself’ (p11, Laura, age 48 105 sessions) 
 
It was noted that these two participants had relatively good adherence, 
therefore individualising the intervention may be an important aspect in 
adherence. 
 
The second sub-theme of the views of the web-based physiotherapy theme was 
accessibility. This related to the participants’ views on convenience when 
accessing the programme and resource. The opportunity to choose when and 
where to access the website was reported as an advantage of the web-based 
physiotherapy approach. Five participants reported a preference for exercising 
in the privacy of their own home as it was more convenient, avoided the 
embarrassment of exercising in front of others and fitted in with other daily 
activities.  
 
‘It’s great [exercising at home] You’re more likely to do it ….but as far as I’m 
concerned it’s perfect doing it in the house. It’s much more convenient and I’m 
much more likely to do it. …and after a while you look forward to it. … I think 





‘I prefer to do it in my own home because I get a bit embarrassed being in 
amongst other people sometimes’ (P11 Laura, age 50, 105 sessions). 
 
‘Oh I’m happy with that [exercising at home]. I wouldn’t dream of exercising in 
a group, that’s not my character’ (P25, Fay, aged 79, adhered to 28 sessions) 
 
‘it’s very good because you can do it in your own time which is good and so 
obviously do it when you want to. Personally I’d rather do it at home, I 
wouldn’t want to do it in a group, I don’t really like group activities and I think 
a lot of people would rather do it. Well it’s up to the individual, some people 
like doing group activities, some people might get embarrassed but eh, for me, 
I’d rather do it on my own’ (P2 Robert, age 54, adhered to 106 sessions) 
 
‘I think it actually makes it easier because you just do it when you’ve got time 
whereas if you’ve got to go to a gym or a community you need to then, there is 
extra effort’ (P5, Fred, aged 52, adhered to 52 sessions) 
 
In contrast, two participants reported missing the social interaction and social 
aspects of exercising with others. 
 
 ‘if I had been in a group, that might have helped but it was lonely’ (P36, 
Hannah, aged 61, 0 sessions) 
 
‘for me there is no substitute for going to a class which was led by a 
physio……just being around people that have the same thing, you can relax’ 
(p44, Peter, aged 49, 19 sessions) 
 
Participants who preferred exercising at home appeared to complete more 
sessions although P28 Fay did not, illustrating there were some exceptions. 
 
The third sub-theme within the views on the web-based programme was 
usability. This was the ease at which participants were able to use the web-
based physiotherapy programme. Three participants commented that the 





‘it was simple and straight forward…. I thought it was very easy to use and user 
friendly. It was a nice format, easy to use, I think’ (P44, Peter, aged 49, 19 
sessions) 
 
‘I think it’s easier to follow in some ways, you can d o it in your own time and 
can be – it’s well laid out’ (P5, Fred, aged 52, 52 sessions)’ 
 
‘it’s good and it’s certainly made me remember a lot more. I have no criticisms 
at all and I think it’s been so far a good thing for me’ (P24, Mary, aged 60, 108 
sessions) 
 
However, it was noted that although the participants found it easy to use, this 
did not always translate into higher adherence.  
 
However, one participant also found accessing the programme on their device 
difficult: 
 
‘My problem was that, I’ve got internet in the house but my tablet, I had 
problems with my tablet so that caused a bit of trouble… cos I’m not good with 
computers so I struggled initially. Sometimes it wouldn’t upload and sometimes 
it would, eh, I couldn’t get volume on it. And then later it was ok’ (P2 Robert, 
age 54, adhered to 106 sessions) 
 
Not being able to record some exercise sessions appeared to be a problem for 
two participants as the programme at that time did not allow people to 
retrospectively complete exercise diaries. 
  
‘So a few times, or quite a lot of times I’ve not put it in but I’ve done all the 
exercises… it’s a bit frustrating’ (P24 Mary, aged 60, 108 sessions).  
 
Therefore, in this participant’s case her adherence may be higher than that 
recorded. 
 
‘really frustrating because you can’t go back. That’s one of the things that’s 




exercises, you want to tell someone you’ve done them and get brownie points 
for it and you’ve not got the connection you can’t do it, so that’s definitely an 
issue’ (p33 Sophie, age 55, adhered to 181 sessions) 
 
The second theme was adherence to the programme. This highlighted some 
challenges that individuals faced, even when they intended to adhere to the 
programme. The subthemes identified here were: starting and maintaining the 
programme, symptoms, getting into a routine and support. 
 
Two participants found it difficult to start the programme; 
 
‘A lot of people maybe have the inclination to do it. I’m afraid I’m just a bit 
lazy when it comes to things like that… I’ve great intentions that never really 
materialise’ (P44 Peter, aged 49, 19 sessions) 
 
‘it took me a couple of weeks to get into it’ (P5, Fred, aged 52, 52 sessions) 
 
Three participants noted difficulty in maintaining the programme. Their 
adherence reduced over time, even though they intended to adhere to the 
programme, with some commenting on life events getting in the way of their 
intention to exercise: 
 
‘well started off very good ….And we looked forward to doing it and I think it 
was about November that we fell away. A lot happened with my aunt being 
unwell and then we had a holiday and after that it just got on top of me and I 
didn’t get it done. Right and it wasn’t because I didn’t want to do it’ (P2 
Robert, age 54, 106 sessions) 
 
 ‘Over the year… I think… I think I attended more at the beginning of the course 
and it just kind of tail off. I was ashamed to say’ (P44, Peter, aged 49, 19 
sessions)  
 
 ‘you can be really enthusiastic about something when its new and then it tails 





Symptoms was a sub-theme of adherence. When individuals noticed an 
improvement in symptoms, such as feeling better or if they experienced less 
pain, this would help them adhere to their exercise programme: 
 
‘because I find it works…. because it makes me feel better’ (P25 Fay, aged 79, 
28 sessions) 
 
It is worth noting that this participant did very few sessions even though she had 
noted that exercise improved her symptoms.  
 
‘I don’t want to be stiff. And now I’m much more supple I’m enjoying it and I 
don’t want to take pain killers if I am sore, so obviously exercise is simple, it’s 
like a tablet isn’t it, if you take it you aren’t going to be sore. And now I know 
that if I do get a flare up and I’m sore, maybe a bit of exercise can be the 
answer’ (P2 Robert, age 54, 106 sessions) 
 
‘I feel better, I feel em, I feel I’m achieving something (P11 Laura, age 50. 105 
sessions)’ 
 
‘feeling good (helps do the programme)’ (P1, John, age 79 adhered to 151 
sessions)’ 
 
In comparison, one participant commented that if symptoms weren’t too 
troublesome, then they didn’t feel the need to exercise 
 
‘because my condition is really quite good now between getting the new hips 
and the good medication, I just don’t feel a great need for it, going to the class 
but the big thing is that if my condition deteriorated, then I would need to, I 
would really need to look at a web based thing where I have to do it in the 
house. If my condition was bad it would have motivated me to do more but 
because I’m good I taken my foot off the pedal, the gas’ (P44, Peter, aged 49, 
adhered to 19 sessions) 
 
The perceived lack of need for exercise for his condition may explain the low 





In contrast, if an individual noticed troublesome or increased symptoms when 
exercising, such as pain or fatigue, they reported they were less likely to stick to 
their exercise programme: 
 
‘if you feel the pain is worse then you don’t do as much as you should’ (P25 Fay, 
aged 79, 28 sessions) 
 
‘when I had an off day where my hip was sore or my shoulder was inflamed and 
I found it hard. Also my neck flared up and even though they say it helps it, it 
was just that I wanted to just lie down and sleep to get over it. It’s the fatigue 
that gets you because you’re tired and also when you do exercises you can 
actually make bits sorer and it can last for days’ (P36, Hannah, aged 61, 
adhered to 0 sessions) 
 
Of note with the above comments is the low number of sessions completed in 
those who commented their symptoms were troublesome. 
 
Finding a routine, was identified as a sub-theme of adherence. Adherence 
appeared to improve if an individual was able to find a routine with their 
exercises: 
 
‘the main thing is to get into a routine and then you actually enjoy it. Look 
forward to it. In fact, you miss it if you don’t do it. Routine is one of the main 
but also feeling good’ (P1, John, age 79, 151 sessions) 
 
‘it’s, see I’ve got into the habit of well, cos I’ve now got into the routine of the 
exercises’ (P5 Fred, aged 52, adhered to 52 sessions) 
 
In contrast, social pressures, such as Christmas or family, were identified by 
participants as a barrier to adhering to their exercise programme: 
 
‘There is occasional days when there’s so much family stuff going on that I’m 
just too tired to do them all. I do some of them every day but I don’t do them 




and more tired and I wasn’t able to do as much and just wee phases when I’ve 
been having a flare as well’ (P24 Mary, aged 60, adhered to 108 sessions) 
 
‘coming near to the holiday time it sort of dropped a wee bit and then during 
the holiday sort of got back’ (P5 Fred, aged 52, 52 sessions) 
 
‘before Christmas I had a bad cold and there’s lots of stuff going on and I kind 
of didn’t do as much in the run up’ (P33 Sophie, age 55, 181 sessions 
 
Support was identified as being important in terms of adherence to the exercise 
programme. In the study, support was included the PhD student being in regular 
contact and checking participants’ exercise diaries: 
 
‘it’s good, I need people to see I’m doing it right, I need pushed to do things.. 
Like when you say to me you want to check it [the exercise diary], I mean that’s 
good’ (P17, Gary, age 47, 43 sessions) 
 
‘over the years I’ve had personal programmes and things over year, you know to 
follow. And I did go through stages where I would do it and be really good and 
then I would fall away from it again. But I wasn’t as, so this time em I’ve been 
finding that I have been kinda sticking to it. Probably cos I know someone’s, you 
know, kinda checking it as well you know’ (P11 Laura, age 50, 105 sessions) 
 
Support could also be from family.  
 
‘.. I think summer time I did a wee bit more as well plus I was going to ____ 
[holiday] so I thought I better get out and do something ...looking in the mirror 
sometimes and getting encouraged to do it. My partners on my case so I better 
do it (laughs)’ (P17, Gary, age 47, 43 sessions) 
 
‘I could look at my diary and discover like ok I’ll do that day and that day but 
my wife is very good and she forces me into doing it … so we both done it 
together so she was good at saying you’ve got to do it but eh yeah. You can’t 
fall by the way side, its good someone else doing it with you because they give 







This PhD study aimed to explore adherence in the Versus Arthritis WEBPASS 
cohort study. The PhD study measured adherence levels and factors affecting 
adherence to a 12-month web-based physiotherapy programme. The programme 
consisted of an individualised exercise programme three days per week and 
patient choice of exercise two days per week. To explore adherence to the 
WEBPASS programme a number of different methods were investigated. Firstly, 
the number of sessions participants engaged with (doing at least one exercise 
within the session) was measured. Secondly, how many participants had good 
adherence (pre-defined as engaging in a mean of at least three sessions a week 
over the year) was calculated. Thirdly, a comparison between adherence levels 
of the patient choice and the prescribed component of the programme was 
examined. Fourth, to measure if all individual exercises completed within the 
prescribed sessions were completed. To consider adherence over the course of 
the intervention, the number of participants who had good adherence each week 
of the intervention and the number of engaged sessions were calculated. The 
baseline factors affecting adherence were also investigated. Finally, qualitative 
data from the WEBPASS interviews specifically relating to adherence were 
interpreted. 
 
4.7.1 Adherence to Sessions Engaged with 
Firstly, the PhD study measured the number of sessions that participants 
engaged with. The results of this study found that overall participants in the 
study adhered to 27.6% of all available sessions. This is notebaly lower than the 
51%-95% rates of adherence reported in the systematic review (Chapter 3) 
(McDonald., 2019). The types of exercise interventions, characteristics of the 
participants and differing measures of adherence potentially account for the 
differences in adherence rates between the WEBPASS cohort study and the 
studies included within the systematic review.  
 
Within Chapter 3 the duration of interventions ranged from 6 weeks (Hidding et 




study within the systematic review reported an intervention of longer than 9 
months with 95% adherence to a once weekly exercise session at 12 months. This 
adherence rate is open to reporting bias as participants were only asked about 
adherence once, at the end of the study. Therefore, poor recall may have 
affected this result (Fernandez-de-Las-Penas et al. 2006). McPhate et al (2013) 
suggest that the longer the duration of any given intervention, the lower the 
level of adherence. Five of the studies included in the systematic review had 
interventions that lasted for 12 weeks or less with two of the studies reporting 
adherence rates of 76.6% and 75% (Gross & Brandt 1981, Barlow & Barefoot 
1996, Niedermann et al., 2013, Chimenti et al 2014, Svaass et al., 2020). In the 
first 12 weeks of the WEBPASS cohort study, the percentage adherence of 
sessions engaged in was notably higher than the last 12 weeks of the study (33% - 
49% first 12 weeks versus 17 -27% last 12 weeks). However, the longer duration 
of the WEBPASS intervention may only partly explain the lower adherence rate, 
the frequency of session may have also played a role. Other possible factors 
include participants in the WEBPASS study had high disease duration (mean 16.9 
years), high disease activity, low baseline exercise levels and the method of 
measuring adherence. 
 
Within WEBPASS, participants were required to do exercise sessions five times 
per week, while the number of weekly exercise sessions in the studies reported 
in Chapter 3 ranged from once to daily. The highest rate of adherence reported 
in the systematic review (Chapter 3) was 95% for a once weekly intervention 
over 12 months. However, as mentioned this rate may be biased due to the 
measurement of adherence of asking participants once at the end of the 12-
month intervention (Fernandez-de-Las-Penas et al., 2006). Three linked studies, 
using the same participants in the systematic review reported adherence to a 
daily HEP, with some participants receiving an additional supervised component 
and reported 86% (12 weeks), 51% (nine months) and 63% (nine months) of 
minutes of the prescribed HEP completed, higher than the overall 27.6% 
reported to a less frequently prescribed HEP than in WEBPASS (Hidding et al., 
1993, Hidding et al., 1993, Hidding et al., 1994). Differences in how adherence 
was defined and measured may have contributed to the different adherence 
results, while it also possible that people who agree to participate in a series of 




This possibility is supported by the unusual lack of any drop-outs over the 20 
months of these three studies. Furthermore, within the Hidding et al studies, the 
participants were relatively newly diagnosed (less than 8 years see Fig 3-4, 
chapter 3) compared to the cohort within WEBPASS who had a mean diagnosis of 
16.2 years. Therefore, the WEBPASS cohort may represent an older population 
who have become less motivated to exercise having had the condition for several 
more years. It is also possible that the addition of supervision of the exercise 
sessions for some of the participants in the Hidding et al studies also contributed 
to higher adherence.  
 
Troublesome symptoms such as pain and fatigue may reduce adherence (Jack et 
al., 2010), this is fully discussed in the factors affecting adherence section 
(4.7.7). Of note 58% of participants within WEBPASS were classed as having high 
disease activity, which potentially reduced adherence. Furthermore, the low 
baseline exercise activity of the participants in the present study is likely to be 
an important factor, discussed below. 
 
In order to demonstrate change in activity levels, the WEBPASS study was 
designed to recruit axSpA patients who were not currently exercising. The 
WEBPASS cohort study inclusion criteria required that people should not be 
exercising more than three times per week, whereas no such inclusion criteria 
on baseline exercise were noted for studies within the systematic review. 
Research has shown that people who are physically active are more likely to 
adhere to HEPs (Schoo et al., 2005, Jack et al., 2010). However, the majority 
(n=28) of participants who were recruited to the WEBPASS cohort study were not 
exercising at all.  Therefore, this may account for the lower overall adherence 
figures in WEBPASS in comparison with the studies within Chapter 3.   
 
It is standard practice for all patients with axSpA in the local health board, NHS 
GGH to be regularly informed of the need to exercise as part of their standard 
care. It is therefore likely that participants would have been informed of the 
importance of exercise before joining the study, although if they had retained 
this knowledge was not formally assessed as part of this study. Despite the 
probability of having the knowledge of the importance of exercise the majority 




form of initiating and then maintaining exercise participation is challenging 
(Meade et al., 2019). Individuals can know the benefits of exercise but have no 
intention of starting or continuing with an exercise programme, described in the 
literature as the knowledge-behaviour gap (Connell et al., 2016). It could be 
argued that our participants had the intention of exercising, as they volunteered 
for the study, although it is also possible they felt they should participate or felt 
encouraged to do so by the physiotherapist; without the intention, commitment 
or ability to actually do this. When intentions do not translate into desired 
action, this is commonly referred to in behaviour change literature as the 
intention-behaviour gap (Kersten et al., 2015).  Evidence suggests that, within 
the general population, intentions are only translated into action between 20-
50% of the time (Kersten et al., 2015,  Bassett, 2015). The overall adherence 
rate of 27.6% of exercise sessions completed concurs with intentions translating 
into action 20-50% of the time and therefore is consistent with what is expected 
in changing behaviour (Kersten et al., 2015). 
 
The measurement of adherence most probably played a role in the lower 
adherence rate found in WEBPASS in comparison to the previously published 
literature. In WEBPASS an electronic diary was utilised which only allowed 
participants to complete their exercise diaries measuring adherence on the day 
of exercise. This may have resulted in an underestimate of the adherence for 
participants who carried out their programme but did not fill in the diary due to 
either internet connection issues or forgetfulness and is discussed in section 
4.7.8. 
 
4.7.2 Good Adherence 
The PhD study aimed to find out the number of participants with good 
adherence. Seven of the 49 participants in the WEBPASS trial did not initiate the 
exercise intervention, completing no sessions at all. For those who provided 
adherence data for the 12-months (n=38), only 18% (7/38) achieved good 
adherence according to our pre-defined cut-off. This indicates difficulties for 
some people in initiating an exercise programme, whilst for others maintaining 
the WEBPASS exercise programme was the issue. Overall adherence to sessions 




also identified in the telephone interviews where two participants with low 
adherence (19 and 52 sessions) commented that they found it difficult to initate 
the programme, and three participants, again with low adherence (19, 55,106 
sessions) found that their adherence tailed off throughout the year.  
 
Although pre-defining good adherence illustrated the small number of 
participants who achieved ‘good’ adherence over the study and highlighted the 
difficulties in maintaining the programme it should be recognised that there is 
no standard measure of what constitutes good adherence (Vitolins et al. 2000). 
Although research in OA shows a link between the clinical outcomes achieved 
and adherence (Pisters et al 2010), no such link exits for people with SpA. Future 
research could link adherence to outcomes in SpA and a cut-off point of what 
constitutes good adherence could be linked to this. It may be that any 
adherence improves outcomes and therefore labelling good adherence may not 
be helpful.  
 
4.7.3 Adherence to Prescribed and Patient Choice 
The PhD study aimed to compare the prescribed component of the exercise 
(three times per week) with the patient choice component (two times per 
week). Participants adhered significantly more to the prescribed exercise 
component than the patient choice component. The patient choice component 
was included to give participants flexibility in their programme; for example, to 
allow them to attend a NASS exercise class or go for a recreational swim. The 
participants ticked the box named ‘other’ on the website. It is possible that 
participants forgot to enter their other exercise as these were not being 
completed at the same time as the online diary was completed, whilst for the 
prescribed contact they may have accessed their prescribed exercises and diary, 
resulting in under-reporting of patient-choice exercise element of their overall 
programme. Furthermore, for those participants who did tick the other box, 
most did not provide details about the activity that was undertaken. Therefore, 
this data could not be analysed further, beyond a binary completed or not. The 
characteristics of the intervention and participants may have played a role in 





Behaviour change techniques are observable and replicable components of 
interventions and can be used alone or in combination with other behaviour 
change techniques (Michie et al., 2011). Published literature suggests that 
interventions that incorporate greater number of behaviour change techniques 
have a larger effect in changing behaviour than interventions that incorporate 
fewer techniques (Webb et al. 2010).  WEBPASS incorporated the following 
behaviour change techniques reported to be important in facilitating adherence: 
goals and planning, feedback and monitoring, shaping knowledge, natural 
consequences, comparison of behaviours, repetition, substitution and 
antecedents (Michie et al., 2011). While these behavioural change techniques 
may potentially have influenced adherence to the prescribed component in 
WEBPASS, the impact of this could not be ascertained as there was no control 
arm without these techniques. However, in the interviews, several individuals 
commented positively on the benefit of the exercise videos on the website. The 
behavioural techniques of comparison of behaviours and repetition were 
provided in the form of exercise videos, which also included written and spoken 
instructions.  
 
Individualising exercise interventions has the potential to improve adherence 
and could account for higher adherence in the prescribed exercise component. 
Participants may have believed that the prescribed exercises provided by the 
physiotherapist would be more efficacious or less likely to cause harm than their 
own choice of exercises. Quotes from two participants who were interviewed 
concurred that the fact that the programme was individualised to their own 
particular needs and that it was prescribed by a trained physiotherapist were 
important to them and helped empower them to participate in the programme. 
This is consistent with a qualitative study investigating adherence to 
physiotherapy prescribed exercise in people with persistent musculoskeletal 
pain, which reported that exercise adherence increased where there was a 
collaboratively developed, tailored and individualised exercise prescription 
(Escolar-Reina et al., 2010). A systematic review investigating adherence to falls 
programmes also found higher levels of adherence in physiotherapy-led 
programmes compared to exercise instructors (Simek et al., 2012), suggesting 
that confidence in the instructors’ expertise is important for patients who are 





Self-efficacy may be important when considering adherence and may account for 
the higher adherence within the prescribed component in comparison to the 
patient choice component. Self-efficacy is the belief in one's own ability to 
perform a task within a given context (Bandura 1997, Bassett, 2015). Self-
efficacy is situation specific, with people feeling efficacious about doing some 
activities, but not others, and being able to do some tasks in some situations but 
not others (Bassett, 2015). Self-efficacy was not measured in WEBPASS, 
therefore the self-efficacy of the participants is unknown, but it is possible the 
cohort may have had higher levels of self-efficacy, in terms of performing the 
prescribed exercises, where they had clear direction, fixed instructions, 
demonstrations, support and guidance but had lower self-efficacy about 
choosing their own exercises.  
 
Therefore, physiotherapist led, individualised exercise programmes 
incorporating behavioural change techniques may support adherence. However, 
developing participants’ skills and self-efficacy to participate in their own choice 
of exercise programme is also important and may help with long-term 
maintenance of healthy physical activity and exercise lifestyles. Physiotherapists 
should consider strategies such as educational programmes or self-management 
programmes to achieve this and future research should investigate ways to 
encourage people with axSpA to choose and participate in their personal choice 
of activities.  
 
4.7.4 Adherence within Each Prescribed Session 
Whilst it is important to consider the number of sessions engaged in, it is also 
important to investigate if the exercises within each session were completed. In 
the WEBPASS study, participants were prescribed individualised exercise 
programmes containing different exercises to complete three times per week for 
the 12-month intervention. All sessions which were started were analysed 
(n=2515) and results demonstrated that when these exercise sessions were 
started the participants were likely to complete the session (74% fully completed 
sessions versus 26% of sessions incomplete). One similarly study within the 




and found that over 12 weeks all exercises in the sessions were completed 
(Chimenti et al, 2014). Similarly, Chan and Can (2010) measured adherence to 
individual exercises within a physiotherapy session (no information given on 
conditions) and measured short term adherence (over the past week) using a 
questionnaire, with 74.4% of patients doing the prescribed number of exercises 
and all the repetitions (Chan & Can, 2010). This is the first study to investigate 
adherence to exercises within sessions over a longer time period (12months).  
Although there is limited data on within session adherence to exercise, studies 
concur that there are high levels of adherence to individual exercises within 
sessions. Taken together, this study and shorter-term studies indicate that 
physiotherapists should concentrate particularly on strategies to encourage 
service users to initiate exercise sessions in the knowledge that they will likely 
complete all the exercises within the designated session. This also applies to 
maintenance of adherence over the longer term, where getting people to 
initiate the exercise session appear to be key to developing routine and 
increasing long-term adherence rates.  
 
4.7.5 Adherence over Time 
As adherence fluctuates, the PhD study also considered adherence over the 
course of the 12-month invervention. Overall, the findings from the WEBPASS 
cohort study show that adherence to sessions declined over the 12-months. The 
weeks with the highest percentage completion were early in the study, with 
adherence to sessions increasing around the predetermined study visits (6 and 12 
months ± 2 weeks), suggesting that the contact to arrange these visits acted as a 
prompt or incentive to do the exercises.  
 
As far back as the 1980s, researchers reported difficulties for participants in 
maintaining adherence to exercise programmes. Ice (1985) reported dropout 
rates of between 30-50% of a cohort of cardiac rehabilitation patients within 12 
months of initiation.  More recently, Simek et al (2012) reported that 
approximately 48% of older adults ceased exercising altogether within six months 
of initiating an exercise programme to prevent falls. Similarly, Pisters et.al. 
(2010), reported 75% adherence at 13 weeks and 59% adherence at 65 weeks 




activity programmes for people with osteoarthritis. Reducing adherence over 
time has also been demonstrated in studies exploring the efficacy of exercise 
programmes delivered using the internet in people with long-term conditions 
(Akinci et al., 2018, Paul et al., 2019, Tallner et al 2016, Motl et al 2011, Conroy 
et al 2018). Akinci et al., (2018) examined the impact of a web-based exercise 
intervention over 8 weeks in people with type two diabetes and reported that 
52% of participants were non-adherent, defined as failing to complete three 
sessions for three consecutive weeks. Paul et al., (2019) examined the impact of 
a web-based exercise intervention prescribed twice weekly for six months in 
people with multiple sclerosis and reported that 63% of participants completed 
75% or more of their programme during the first four weeks which reduced to 
40% during the last four weeks. Similarly, Tallner et al 2016, investigated 
adherence to an online exercise programme in people with MS delivered over six 
months, three times per week. They reported that 73% of participants 
completed 80% or more of their programme during months 1-3 which reduced to 
36% during months 4-6. Motl et al (2011) investigated a 12 week varied 
frequency online programme in people with multiple sclerosis and reported 96% 
of participants logged on to the website in weeks 1-2 which reduced to 52% at 
week 8, while Conroy et al (2018) investigated a six month telerehabilitation 
exercise intervention in people with multiple sclerosis and reported only half of 
participants adhered to their programme and almost one quarter completed no 
exercise diaries at all. 
 
Of note, three studies reported in the systematic review for SpA ran 
consecutively using the same participants, allowing assessment over time, the 
first was a 12-week intervention, followed by a nine-month intervention, 
followed by a further nine-month intervention (Hidding et al. 1993a, Hidding et 
al. 1993b, Hidding et al. 1994, McDonald et al., 2019). These linked studies show 
that adherence to a daily HEP reduced from 86% to 51% and in the supervised 
sessions from 74% to 62%. Similar to the results in the WEBPASS cohort study, the 
adherence rates in these studies reduce over time.  
 
Good adherence to exercise (at least three times per week) over time was also 
considered. The pattern of participants with good adherence over the 12-month 




participants with good adherence was highest early in the study and declining 
over the course of the study, with peaks around the study visits.   
 
Physiotherapists should be aware of reduced adherence over the course of an 
intervention and should consider strategies and time points to support people 
with axSpA. Future study could identify the optimum or helpful strategies such 
as phone calls, text, and the cost effectiveness of these measures. 
 
4.7.6 Online Programmes & Adherence 
Although adherence in the WEBPASS cohort study was lower than other axSpA 
studies in the systematic review Chapter 3, no other study reported adherence 
to an online physiotherapy programme over 12-months. Web-based programmes 
have many theoretical advantages, including accessibility, flexibility and 
asynchronous use, which may be useful for people in employment or with other 
commitments. Interestingly 8% of people who were approached about the 
WEBPASS study did not have access to the internet therefore this approach is not 
suitable for all. The same web-based physiotherapy platform has been examined 
for individuals with multiple sclerosis and show promising results with adherence 
rates (average 1.3 logs in per week of a possible 2) (Paul et al., 2014). A study 
involving participants with a range of musculoskeletal conditions, showed 
adherence was better with online HEP compared to a paper handout, but this 
intervention was limited due to the short duration of four weeks and therefore 
to be interpreted with caution (Lambert et al., 2017). There is other emerging 
evidence that digital interventions, such as the use of apps, can support 
adherence to exercise programmes although this is in its infancy (Argent et al., 
2018). Web-based programmes can be more cost effective than standard 
treatment which is an increasingly important consideration for all healthcare 
interventions (Paul et al., 2019). Web-based programmes are of increasing 
importance in response to the 2020 coronavirus pandemic where, many people 
with long term chronic conditions were unable to assess face to face 
physiotherapy services. 
 
People with axSpA gain most benefit from exercise programmes of high 




should theoretically aid people to exercise in the long term. However, from the 
results within this study it is important to note that some individuals do not 
initiate their programme. For others, adherence reduces over the course of the 
intervention. Therefore, careful consideration of strategies to support both 
initiation and maintenance of adherence should be considered. A blended 
approach with face to face physiotherapy and online physiotherapy may be 
appropriate, especially for people with axSpA who are not exercising regularly 
and may help overcome some obstacles of ‘getting going’ and ‘keeping going’. 
Further research should compare adherence rates between web-based 
programmes, HEP and a blended approach, to investigate if the delivery of the 
intervention affects adherence. Personal preference is a key factor and it is 
likely that no single approach will be appropriate for all people. Availability of a 
selection of options may be the most effective strategy. 
 
4.7.7 Factors Affecting Adherence 
This PhD study also aimed to investigate the factors which affected adherence to 
a web-based 12-month exercise programme in people with axSpA. Associations 
between age, weight, disease duration, steps/day, standing time, quality of life, 
pain, health related quality of life, attitude to exercise, spinal mobility, 
function, disease activity, fitness and work impairment and completed WEBPASS 
exercise sessions were explored. There were no statistically significant 
associations found; this may be due to the small sample size or because these 
were not associated with adherence in this cohort.  
 
The qualitative data from the semi structured interviews provided insight into 
the factor’s participants perceived as influencing adherence. Four sub themes of 
adherence were explored; initiating and maintaining the exercise programme, 
symptoms, getting into a routine and support. The themes of initiating and 
maintaining the exercise programme are considered in good adherence (section 
4.7.2). As expected in patients being asked to exercise for their underlying 
condition, the symptoms a person experiences as a result of an intervention have 
the potential to positively and negatively influence adherence to that 
intervention. Participants reported that when exercise positively impacted on 




programme. This is consistent with the health belief model, where the expected 
benefits of a health behaviour are key factors in influencing participation in that 
health behaviour (Stretcher and Rosenstock 1997). Drawing from this theory, if 
participants in the current study believed that the exercise programme was an 
effective means of reducing symptoms, for example pain or joint stiffness, then 
they would be more likely to adhere. Increasing adherence to exercise 
associated with symptom reduction was also reported in a qualitative study 
investigating adherence to physiotherapy exercises in people with OA (Campbell, 
2001). However, it is possible for those people whos baseline symptoms were not 
troublesome, then there would be less to be gained from the intervention and 
this could potentially negatively affect adherence. One participant in WEBPASS 
commented that he did not feel the need to adhere to his exercise programme 
as his symptoms were not sufficient to affect his quality of life.  
 
In contrast, new or worsening symptoms, such as pain or fatigue, experienced as 
a result of exercising have the potential to reduce adherence. Three individuals 
reported their pain and fatigue increased when doing their exercise programme 
and as a result, they adhered less to the programme. This is consistent with a 
systematic review investigating adherence to exercise in people with 
musculoskeletal complaints which found evidence that higher pain levels 
experienced during exercise was a barrier to adherence (Jack et al., 2010). 
Lower adherence with high symptoms, has implications for people with SpA, 
many of whom have active disease, frequent flares and fatigue as part of their 
condition which if troublesome when exercising may reduce their adherence. 
Therefore, for this cohort of participants, a more gradual increase in exercise 
dose (intensity, time) to help minimise their symptoms as they start an exercise 
intervention is required. Further support and contingency plans for how to adapt 
their exercises in the event of worsening symptoms would also be beneficial. A 
small number of participants in WEBPASS experience an increase in symptoms in 
the early stages of the exercise programme which were recorded as AE. Future 
study could further develop the knowledge of how symptoms affect adherence 
to exercise programmes.   
 
Getting into a routine was identified from the WEBPASS interviews as improving 




adherence to a prescribed, individualised physiotherapy exercise programme of 
three-month duration in participants with OA. As mentioned previously, web-
based physiotherapy programmes offer flexibility and reduce the need for travel. 
However, the web-based platform did not include regular scheduled times for 
exercises and it was left to the individual decide when to do them. Strategies to 
address this could include the physiotherapists encouraging them to incorporate 
their exercises into their everyday routine, for example at work or at set times 
throughout the day. It could be that web-based programme of physiotherapy-
tailored exercises together with regular scheduled prompts to schedule exercise 
sessions would provide the optimal balance of flexibility and routine. This is 
particularly important for people with axSpA who are encouraged and required 
to exercise throughout the course of their lives.  
  
Social support was also identified in the interviews as important in improving 
adherence. Support can be from friends and family members as well as from 
HCPs. Several qualitative comments pointed to the social support network of the 
participant having a positive effect on adherence. Studies investigating 
adherence to sport injury rehabilitation programmes found that social support 
and emotional support from friends and family can improve adherence in both 
the clinic and home setting (Levy et al., 2008). Furthermore, two systematic 
reviews report evidence that social support can predict adherence to exercise in 
people with RA and other musculoskeletal conditions (Jack et al., 2010, Essery 
et al., 2017).  
 
Support can also be in the form of group exercise. Qualitative data from two 
participants, neither of whom adhered to the programme, refers to preferring to 
exercise in groups. In a previous systematic review in people with dementia or 
cognitive impairment, a group format was identified as supporting adherence by 
most of the participants (van der Wardt et al., 2017).  Whilst this may not be 
directly applicable to people with axSpa within the systematic review (Chapter 
3) one study found that adherence was higher in supervised groups exercise in 
axSpA (Hidding et al., 1994). Although it is not clear whether this increased 
adherence could be attributable to the supervision or the social support within 
the group, a Cochrane review of physiotherapy interventions for people with 




spinal mobility and overall wellbeing more than individualised home exercise 
programmes (Dalfinrud et al., 2008). As people with axSpA are required to 
exercise regularly and frequently in the longer term, support in terms of HCP 
supervision and/or group exercise is not always feasible. Therefore, 
physiotherapists should encourage service users to build their own support 
networks into their exercise regimes to support adherence. The NASS exercise 
groups link (www.nass.co.uk) are popular with people with axSpA and offer peer 
to peer support and contact while exercising in groups, physiotherapists could 
encourage people with axSpA to attend these groups (NASS, 2020).  Future 
research should aim to incorporate more social contact, group and supervision 
within web-based physiotherapy interventions and consider a blended approach. 
 
Within WEBPASS adherence rates increased around the time of study visit 
appointments suggesting that support or contact with a HCP is important to help 
facilitate adherence. Similarly, regular consultation with a physiotherapist, 
compared to use of a brochure, has previously been found to be associated with 
increased adherence to a HEP in adults (Simek et al., 2012). However, it is 
possible that increased adherence around these study visits represents that the 
service user feels indebted to adhere around these times and motivation was 
stimulated through pleasing the physiotherapist (Frey, 1994). Adherence rates 
increased less at the end of the study than the six-month study visit (Fig 4-9 & 4-
10) suggesting that this increased adherence at the time of study visits, also 
reduces over time. 
 
4.7.8 Measurement of Adherence 
Comparing adherence rates between studies is hampered by differences in the 
measurement of adherence. There is no standardised manner in which 
adherence is measured (Newman-Beinart et al., 2017). Most commonly 
adherence to a HEP is measured with a diary, albeit with no standardised diary 
or timeframes for filling in the diary (Frost et al., 2016). Adherence to HEPs in 
SpA was usually measured using self-reported paper home diaries (McDonald et 
al 2019). Over-estimating adherence is a common problem with self-report 
diaries as participants do not accurately recall or report their behaviour. They 




their behaviour, or may report multiple entries at a given time (Bollen et al., 
2014, Newman-Beinart et al., 2017). In WEBPASS we utilised an electronic diary 
which only allowed participants to complete their exercise diaries measuring 
adherence on the day of exercise. This mitigated for poor recall and multiple 
retrospective entries but did not mitigate against participants giving the desired 
response rather than an accurate one. It may have however underestimated 
adherence for participants who carried out their programme but did not fill in 
the diary due to eg. internet connection issues or forgetfulness. This was 
confirmed in the participant interviews where two participants stated this was 
the case and therefore may have accounted for the lower adherence rate in 
WEBPASS. Since this study was undertaken, the online physiotherapy platform 
has been upgraded to allow people to retrospectively complete their exercise 
diaries. A robust, standardised measure of adherence that is used across studies 
would greatly improve the ability to compare between studies and interventions.  
 
4.7.9 Limitations 
There are several limitations of this study. As this was a cohort study with no 
control arm, the adherence rate could not be compared with usual care HEP, 
such as a leaflet or a brochure. Comparing adherence rates within an RCT would 
allow for a more meaningful comparison of adherence between interventions of 
similar content, frequency and length using different modes of delivery. 
Furthermore, the small sample size and lack of power meant it was not possible 
to ascertain the baseline factors which influence adherence. Two different 
assessors were involved in taking the outcome measures at baseline, 6-months 
and 12-months, although both assessors followed standardised procedures this 
could affect the reliability of the measurements.  
 
The activities that participants did as part of their ‘other’ patient-choice 
exercises were not captured and therefore could not be analysed. As indicated, 
the requirement for same day reporting in the electronic diary used in WEBPASS 
may have under-reported adherence. Further work is required to establish a 





The low level of baseline exercise level of the participants within WEBPASS 
limits the generalisability of this study to those not currently exercising or doing 
very little exercise. 
 
Lastly, the research physiotherapist (PhD student), who was well known to 
participants, carried out the telephone interviews. Therefore, participants might 
have felt that they should comment positively. However, all participants were 
informed that negative comments would help to improve future work. They were 
also assured that the outcomes of the interviews would not affect the progress 
of the PhD student or their care. Member checking, or respondent validation, is 
a technique used to enhance trustworthiness of qualitative findings in which 
qualitative results are sent back to participants to check for accuracy (Burnard 
et al., 2008). In this study, findings were not sent back to participants due to 
time constrains for both participants and the CI. However, to enhance 
trustworthiness the analysis was verified and discussed with a supervisor (LP). 
Both PhD student and supervisor also commented on the final emerged themes. 
 
4.7.10 Adverse events 
The most common intervention-related adverse event within this trial was 
patient reported flares, which are a common feature of axSpA. A study 
investigating the prevelance of flares in 170 people with axSpA  reports that on 
any given week around 30% of people with axSpA will self-report a flare 
(Jacquemin et al., 2017).  In WEBPASS there were five musculoskeletal reactions 
(three axSpA disease flare ups and 2 increased localised pain) that were 
considered possibly related to the exercise intervention as they occurred on 
commencing the exercise programme.  There was some initial concern this was 
related to rapid increases in exercise intensity. Therefore, the exercises were 
increased more gradually for subsequent participants with no further flare ups 
reported. There were also three episodes of axSpA flare ups that were not 
considered related to the study intervention as there were no coinciding factors, 
i.e. these participants had either not been adhering to their programme or had 
been exercising with no change in the level of exercise but had concurrent 
infections which were the likely triggers for these episodes. The three remaining 




exercise for people with axSpA appears to be a safe intervention, provided this 
is started gradually in people with low baseline exercise levels. 
 
4.7.11 Generalisability of Findings in Relation to Sample 
The majority of participants within this study (n =48, 96%) had AS, while only 
(n=2, 4%) had nr-axSpA, therefore the evidence from this study is mostly 
generalisable to those with AS. Furthermore, the participants within this study 
had been diagnosed for a mean of 16.2 years (±11.9 years), so it cannot be 
assumed that people who are newly diagnosed would show similar patterns of 
adherence. The inclusion criteria for this study stated that the participants 
should not be exercising more than three times per week, therefore the findings 
of this study may only be generalisable to those people with axSpA with similar 
exercise behaviours. As discussed this low level of exercise levels may partially 
account for the lower adherence rate found in the WEBPASS cohort study in 
comparision to studies within the systematic review (Chapter 3). Participants 
were recruited from NHS GGC, which sees patients mostly from urban locations; 
furthermore, Glasgow in known to have high poverty rates, higher rates of 
excess mortality and chronic illness than other similar urban areas (Walsh et al., 
2017).  People in lower socio-economic groups are less likely to meet the current 
PA target than the rest of the population and therefore this could have impacted 
on the adherence rates found in the WEBPASS cohort study (Schmidt et al., 
2008). 
 
4.7.12 Implications for clinicians 
This trial adds to the body of evidence of non pharmalogical management in the 
management of axSpA by (Regel et al 2017) contributing new long-term data 
about adherence to an online exercise intervention in people with axSpA. 
Furthermore, due to the inclusion/exclusion criteria this trial has provided an 
insight into adherence of patients with low baseline exercise levels despite 
longstanding disease. However due to the relatively small sample size the 
generalisability of the study results to the wider clinical axSpA population 





The study also identified issues with getting people to initiate exercise sessions, 
with encouraging data that when initiated, most sessions are completed. Thus 
indicating initiation of exercise programmes should be a key focus for HCPs. The 
study also indicated that exercise programmes can be individualised and 
supported using this model of physiotherapy-assessment and online delivery. The 
use of embedded exercise videos and other strategies reported within the study 
were deemed beneficial by participants. Physiotherapists should employ 
strategies to get people with axSpA initated on their exercise programme, as 
although some participants will struggle to maintain the programme, others will 
demonstrate good adherence.  
 
A number of key lessons were identified for future strategies and interventions 
for improving adherence such as scheduling exercise as part of daily routine and 
engaging the support of family, friends and HCPs.  
 
Clinicians should be aware that no single programme will work for all people 
with axSpA, with multiple inter-related factors that may influence adherence. 
HCPs should explore individual key barriers and facilitators with their patients. 
 
4.7.13 Recommendations for future research 
While the optimal study design for comparing interventions are large scale RCTs, 
these are often not feasible for complex interventions such as exercise 
particularly when this is already part of routine clinical care in axSpA.  Other 
strategies and indirect comparisons are therefore likely to be required.  
 
In order to progress to improve the understanding of adherence this field 
urgently requires agreed and robust measures of adherence, which would allow 
comparison between different interventions.  
 
There are several models of exercise interventions worthy of study in axSpA, 
including comparing adherence rates between online programmes, standard 
HEPs, traditional physiotherapy-led supervised interventions and blended 
approaches. In addition to effectiveness and adherence, these studies should 





Such studies should investigate the key factors which may affect long term 
adherence to different types of exercise interventions in axSpA. This would 
enable physiotherapists to identify those who may benefit from specific 
interventions and better tailor interventions for those who need greater support. 
 
Further research should investigate how different components of interventions, 
such as how specific behaviour change techniques are operationalised and 
impact on adherence to prescribed exercise programmes and when is the best 
time point to offer these.   
 
4.7.14  Conclusion  
The aim of this cohort study was to measure adherence, and factors affecting 
adherence, to 12-month web-based exercise intervention.  
 
Adherence to exercise sessions engaged with in the WEBPASS cohort study was 
27.6% of all sessions. Due to differences in participant characteristics, length 
and frequency of intervention and differing measures of adherence it is difficult 
to directly compare this level of adherence to other interventions in people with 
axSpA. More research is required to compare adherence rates between different 
modes of delivery of exercise interventions. 
 
Online programmes, have many advantages such as lower costs, more flexibility 
and availability, as well as being able to capture adherence on the same system. 
Individualised online exercise programmes are a viable option for some people 
with axSpA, particularly due to the long term and frequent exercise required in 
this condition, so are an option that physiotherapists should consider as part of 
their management of axSpA. However, it is clear that, like all interventions, this 
is not effective for all and strategies to identify those most likely to benefit from 
these methods are required, as are strategies to improve adherence with this 
programme. 
 
When participants started a session, more often than not they completed all the 




concentrate on strategies to encourage participants to start sessions. Similarly, 
higher adherence was found in those who initated the programme, so getting 
started with exercise programmes and each session appears to be a cruicial to 
facilitate adherence. 
 
Adherence reduced over the course of the intervention. Physiotherapists should 
consider when adherence reduces and instigate strategies to improve adherence.  
 
The factors which influence adherence remain unclear, but symptoms, getting 
into a routine and support may play a role in influencing adherence. 
Physiotherapists should encourage service users to build support networks, and 
























5  Chapter: Physiotherapists’ Perceptions of Adherence to Exercise 
in People with Spondyloarthritis  
This chapter presents the third study within this thesis, a national survey of UK 
physiotherapists’ perceptions of patient adherence to exercise in people with 
SpA.  
 
5.1 Justification  
As previously discussed, exercise is essential in the management of SpA .This is 
paramount within axSpA patients to maintain or improve mobility, strength, CV 
health, function, quality of life and to limit spinal deformity (Reimold and 
Chandran, 2014). Evidence supports that exercise improves clinical outcomes in 
people with AS, therefore they should exercise frequently at every stage of their 
condition (Regel et al., 2017) .  
  
Earlier within this thesis, the level of and factors that may affect adherence to 
exercise programme in people with SpA were investigated. The systematic 
review (Chapter 3) demonstrated adherence rates of 51% -95% across a range of 
physiotherapy prescribed interventions for people with SpA.  It also highlighted 
single studies, with limitations, that identified severity of disease and delay in 
diagnosis increased adherence and reported that age, gender, body mass index, 
blood pressure or heart rate did not influence adherence. Interventions which 
had a supervised component and which incorporated education programmes may 
increase adherence in people with SpA. However, there was no consensus 
between these studies which limited the conclusions that could be drawn from 
current evidence. Furthermore, it is probable that there are other factors that 
could affect adherence that have not been investigated.  
 
The cohort study of web-based physiotherapy (WEBPASS) (which combined 
unsupervised web-based physiotherapy three times per week and patient choice 
exercise twice per week) for people with axSpA (Chapter 4) found adherence 
levels of 27.6% of all sessions over 12 months.  It investigated a wider range of 
potentially related factors. However due to the small sample size, it was not 
possible to quantitatively identify any patient or disease-related factors 




axSpA adhered significantly more to the prescribed exercise component. This 
was individualised and contained behavioural change techniques and adherence 
was greater than the patient choice component. The qualitative evaluation in 
the WEBPASS cohort study identified that current symptoms, getting into a 
routine and support all affected adherence.  
 
Whilst the WEBPASS study (Chapter 4) and the systematic review (Chapter 3) 
added a number of potential factors affecting adherence, when this evidence is 
considered together there remains uncertainty about the factors which affect 
adherence in SpA and with a number of factors and domains, such as health 
care, not investigated (A summary of the key results related to the WHO model 
















































Figure 5-1. WHO model of adherence (Sabete et al., 2003) with possible factors from the 
systematic literature review and WEBPASS Cohort Study added in ovals. Factor labelled with R if 
found from review and C if found from the cohort study. 
 
The beliefs held by physiotherapists may influence their approach to considering 
adherence. Older research suggests that physiotherapists do not always consider 
how adherence to their prescribed exercise programmes affects the 
achievement of clinical outcomes (Turk and Rudy 1991). If there are no 
improvements in clinical outcome from the exercise prescription, 
physiotherapists may think the exercises prescribed are at fault and modify the 
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perceptions of patient adherence to prescribed self-management strategies in 
MSK conditions (not including SpA), suggests that physiotherapists now consider 
the impact of adherence to the exercise programmes on the achievement of 
clinical outcomes (Peek et al., 2017). As stated previously, physiotherapists are 
at the forefront of exercise management for people with SpA. Therefore, it is 
imperative to have a clear understanding of their beliefs and perceptions 
regarding adherence to exercise in SpA.  
 
It is also important to consider the views of physiotherapists specialising in 
exercise prescription for people with SpA as they may themselves be aware of 
factors influencing adherence. To date no study has ascertained what patient-
related, condition specific, socio-economic, treatment and healthcare factors 
physiotherapists perceive as affecting adherence to prescribed exercise 
programmes for people with SpA. Understanding the factors which 
physiotherapists consider as impacting on adherence and discuss with their 
patients or use to tailor their support would be valuable.  
 
Furthermore, understanding the unique challenges and issues facing 
physiotherapists in adopting interventions and strategies to improve adherence 
to prescribed exercise is an essential key step to facilitate improved exercise 
adherence in people with SpA. To date no study has looked at what barriers are 
faced by physiotherapist when adopting methods to improve adherence.  
 
5.2 Aims and Research Questions 
Therefore, to address the gaps in the current literature relating to the view of 
physiotherapist an online survey was performed to explore the beliefs and 
perceptions of physiotherapists specialising in prescribing exercises to people 
with SpA. The following specific research questions were formulated; 
 
1. What are the methods of prescribing exercise currently used by 
physiotherapists? 
2. Do physiotherapists believe that patient adherence is important to 




3. What factors do physiotherapists perceive affect adherence to prescribed 
exercise in people with SpA? 
4. What strategies and interventions do physiotherapists perceive increase 
patient adherence to prescribed exercises in SpA? 
5. What are the barriers to employing these interventions to aid adherence? 
 
5.3 Methods 
5.3.1 Study Design and Ethical Approval 
A cross-sectional web-based survey was carried out between 1 July 2019 and the 
30 September 2019. Ethical approval was obtained from the College of Medical, 
Veterinary and Life Sciences Ethics Committee, University of Glasgow in June 
2019 (Appendix 6).  
 
5.3.2 Participants and Recruitment 
It is unknown how many physiotherapists within the UK regularly assess and treat 
people with SpA, with no central register of UK physiotherapists who specialise 
in this condition held. Therefore, snowball sampling (TenHouten, 2017) was 
chosen as a way of identifying the target population. Several different 
dissemination routes were utilised. The AStretch committee, a group of 11 
physiotherapists who specialise in promoting best practice in treatment and 
assessment of people with axSpA in different areas within the UK, in conjunction 
with the NASS charity, were first asked to complete and forward the survey on 
to other physiotherapists who regularly assess and treat patients with SpA. 
Thereby identifying local networks of physiotherapists within each area. NASS, 
the UK charity for people with axSpA and provider of resources to HCPs working 
with people with axSpA, was asked to advertise the study, via email to all 
physiotherapists from their database and advertise the survey on twitter and 
Facebook with a link to the survey. In the introduction to the survey, there was 
a request for participants to forward the survey on to other eligible 
physiotherapists. 
 




• qualified physiotherapists who specialise in the assessment and treatment 
of adults with SpA within the UK 
• adults making up 80% of caseload 
• seeing adults with SpA at least each month and  
• willing to participate 
• Had not already completed the survey. 
 
5.3.3 Survey Development and Content 
A survey method was used in preference to focus groups or interviews in order to 
capture the views of a nationally representative sample of physiotherapists. An 
electronic survey was chosen for the study as research has shown electronic 
surveys to be superior to paper surveys in terms of response rates, completion 
rates and the representativeness of the sample from which the data are 
collected (Denscombe, 2006). This survey was informed by a previous survey 
which had been developed to capture physiotherapist perceptions of patient 
adherence to self-management strategies, which included exercise, orthotics, 
advice and braces, in various MSK conditions but did not include people with SpA 
(Peek et al., 2017). Google Forms was chosen as the platform to base the 
electronic survey due to the ease of use by both participant and researcher and 
as it is widely accessible and freely available.  
 
The survey included a participant information paragraph at the start of the 
survey explaining the purpose of the survey and informing each participant there 
were no known risks or benefits to completing the survey (Appendix 7). Consent 
was assumed if the survey was completed. Only submitted surveys could be 
viewed and included. 
 
The survey included screening questions confirming whether adults made up 80% 
of the physiotherapist’s workload, if they regularly saw patients with SpA (at 
least every month) and if they practised in the UK. If they answered ‘no’ to any 
of these questions they were thanked for their participation and informed they 





The main survey (Appendix 8) consisted of 10 questions which took 
approximately 10 minutes to complete.  Socio-demographic data questions were 
asked pertaining to where in the UK the physiotherapist was based and for how 
many years the physiotherapist had been qualified. 
 
In order to understand physiotherapists views on the importance of adherence to 
prescribed exercises, participants were asked how important they considered 
adherence to prescribed exercise to be in improving outcomes in people with 
SpA. Specifically, physiotherapists were asked to indicate the extent to which 
they agreed or disagreed with the statement ‘Treatment outcomes in 
Spondyloarthritis can be positively affected by patients adhering to 
physiotherapy prescribed exercise programmes’. Physiotherapists responded 
using a five point Likert scale (strongly agree; agree; neither agree nor disagree; 
disagree; strongly disagree). 
 
In order to evaluate the current methods of prescribing exercise in SpA. 
Physiotherapists were provided with a list of possible ways of prescribing 
exercise and asked to tick all that apply. In addition, a free text box was 
provided for physiotherapists to list any other ways in which they prescribed 
exercise. 
 
To evaluate the factor which physiotherapists perceive affect adherence, 
physiotherapists were provided with a list of factors, selected from the 
literature and previous phases of the PhD, that may affect patient adherence, 
including patient characteristics, disease characteristics, healthcare and social 
factors. Physiotherapists responded using a six point Likert scale (frequently 
increases adherence; sometimes increases adherence; does not affect 
adherence; sometimes reduces adherence; frequently reduces adherence; don’t 
know). A free text box was provided for physiotherapists to list any additional 
factors which they felt influenced adherence. 
 
In order to understand the methods physiotherapists employ to improve patient 
adherence, physiotherapists were provided with a list of possible methods to 
improve adherence and they responded using a four point Likert scale (Yes 




adherence; has no effect on a person's adherence; not sure/have no experience 
of this). A free text box was provided for physiotherapists to list any other 
methods that they use that helps increase patient adherence to prescribed 
exercise programmes. 
 
To understand the barriers physiotherapists perceived to in employing methods 
to aid patient adherence, physiotherapists provided with a list of statements 
such as ‘I don’t have enough time to assess patient adherence’ and I have 
limited knowledge/skills in assessing patient adherence’. Physiotherapists were 
asked to indicate the extent to which they agreed or disagreed with these 
statements using a five point Likert scale (strongly agree; agree; neither agree 
nor disagree, disagree, strongly disagree). The survey can be found in Appendix 
8. 
 
The survey was piloted for acceptability and feasibility by two qualified 
physiotherapists before the final survey was sent to participants; no changes 
were required from this pilot test. 
 
5.3.4 Data Collection 
The electronic survey was available for a period of three months between July 
2019 and September 2019. The participant was asked to complete the survey 
once.  
 
5.3.5 Statistical analysis and handling of data 
The data were downloaded to a spreadsheet (google sheets) on a password 
protected computer. Data were analysed using descriptive statistics. The 
responses from the physiotherapists were grouped into the following five 
constructs proposed by the WHO multidimensional model of adherence; 
socioeconomic, healthcare, condition, patient and treatment factors (Sabete et 
al., 2003). Answers to each question were presented descriptively in tabular 






5.4.1 Survey response 
Fifty-two physiotherapists responded to the survey in the allocated three-month 
period. Levels of missing data were extremely low with only one missing 
response to one question from one respondent.  
 
5.4.2 Socio-demographic Information 
Whilst there was variation in terms of years qualified as a physiotherapist, 71% 
of physiotherapists were qualified for greater than 10 years and 44% over 20 
years (See Table 5-1). Over half of the physiotherapists were from England 
(n=29, 56%), with the remainder from Scotland (n=20, 38%) and Wales (n=2, 4%). 
missing data (n=1, 2%). No physiotherapists from Northern Ireland completed the 
survey. 
Table 5-1. Years Since Graduating as Physiotherapist. 
Years since 
Graduating 
Number of Physiotherapists (%) 
0-2 2 (4%) 
3-5 2 (4%) 
6-10 5 (10%) 
11-15 9 (17%) 
16-20 11 (21%) 
21-30 11 (21%) 










5.4.3 Perceived Importance of Patient Adherence and Methods of Prescribing 
Exercise 
 
Almost all respondents (96.1%) agreed that adhering to physiotherapy prescribed 
exercise was important to positively influencing patient outcomes (n= 38 
strongly agree, n=11 agree). Only 2 respondents disagreed (3%).  
 
The most common method of prescribing exercise in SpA was signposting to NASS 
exercise groups (n=50, 96.2%). NASS run group exercise classes branches in 
Scotland, England, Wales and Northern Ireland. Physiotherapists surveyed 
commonly prescribed exercises using demonstrations of the exercise (n=48, 
92.3%) and written instructions (n= 47, 90.4%). Slightly less commonly used were 
group exercise (n= 41, 78.8%) and digital resources such as apps or online 
exercise programmes (n=39, 75%). Hydrotherapy and residential programmes 
were reported by two physiotherapists.  
 
5.4.3 Physiotherapists Perceptions of Factors Which Influence 
Patient adherence  
Physiotherapists were presented with a list of factors from previous research and 
asked whether each factor could increase, decrease or did not affect adherence. 
Physiotherapists could also indicate if they did not know or had no experience of 
the factor. Physiotherapists were asked to provide any further factors not listed. 
 
In addition to the specific factors listed in the survey, there were free text 
responses. The responses from the physiotherapists were grouped into one of the 
following four constructs proposed by the WHO multidimensional model of 
adherence; socioeconomic, healthcare, condition, and the patient factors 
(Sabete et al., 2003). The fifth construct - treatment factors was considered in a 
later question.  
 
The factors which were perceived by physiotherapists to affect adherence are 
presented in Table 5-2. Factors which predominately increased adherence are 
coloured green, those factors which were predominantly perceived to reduce 




corresponding WHO construct. If a free text response contained more than one 
construct the quote was broken down into each corresponding construct, 




Table 5-2. Physiotherapists’ Perceptions of Patient, Condition, Socio-economic, Healthcare-related factors which negatively (red shading) or positively (green 





















Concurrent mental health 
condition(s) such as anxiety or 
depression. 
1 (2%) 1 (2%) 0 17 (33%) 32 (62%) 1 (2%) 
High disease symptoms, such as 
pain, fatigue, stiffness, frequent 
flares. 
2 (4%) 0 1 (2%) 18 (35%) 31(60%) 0 
Multiple comorbidities 1 (2%) 0 0 35 (67%) 15 (29%)  1(2%) 
Patient-related factors 
Lack of time  0 0 0 21 (40%) 31 (60%) 0 
Being Afraid of Exercise 1 (2%) 1 (2%) 0 18 (35%) 30 (58%) 2 (4%) 
Lack of interest  0 0 0 24 (46%) 27 (52%) 1(2%) 
The person believes the exercises 
will not improve the symptoms or 
outcomes 
0 0 2 (4%) 25 (48%) 23 (44%) 2(4%) 
Low confidence or Self efficacy in 
ability to exercise 




High motivation 45 (86%) 7 (13%) 0 0 0 0 
The belief that exercises will help. 40 (77%) 9 (17%) 1 (2%) 0 2 (4%) 0 
Enjoying the exercises that have 
been prescribed. 
38 (73%) 10 (19%) 1 (2%) 1 (2%) 1(2%) 1(2%) 
Already being physically active. 36 (70%) 10 (19%) 1 (2%) 4 (8%) 0 1(2%) 
Socio-economic factors 
Lack of support from friends, 
family, work or a charity. 
1 (2%) 0 2 (4%) 28 (54%) 21(40%) 0 
High levels of social deprivation. 1 (2%) 1 (2%) 4 (8%) 21(40%) 21(40%) 4 (8%) 
Support from friends of family, 
work or a charity. 
27 (52%) 22 (42%) 2 (4%) 0 1 (2%) 0 
Healthcare-related factors 
Good Access to physiotherapy 28 (54%) 18 (35%) 2 (4%) 3 (6%) 0 1(2%) 
Receiving effective medicine for 
symptoms of spondyloarthritis 










Table 5-3. Free Text Comments from the physiotherapist survey, relating to Patient, Condition, Socio-economic, Healthcare-related factors from the WHO 




‘If they feel their condition/symptoms are controlled with meds they may not see the importance of exercise therefore adherence can be 
decreased (p5)’ 
Patient-related  ‘Lack of education and understanding of their condition can decrease adherence (p2)’ 
‘Decreases: family history of poor outcome despite exercise (p15)’ 
‘Some people put off NASS class due to age range, extent of disease progression of regular members (p45)’ 
‘Lack of understanding of condition and evidence base for exercise and condition management (p48)’ 
‘Increases: family history of SpA with poor outcomes (i.e. don’t want to end up like dad) (p15)’ 
 ‘Enjoyment (p19)’ 
‘Limited health literacy- reduces adherence (p22)’ 
‘Understanding their condition (p37)’ 
‘Understanding their condition, their medical management being able to take on responsibility for managing aspects of their condition 
(p38)’ 
Socio-Economic ‘Financial limitations - even services such as Live Active/Vitality are charged (p14)’ 
‘Increases: peer support, being part of a NASS group, having an active hobby or work role, previous or current employment in the military 
(p15)’ 
‘Contact with peer group e.g. NASS increases adherence (p23)’ 
Healthcare-related ‘Attending an immersive inpatient programme, which has the patient exercising in a group setting nearly every day for the duration of the 





‘Ease of access time wise and physically to relevant/preferred exercise environment Patients don’t believe that the community gym 
based staff understanding their conditions enough to be able to help them safely (p38)’ 
‘Access to hydrotherapy (currently only NASS class) (p23)’ 
‘Using rheumatology physiotherapists to take classes in leisure facilities to increase adherence using a group and someone they trust to 
advise suitable exercises. Finding the activity that they enjoy and using a personal outcomes based approach to facilitate increase 
adherence and initiation of exercise (p48)’ 




5.4.3.1 Condition-related Factors 
Condition-related factors were generally perceived (>90% agreement) to have a 
negative impact on adherence. High disease activity, concurrent comorbidities 
and mental health conditions were all reported by the physiotherapists to reduce 
an individual patient's adherence to exercise. One physiotherapist commented 
that if symptoms were controlled with other treatments, then individuals did not 
feel the need to exercise. 
 
5.4.3.2 Patient-related Factors 
Physiotherapists perceived that adherence was reduced (>92% agreement) in 
people with SpA who lack the time or interest or who believed the exercises 
were not beneficial in improving symptoms and/or outcomes. Conversely, 
adherence was perceived to be increased in individuals who believed that the 
exercises would improve symptoms and/or outcomes (96% agreement). High 
motivation, enjoying the exercises and already being physically active were all 
perceived (>89% agreement) to increase adherence to prescribed exercises.  
 
Free text comments were provided by eight physiotherapists who remarked that 
adherence could be affected positively by having a greater understanding of the 
condition and reduced by poorer understanding. Free text comments also 
highlighted family history of SpA as being important in adherence. 
 
5.4.3.3 Socio-economic Factors 
Physiotherapists perceived that socio-economic factors could affect an 
individual's adherence. 80% of physiotherapists indicated that high levels of 
socio-economic deprivation reduced adherence (40% frequently and 40% 
sometimes). The level of support from work, family, friends or a charity was 
perceived to increase adherence and that it was reduced where there was lack 





Additionally, two physiotherapists commented that the support of a peer group, 
such as a NASS exercise group, helped increase adherence. Financial limitations 
in relation to having to pay for community programmes were reported by one 
physiotherapist to reduce adherence. 
 
5.4.3.4 Healthcare-related 
Healthcare-related factors were also perceived to play a role. Good access to 
physiotherapy services (89% agreement) and receiving effective medication (80% 
agreement) to relieve symptoms were perceived by physiotherapists to increase 
adherence. 
 
Free text comments relating to the availability of healthcare were made by six 
respondents. Access to hydrotherapy, in-patient programmes, or community 
programmes were perceived to increase adherence. Furthermore, having a 
variety of programmes available at times that suited the individuals with SpA 
and with suitability qualified staff, such as physiotherapists, was perceived to 
increase adherence.  
 
5.4.4 Treatment factors to Improve Patient adherence to 
Physiotherapy Prescribed Exercises. 
The content and delivery of interventions have potential to affect adherence to 
prescribed exercise programmes. As this is the component that the 
physiotherapists have the most direct control over, this aspect is considered 
separately in more detail. The physiotherapists were presented with a list of 
components of interventions and interventions with different methods of 
delivery, taken from previous research, and asked to indicate their opinions on 
the impact of these on adherence. The results are shown in Table 5-4. The 
physiotherapists were also asked to add any additional methods not listed, with 









Table 5- 4. Physiotherapists’ Perceptions of Interventions/Treatment-related factors to Improve 








Has no effect 
on adherence 
Not sure or have 
no experience of 
this 
Individualising the exercise 
programme to the person  
37 (71%) 15 (29%)  0 (0%) 0 (0%) 
Goal Setting with person 23 (44%) 27 (52%) 1 (2%) 1 (2%) 
Providing patient education of 
importance of exercise 
29 (56%) 21 (40%) 2 (4%) 0 (0%) 
Providing patient education on 
the expected outcomes or 
consequences 
21 (40%) 29 (56%) 1 (2%) 1 (2%) 
Practicing the exercises within 
the consultation  
36 (69%) 14 (27%) 2 (4%) 0 (0%) 
Physiotherapist 
communication skills 
32 (62%) 18 (35%) 2 (4%) 0 (0%) 
Providing patient education: 
supportive material 
21 (40%) 29 (55%) 2 (4%) 1 (2%) 
Discussing the barriers and 
facilitators to adherence 
25 (48%) 24 (46%) 1 (2%) 2 (4%) 
Addressing the general health 
of the patient, including 
referral to GP or AHP 
colleagues 
13 (25%) 34 (65%) 3 (6%) 2 (4%) 
Involvement of the patient's 
support person 
14 (27%) 32 (62%) 1 (2%) 5 (10%) 
Monitoring of patient 
adherence 
20 (38%) 24 (46%) 1 (2%) 7 (13%) 
Novel digital interventions  13 (25%) 31 (60%) 2 (4%) 6 (11%) 






Table 5-5. Free Text Responses from the physiotherapist survery relating the the treatment-
related domain which affect adherence. 
Theme  Comments 
Treatment/ 
Interventions 
‘Identify what the outcome will be and advise I will challenge it next time, i.e. your 
goal we discussed is X which with compliance you will be able to do next time so let’s 
start with that (P4)’ 
‘Weekly access to the stretch class (p16)’ 
‘Signposting to group exercise such as NASS or community programmes (p19)’ 
‘Encourage to come to NASS class (p23) & (p45)’ 
‘Exercise groups for social support (p48)’ 
‘Intensive exercise programme at Highland Rheumatology unit for 2-week inpatient 
stay (p23)’ 
‘Combining exercises into activities of daily living (p34)’ 
‘Intensive input of education and guided exercise practice (p36)’ 
‘The main one is keeping things real for the patient being fully aware of what is 
preventing them from exercising and looking to work towards overcoming any 
identified factors. Making things as easy and ‘seamless’ as possible p38)’  
 
 
All physiotherapists surveyed had experience of, and agreed that individualising 
the exercise programme to the person increased adherence, with 71% of 
physiotherapists believing that it frequently increased adherence and the 
remaining 29% believing that it sometimes increased adherence. There were high 
levels of agreement (equal to or above 96% of all physiotherapists surveyed) that 
providing; patient education on the importance of the exercise and the expected 
outcomes or consequences, practicing the exercises within the consultation with 
the patients and physiotherapist communication skills increased adherence. 
There was lower agreement regarding motivational interviewing and providing 
novel digital interventions, although this was still high with 77% and 85% of 
physiotherapists agreeing that this improved adherence. However, 11.5% of 
physiotherapists felt motivational interviewing did not have an effect on 
adherence, with 11.5% of physiotherapists having no experience or not sure of 
these interventions. 
 
There were nine free text comments from physiotherapists which highlighted the 
need for social support, group exercises, intensive inpatient programmes and 





5.4.5 Barriers to Employing Interventions and Strategies to 
Improve Adherence. 
Acknowledging the unique challenges and issues facing physiotherapists in 
adopting methods to improve adherence to prescribed exercise is an essential 
step to facilitating and improving exercise adherence in people with SpA. The 
barriers to the adoption of strategies to improve adherence were explored by 
providing the physiotherapists with a list of common barriers in employing 
interventions. Physiotherapists could also add free text responses. These barriers 







Table 5-6. Barriers to Employing Interventions and Strategies to Improve Adherence. 










I do not have enough time to 
assess patient adherence with 
prescribed exercise 
4 (8%) 14 (27%) 25 (48%) 9 (17%) 0 
I have limited knowledge/skills in 
assessing patient adherence 
0 4 (8%) 25 (48%) 23 (44%) 0 
I do not have enough time to 
provide adherence aiding 
strategies 
2 (4%) 16 (31%) 26 (50%) 8 (15%) 0 
I am uncomfortable discussing 
adherence with patients. 
1 (2%) 5 (10%) 17 (33%) 28 (54%) 1 (2%) 
I have limited access to resources 
such as patient educational 
materials 
1 (2%) 9 (17%) 19 (37%) 22 (42%) 1 (2%) 
There can be a lack of continuity 
of care; patients often see 
different physiotherapists 
1 (2%) 10 (19%) 23 (44%) 17 (33%) 1 (2%) 
I don't believe that I can alter 
patient adherence - either 
patient adhere or they don't. 
0 2 (4%) 25 (48%) 24 (46%) 1 (2%) 
I don't believe that adherence is 
a problem with my patients 
0 8 (15%) 24 (46%) 20 (39%) 0 
I don't believe that improving 
patient adherence is relevant to 
physiotherapy practice 






Table 5-7. Free Text Responses from the physiotherapist survey relating to Barriers to Employing 
Interventions and Strategies to Improve Adherence. 
Theme Comments 
Barriers  ‘A generally poorly run rheumatology service with lots of referrals from 
consultants to Physio (p5)’ 
‘No access to hydrotherapy (p16)’ 
‘Lack of technology and training in using it (p32)’ 
‘Lack of facilities available in the hospital, closing our hydro pool not being 
allowed to issue pulleys etc, and sporadic facilities in the community with very 
poor hospital community. Interface/communication/bridges to give patients the 
confidence that any sports/gym based professional understands their conditions 
enough for the to be in safe hands (p38)’ 
‘No time given to develop the service, resource etc (p43)’ 
‘Non-attendance (p45)’ 
‘The readiness of the patient to change and other stressful factors in their life at 
the time and mental health issues (p48)’ 
‘Lack of consistency in Physiotherapy service provision/ evidence based pathway 
in NHS [health area] for AS patients. Often influenced by consultant clinics 
staffing and facilities by sector (p49)’ 
 
 
Almost all physiotherapists (96%) reported that improving patient adherence was 
relevant to their clinical practice. However, fewer (85%) respondents believed 
that patient adherence was a problem with their patients and the majority (94%) 
believed that they could alter a person's adherence. However, only 65% reported 
that they had time to assess adherence and similarly only 65% reported they had 
time to use methods to aid adherence. A high percentage (92%) reported they 
had sufficient knowledge/ skills in assessing patient adherence. The majority of 
respondents had access to patient education material (72%) and reported that 
their patients received continuity of care (77%).  
 
There were eight free text comments from physiotherapists. The majority of the 
barriers to physiotherapists employing strategies to improve adherence were 
health system based. These related to poor access to, or between services, 
poorly managed service and local variation. One physiotherapist identified a 
perceived barrier in terms of patient factors relating to adherence and one 






The aim of this survey was to explore UK physiotherapists’ who specialise in 
rheumatology views on the importance of patient adherence to physiotherapist-
prescribed exercise. To explore this in detail the following areas were 
considered: which factors affect adherence to prescribed exercise in people with 
SpA, which interventions physiotherapists perceived increased patient adherence 
and which barriers are perceived in employing these interventions to aid 
adherence. In addition, the physiotherapists were asked about which methods 
they currently use to prescribe exercises. 
 
Traditional methods of prescribing exercises such as signposting to charities, 
providing demonstrations and written instructions were more commonly used 
than digital resources, such as apps or online exercise programmes (90%+ of 
physiotherapists versus 75%). Group exercises were slightly less common than 
providing demonstrations, which may reflect the availability of a group exercise 
format (78.8% versus 90%).  Additional methods suggested by two 
physiotherapists were prescribed hydrotherapy exercises and through a 
residential programme which may not be available in all areas.  
 
The first requirement in changing behaviour and improving outcomes is 
awareness of the issue. Almost all physiotherapists (96.1%) agreed that adhering 
to physiotherapy-prescribed exercise was important in positively influencing 
patient outcomes. Demonstrating that UK physiotherapists who regularly assess 
and treat people with SpA do consider the influence of adherence to their 
prescribed exercise programmes. This is in contrast to older research which 
reported that physiotherapists may wrongly assume exercise programmes are 
ineffective rather than considering lack of adherence with the programme (Turk 
and Rudy, 1991). This awareness provides a good starting point for 
physiotherapists to assess adherence in their patients and take steps to improve 
it.  
 
In order for physiotherapists to act on their awareness of the importance of 
adherence and the issues positively or negatively impacting these, they require 




adherence, a multidimensional approach could be undertaken where adherence 
is determined by the interplay of five domains: condition related, patient 
related, socioeconomic, health and therapy/intervention related (Sabete et al., 
2003). Therefore, this approach has been used as the framework in this thesis 
and in this study it was utilised to garner participants understanding across the 
domains. These are explored further in Section 5.5.1 – 5.5.5 below. 
 
5.5.1 Condition-related Factors Affecting Adherence 
In the WHO model of adherence condition-related factors affect adherence 
(Sabete et al 2003). This survey identified concurrent mental health conditions, 
high disease symptoms and multiple comorbidities as condition-related factors 
perceived by physiotherapists in this survey to reduce adherence to prescribed 
exercise programmes.  
 
Concurrent mental health conditions, such as depression and anxiety were 
identified by respondents as factors that may reduce adherence to prescribed 
exercise in SpA patients. These findings concur with research in MSK and mixed 
population of adults receiving physiotherapy which similarly report that the 
presence of anxiety and depression reduced adherence to physiotherapy 
prescribed exercise programmes (Jack et al., 2010, Essery et al., 2017). Whilst 
depression and anxiety are prevalent within the general population (Global 
Burden of Disease Study 2013 Collaborators, 2015), having a long term chronic 
condition increases the likelihood of an additional depressive or anxiety disorder 
(Meesters, et al., 2014). Within SpA, survey data demonstrates that greater than 
half of people with SpA are affected with concurrent mental health conditions 
(Redeker et al., 2018, Shen et al., 2016). Adherence to medicine is more widely 
studied than adherence to exercise, where a meta-analysis has identified 
depression as a strong predictor of patient non-adherence. Non-adherence has 
been identified as being 27% higher in those with depression compared to those 
without (DiMatteo et al., 2000).  The symptoms of depression include low mood, 
and loss of interest or pleasure in activities that were previously enjoyable. 
These symptoms may contribute to reduced likelihood of adhering to a regular 
prescribed exercise programme (Sobin & Sackeim 1997). Symptoms of anxiety 




breath, and gastrointestinal distress (Dreskin, 2018). These may make adhering 
to regular exercise difficult, particularly if the person also has concerns that the 
exercise could worsen their SpA or pain. Therefore, it is important for 
physiotherapists to recognise these symptoms of depression and anxiety in their 
patients. Future research should investigate whether routine use of screening 
questionnaires for anxiety and depression can improve adherence to exercise 
programmes by identifying and onwards referral for those who would benefit 
from mental health interventions. Such an approach is recommended and 
routinely employed within weight management programmes (NICE, 2014). 
 
High levels of disease symptoms were identified by respondents as another 
common factor that could reduce an individual's adherence to prescribed 
exercise. The clinical presentation of SpA varies between individuals. 
Characteristic manifestations such as inflammatory back pain, oligoarthritis, and 
enthesitis lead to stiffness and pain that can make it difficult for an individual to 
do exercises. Furthermore, individuals with SpA commonly complain of fatigue. 
These symptoms are usually variable but for a proportion of individuals with SpA 
these will be intense, frequent and disabling (Sieper et al., 2006, Atzeni et al., 
2014, Jacquemin et al., 2017). These findings are in contrast to the systematic 
review within Chapter 3 (section 3.3.9) which found that individuals with high 
disease severity had increased adherence. However, this was the result of a 
single study with moderate to weak association between disease severity and 
adherence (Barlow & Barefoot 1996). Similarly, a qualitative study investigating 
the perspectives of adults with AS found signs and symptoms of AS, principally 
pain, stiffness, and fatigue, were significant barriers to physical activity by the 
majority of participants.  When symptoms increased during flare-ups, many 
regarded these as insurmountable barriers to exercise (O’Dwyer et al., 2016). 
Conversely, one physiotherapist within this survey commented that if SpA 
symptoms were well controlled patients may not see the importance of 
exercising. Interestingly, one participant in the WEBPASS interviews (p44, Peter 
Section 4.6.14.1) reported that they did not exercise due to the absence of 
significant symptoms. The relationship between adherence to exercise and 
symptoms is therefore likely to be complex. On the one hand, severe symptoms 
or flare ups may make it difficult for patients to perform exercises due to the 




very mild disease may mean patients do not see the need or value to do 
exercises. These condition-related factors overlap with patient-related factors 
which are discussed in more detail in the following section. Physiotherapists 
should be aware that disease activity levels in SpA fluctuate and may impact on 
an individual's adherence to exercise, thus need to be taken into consideration. 
Patient education about the role of exercise in SpA and contingency plans for 
flare-ups may help with adherence in these situations. Patient education is a 
suggested intervention to improve adherence and is discussed in Section 5.5.5. 
 
In addition to the disease itself, the physiotherapists identified multiple 
comorbidities as factors that could impact negatively on adherence. There is a 
higher risk for comorbidities for individuals with SpA than in the general 
population, particularly for cardiovascular and osteoporosis conditions (Moltó et 
al., 2016). Multimorbidity is defined as the coexistence of two or more chronic 
diseases in an individual (Wong et al., 2014). In an observational study 
investigating comorbidities in people with SpA across 22 countries, at least 1 
comorbid condition was found in 51% of patients, while 9% had ≥3 comorbidities, 
in addition to their SpA (Moltó et al., 2016). In the present survey, 96% of 
physiotherapists agreed that multiple comorbidities reduced adherence to 
prescribed exercise.  The existing literature also suggests a possible link 
between multimorbidity and reduced adherence (Dekker et al., 2019) but no 
quantitative studies were identified that investigated the effect of 
multimorbidity on adherence to exercise.  However, a study of 3866 people in 
China reported that multimorbidity was associated with poorer medication 
adherence (Wong et al., 2014). The reasons why multimorbidity reduces 
adherence are not clear, there may be a high burden of managing each disease 
for example following medical regimes and attending multiple appointments 
(Mair & Gallacher, 2017). Therefore, as multimorbidity is prevalent in people 
with SpA, physiotherapists should be aware that this may reduce their adherence 
to exercise.  
 
5.5.2 Patient-related Factors affecting Adherence 
In this survey, there were high levels of agreement from UK physiotherapists 




belief that the exercises will not help symptoms or outcomes (92%) and low self-
efficacy (92%) were patient-related factors that reduced adherence to 
prescribed exercise. There was also a high level of agreement that high 
motivation (100%), belief that the exercises would help (94%), enjoyment of the 
exercises (92%) and already being physically active (88%) increased adherence. 
 
Motivation can be defined as the energisation of behaviour towards positive 
stimuli, such as objects, events, possibilities, or in this case toward the 
prescribed exercise (Elliot, 2006).  All physiotherapists within this survey agreed 
that high motivation would increase adherence. However, lack of time, interest, 
self-efficacy, lack of enjoyment, have the potential to reduce motivation and 
ultimately adherence to exercise. While the belief that the exercises will help 
symptoms or outcomes may increase motivation toward exercise and therefore, 
ultimately adherence to exercise (Woodard and Berry, 2001, Teixeira et al., 
2012).  
 
This survey found that all respondents perceived that lack of time reduces an 
individual's adherence. Lack of time is frequently reported as a barrier to 
physical activity and exercise (Reichert et al., 2007). In a general population 
survey of 320,000 individuals in Brazil, 31.5% reported lack of time as a barrier 
to physical activity. Those 31.5% who reported lack of time as a barrier to 
physical activity had significantly less self-reported leisure time in comparison to 
those who did not report time as a barrier, therefore lack of time appears to be 
a real barrier and does not just represent lack of motivation (Reichert et al., 
2007). Similarly, a qualitative study of 17 people with AS investigating physical 
activity and exercise perspectives of adults reported that the participants 
expressed difficulty finding time to exercise, with time spent with family, 
working and studying being prioritised over exercise (O’Dwyer et al., 2016). 
Given these findings, it is important for physiotherapists to discuss and evaluate 
time constraints with individuals for whom they prescribe exercises and help 
them to develop strategies to mitigate against lack of time. 
 
Self-efficacy is an individual’s belief in their ability to complete specific 
tasks (Oshotse et al., 2018). Low self-efficacy was perceived by 92% of 




low self-efficacy typically stop the task if they encounter problems such as 
understanding the regime, being physically unfit, busy or tired. In contrast, 
those with high levels of self-efficacy, do their best to improve skills and 
overcome the obstacles (Bandura, 2004).  Therefore, the belief and confidence 
that a person can exercise, even given constraints, different situations and 
impediments such as feeling tired or being busy is associated with a greater 
likelihood of completing it (Bandura, 1997). Self-efficacy is situational and may 
be one possible reason for the reduced adherence to the patient choice element 
in comparison to the prescribed component in the WEBPASS cohort study 
(Section 4.7.3). Therefore, physiotherapists should explore each individual’s 
self-efficacy toward the exercise prescribed and consider the impact of self-
efficacy on adherence and, if appropriate, implement interventions which may 
improve self-efficacy (See Section 5.5.5). 
 
This survey found that 94% of physiotherapists perceived individuals who 
believed the exercises would help symptoms or outcomes would have increased 
adherence and 92% of physiotherapist perceived individuals who did not believe 
the exercises prescribed would improve symptoms or outcomes would have 
reduced adherence. This relates to, and overlaps with, the condition-related 
factors identified in Section 5.5.1 as it is both the level of the symptoms and the 
patient’s perception of the impact of exercise on these that is likely to impact 
on adherence to exercise programmes in these situations. This is supported by 
the four free text comments in the survey which highlighted that 
physiotherapists believe the patient’s degree of understanding of the condition 
as being important, where lack of understanding reduces adherence and greater 
levels of understanding improves adherence. Physiotherapists should be aware 
that the beliefs the patient holds regarding the possible outcomes achieved from 
exercise may influence adherence to the programme. Physiotherapists should 
explore this with their patients, and consider interventions which may influence 
their belief and therefore their adherence. The interventions which include 
patient education to improve adherence are discussed in Section 5.3.5.  
 
In the survey, 93% of the physiotherapists agreed that individuals who enjoyed 
the exercises that had been prescribed would have increased 




reflects feelings such as pleasure, liking, and fun (Hu et al., 2007). There is a 
recognition of the importance of enjoyment in positively influencing 
participation in exercise (Hagberg et al., 2009). This is supported by the results 
by O’Dwyer et al (2016) from a qualitative study investigating barriers and 
facilitators to exercise in AS, which indicated that enjoying the programme 
improved participation (O’Dwyer et al., 2016).  
 
In contrast, lack of interest in exercise was reported by 98% of the surveyed 
physiotherapists to reduce adherence. Lack of interest in physical activity and 
exercise is a significant challenge and common within the general population in 
Europe (Carraça et al., 2018). Physiotherapists should consider that lack of 
interest reduces adherence and that enjoyment increases adherence and 
incorporate strategies to optimise these. For example, physiotherapists could 
explore the goals of rehabilitation and the type of exercise that is likely to 
interest and be enjoyable to the individual and prescribe based on this 
premise. Furthermore, fun activities within group exercise could be 
incorporated. This is discussed further in the therapy-related Section 5.5.5. Even 
if an individual’s lack of interest in exercise cannot be changed, recognising this 
and the fact that these individuals are less likely to adhere to exercise, can still 
be helpful in understanding poor outcomes and determining where limited 
physiotherapy resources can best be focussed.  
 
Already being physically active was a patient-related factor perceived by 89% of 
physiotherapists to increase adherence to prescribed exercise. Already being 
physically active may support adherence as individuals do not have to initiate as 
great a behaviour change in comparision to those who aren’t active. For those 
who aren’t active, physiotherapists could consider the readiness of each 
individual to change their behaviour. A simple method of doing this would be for 
physiotherapists to ask, on a scale of 0-10 how ready are you to change your 
behaviour, this would allow physiotherapists to gauge the likely success of 
interventions (Royal College of Nursing 2019). On the other hand, interestingly, 
8% of physiotherapists perceived that already being physically active could 
reduce an individual’s adherence to prescribed exercises. The reasons for this 
could not be determined from the survey but it is possible this is due to the 




need, to do further or different exercises prescribed by a physiotherapist. This 
apparent contradiction does again highlight the complex and multiple 
interactions affecting adherence to exercise. 
 
5.5.3  Socio-Economic Factors affecting Adherence 
In the WHO (2003) model socio-economic factors are identified as factors that 
may also influence adherence. In this survey there were high levels of 
agreement from UK physiotherapists that support that social deprivation had an 
effect on adherence. 
 
The majority (94%) of physiotherapists agreed support from friends, family, work 
or a charity would increase adherence and lack of support would reduce 
adherence. Two free text comments by physiotherapists specifically highlighted 
the importance of social support in the form of group exercises, such as those 
provided by NASS. The WEBPASS cohort study also highlighted the importance of 
support, which was identified as a theme from the participant interviews 
(Section 4.6.14.1).  Similarly, support has been identified by two systematic 
reviews to be important in supporting adherence to physiotherapy prescribed 
exercises in other mixed musculoskeletal conditions, and mixed population 
receiving physiotherapy (Jack et al., 2010; Essery et al., 2017) and within a 
qualitative inquiry with people with AS (O’Dwyer et al., 2016), where 
participants highlighted the importance of support in the form of friends, family, 
team or club mates, other adults with AS, as well as from exercise instructors 
and HCP including physiotherapist. Therefore, support appears to be an 
important factor in influencing adherence to prescribed exercise and 
physiotherapists should be aware that the level of support that an individual has 
may influence their adherence to prescribed exercise. Support can be built into 
interventions and is discussed in the therapy-related Section 5.5.5 
 
Social deprivation may reduce adherence to exercise. A high proportion (80%) of 
physiotherapists agreed that high levels of social deprivation reduced adherence 
to exercise, while 4% of physiotherapist perceived that it increased adherence 
and the remainder (16%) were not sure or had no experience of this. To the 




deprivation on adherence to physiotherapy-prescribed exercises; however, 
people in lower socio-economic groups are less likely to meet the current PA 
target than the rest of the population (Schmidt et al., 2008). A free text 
comment from a physiotherapist within the survey highlighted that financial 
limitations reduced access to services, such as community based rehabilitation 
classes which charge a fee for taking part. The overall solution to deprivation 
will be at a societal and government level including reducing inequalities. 
However, physiotherapists should be aware that people with high levels of social 
deprivation may be less active and less likely to adhere to prescribed exercise 
programmes, so should specifically enquire about these aspects and discuss 
potential solutions, such as free classes or online resources with their patients.  
 
5.5.4 Healthcare-related Factors affecting Adherence 
In this survey there were reasonably high levels of agreement from UK 
physiotherapists that good access to physiotherapy increased adherence, as did 
receiving effective medication for the symptoms of SpA. There is considerable 
overlap with effective medication within the health-care construct and 
symptoms within the condition characteristic construct of the WHO multi-
dimensional model, again highlighting the complexity of these inter-related 
factors.  
 
The perception of effective medication being important for good adherence is 
supported by a multi-site quantitative study investigating the impact of effective 
medication on exercise behaviour among individuals with A. It concluded that 
effective pharmacological management of symptoms improved motivation to 
exercise and enabled participants to recommence, or further engage with, 
prescribed exercises and PA (Stockdale, et al, 2014). However, 15% of the 
physiotherapy survey respondents felt that receiving effective medication could 
reduce adherence, with a follow up free text comment stating that if a person's 
symptoms were controlled with medication, then they might not see the 
importance of exercising. As discussed within the condition related Section 
5.5.1, this sentiment was echoed by one participant in the WEBPASS interviews 
who felt that his symptoms were not sufficient to warrant exercise (Peter p44, 




may be a poor measure of success and should be combined with other disease 
and health-related QoL outcomes. Therefore, while it is possible that effective 
pharmacological and non-pharmacological management may, in many cases, 
help increase adherence to exercises, for some individuals this will mean their 
symptoms may not be sufficient to motivate them to exercise. Physiotherapists 
should explore this with individuals, review medicines and refer onto other HCPs 
if symptom control is poor. They should also explain the additional benefits and 
rationale for exercise, particularly in those with good symptom control. This is 
further strengthened by 65% of physiotherapists within this survey agreeing that 
adherence to exercise could be increased by addressing the general health of 
the patient for example referral onto a GP. 
 
5.5.5 Intervention and Treatment-related factors to Support 
Adherence 
Once physiotherapists have considered the multiple potential factors influencing 
an individual’s adherence to exercise in each of the above four WHO constructs 
of personal, condition, socio-economic and healthcare-related factors described 
above, the next step is to consider interventions and strategies to improve 
adherence with a particular emphasis on addressing the factors from the 
constructs identified within the assessment. As prescribers of the exercise 
interventions, this is the domain where the physiotherapists can have the most 
direct influence on their patients’ adherence. In the survey there were high 
levels of agreement for different interventions and strategies to increase 
adherence, including individualising the intervention, using novel digital 
interventions, providing education, using communication to improve adherence 
(for example by goal setting, discussing barriers and facilitators, and/or 
motivational interviewing), addressing the general health of the patient, and 
including support in the intervention (such as practicing the exercises, 
monitoring patient adherence, involving a support person). 
 
All physiotherapists in this survey agreed that individualising the exercise 
programme improved adherence, with 71% perceiving that individualising the 
exercise regime frequently increased adherence. This concurs with the findings 




possible reason why participant’s adherence to the prescribed component was 
deemed to be greater than the patient choice component, as also highlighted in 
the participant interviews (Section 4.6.14.1).  Individualising the exercise 
programme to the needs and capability of participants has been reported as 
being important. O’Dwyer et al reported that most participants with AS felt that 
individualised exercise prescriptions were preferable to generic programmes 
(O’Dwyer et al., 2016).  
 
One physiotherapist commented in the survey that variety could also promote 
adherence. Sylvester et al (2016) undertook a cross sectional survey of 499 
adults and reported a positive relationship between perceived exercise variety 
and self-reported exercise behaviour. Variety may support adherence by 
reducing boredom. Physiotherapists have knowledge about pathology, exercise 
prescription and clinical reasoning skills, so are well placed to individualise and 
include variety within programmes based on their assessment findings (Taylor et 
al., 2007). Within individual programmes, enjoyment and variety could be built 
in. 
 
Patient education can be defined as a planned learning experience to influence 
a patient's knowledge and health behaviour (Schrieber and Colley, 2004). Patient 
education can take different forms and have different aims, such as a better 
understanding of the condition or the treatment, or understanding the potential 
outcomes and consequences with and without the treatment (Rosemann et al., 
2007). This education can take place in a group or on an individual basis. It may 
also involve supportive material. In this survey, 96% of the physiotherapists 
agreed that providing education regarding the importance of exercise would 
improve adherence, while the remaining 4% believed it would have no effect on 
adherence. Furthermore, 96% agreed providing education on the expected 
outcomes or consequences of not exercising would increase adherence, with only 
one respondent believing it would have no effect on adherence. Similarly, 96% of 
the physiotherapists agreed that providing patient information in the form of 
supportive material would increase adherence.   
 
Studies using solely education in this field are few and far between, with the 




combination with exercise to form a self-management plan, which is common in 
clinical practice (Argent, et al 2018). Two out of three studies in the systematic 
review (Chapter 3) reported an increase in adherence following an educational 
programme which also incorporated exercise prescription (Barlow and Barefoot, 
1996; Sweeney, et al, 2002). The third found only a trend towards improvement, 
although poor patient participation with the educational programme could 
account for this result (Gross and Brandt, 1981).  Two further systematic reviews 
of physiotherapy prescribed exercises in MSK conditions (with no participants 
with SpA) suggested that adding educational components increased adherence 
(Ezzat et al., 2015, Peek et al., 2016). At present there is no evidence to suggest 
the optimum format of educational programmes although tailoring the support 
for each individual is suggested to be beneficial (Argent, et al, 2018). As the 
addition of education programmes has the potential to improve adherence 
physiotherapists should consider using education programmes in, or alongside 
their exercise interventions to improve adherence. Again this over laps with the 
patient construct of the model, where poor understanding of condition may 
reduce adherence, therefore education could be an intervention to help with 
this. 
 
Communication is an essential component of exercise prescription, both for 
informing patients about their regimens and then encouraging and supporting 
them in performing these programmes (Zolnierek and Dimatteo, 2009). This 
survey found 96% of physiotherapist agreed that the communication skills of the 
physiotherapists could increase adherence, with only 4% stating this had no 
effect on adherence. There is interest in examining the relationship between the 
HCP and patient, with a positive association noted between a good working 
relationship with a HCP and a patient’s ability to manage and cope with a 
variety of illnesses and adhere to the HCP’s recommendations (Hall et al., 2010; 
Bennett et al., 2011).  
 
The HCP-patient relationship includes verbal and non-verbal communication, 
effective questioning and transmission of information, expressions of empathy 
and concern, partnership and participatory decision-making (Zolnierek and 
Dimatteo, 2009). Research in adherence to medication has indicated that 




approach to asking about adherence. The HCP should acknowledge how common 
non-adherence is, then explore barriers and facilitators to adherence, tailor 
communication to suit the patient’s preferences for the quantity and style of 
communication and use a patient-centred approach with shared decision making. 
The HCP should recognise that the patient’s decisions may ultimately not be in 
accord with medical recommendations (Cairns, 2006, Butow and Sharpe, 2013). 
The best method of communication within online delivery of exercise 
programmes, such as WEBPASS (chapter 4), is unclear, but a ‘keeping in touch’ 
session could be built in to web-based interventions, and could be as straight 
forward as adding in a phone call, or a message through the web-based 
platform. Physiotherapists could aim to improve their communication skills, to 
aid adherence, through training and reflection. Further research could 
investigate the success of communication training and ‘keeping in touch’ 
sessions within web-based interventions. 
 
There was a high level (94%) of agreement that discussing barriers and 
facilitators with each individual would increase adherence. Physiotherapists 
could act collaboratively with each person to discuss their personal barriers and 
facilitators to undertaking an exercise programme, and then consider which are 
modifiable and focus on these. This process may include motivational 
interviewing (discussed below) or goal setting.  
 
Goal setting is the social interaction where goals are shaped during a 
conversation between a HCP and service user (Schoeb et al., 2014). Goal setting 
can be used to direct the prescribed exercise intervention towards a specific 
outcome or outcomes and can be used to evaluate the success of rehabilitation 
interventions (Wade, 2009). Goal setting is collaborative between a HCP and the 
patient and/or their family. Almost all physiotherapists (96%) agreed that goal 
setting could increase adherence. This concurs with a systematic review of 
physiotherapy prescribed exercises in other conditions (Peek et al., 2016). Goal 
setting has been suggested as a strategy to improve self-efficacy (Sacomori et 
al., 2015). Low self-efficacy was noted by physiotherapists to reduce adherence, 
in the patient related construct, therefore goal setting may be a strategy to 
improve adherence through improving self-efficacy, however further research 




survey that practicing the exercises within the intervention with the patient 
would increase adherence. Again practising the exercises could improve self-
efficacy, which in turn could improve adherence. 
 
In this survey, 77% of the physiotherapists perceived that motivational 
interviewing increases adherence to prescribed exercise, and 11% felt 
motivational interviewing had no effect on a person's adherence. The remaining 
11% of respondents had no experience of this.  Motivational interviewing is a 
strategy that aims to help individuals articulate and resolve their ambivalence 
regarding a behaviour, such as exercise, and encourages them to find their own 
individualised solutions (Palacio et al., 2016). It can encompass communication, 
discussion of barriers and facilitators and goal setting. MI involves the HCP 
listening, showing empathy and acknowledging an individual's barriers toward 
exercise with understanding and acceptance, rather than as a fault. The HCP 
then provides encouragement and helps the individual set realistic goals and 
instils confidence that the individual will be able to successfully cope with lapses 
and setbacks (Hettema, et al, 2005). Motivational Interviewing was initially used 
in clinical settings almost exclusively by clinical psychologists and is not typically 
part of traditional physiotherapy training or practice (McGrane et al., 2015), 
which may account for the 11% of physiotherapist who were not sure or had no 
experience of this intervention. A systematic review found adherence to 
exercise was improved with the addition of motivational interventions to 
traditional physiotherapy (McGrane et al., 2015). Furthermore, a systematic 
review concluded that motivational interviewing improves adherence to 
medicine (Palacio et al., 2016). Physiotherapists should consider training in and 
using motivational interviewing as another strategy to increase adherence to 
their prescribed exercise programmes.  
 
As highlighted previously, within the socio-economic section, support of family 
and friends appears to be an important factor in adherence. Support can also be 
built into interventions, again highlighting the overlapping complexity of the 
adherence model. Physiotherapist could identify existing support mechanisms 
and encourage new support networks such as HCPs, family, work colleagues, 
carers and group exercise opportunities. Members of the support network could 




with SpA, and taught the prescribed exercises and encouraged to either exercise 
together or to’ check’ in with each other to promote adherence. Within 
WEBPASS (Chapter 4) two participants (p17 Gary & p2 Robert, Section 4.6.14.1) 
noted that their partners either encouraged them to exercise or they exercised 
together which they felt improved their adherence, this highlights the benefits 
of including a person’s support network within the exercise session.  
 
In group exercise the support can come from the physiotherapist and the other 
people within the group. Physiotherapists from this survey agreed that 
interventions which provided support would increase adherence; this could be 
through monitoring adherence, involving the patients support team, through 
addressing the general health of the patient and through practicing the exercises 
within the consultation. It is interesting that 10% of physiotherapists had no 
experience of including support networks and this may be an area to include in 
interventions to increase adherence. 
 
5.5.6 Physiotherapists’ Barriers to Employing Interventions and 
Strategies to Improve Adherence 
To improve patient adherence to prescribed exercise, physiotherapists need to 
be supported in their efforts to assess and promote patient adherence 
(Babatunde, et al, 2017). Time is consistently highlighted by physiotherapists 
and other professions as a constraint to providing patient care (McMahon and 
Connolly, 2013). In this survey, the majority of physiotherapists (65%) did not 
perceive that a lack of time was a barrier to assess adherence and provide 
interventions to aid adherence, although for a third (35%) this was seen as a 
barrier.  
 
An encouraging finding of this study is that limited knowledge about adherence 
(8%), inability to discuss adherence (12%), lack of continuity of care (21%) or 
limited resources (19%) were not perceived by the majority of respondents as 
being barriers to implementing methods to aid adherence. For those who did 
perceive these as barriers, training and support could help physiotherapists with 






Almost all the physiotherapists (96%) perceived that adherence is relevant to 
physiotherapy practice. However, given that the majority of physiotherapists 
(85%) surveyed also responded that adherence is a problem with their 
patients, further research is required to determine methods and strategies to 
improve adherence to exercise in people with SpA. 
 
Free text responses indicated perceived barriers were mainly related to service 
provision, such as facilities and providing hydrotherapy, which are largely out of 
the direct control of the individual physiotherapists. 
 
5.5.7 Overall Physiotherapist Perceptions of Factors Affecting 
Adherence in People with SpA 
It is encouraging that physiotherapists perceive adherence important as part of 
their practice, most but not all thought adherence was a problem in their 
patients, however, evidence from the WEBPASS study and in other existing 
literature suggests adherence to exercise programmes is low (Sluijs et al., 1993, 
Peek et al., 2016). It may be that some physiotherapists underestimate the level 
of adherence of their patients to prescribed exercises. Robust measurement of 
adherence and including routine measurement of adherence within clinical 
practice may help with this. 
 
Physiotherapists who prescribe exercises for people with SpA believe they can 
improve adherence, therefore should aim to determine the relevant factors 
affecting adherence for each individual and design personalised interventions. 
While factors in each WHO construct should be considered, the physiotherapist’s 
focus should be on those factors that they can modify. Physiotherapists, 
especially those within the NHS, have very little control over health care related 
factors such as the access to services. 
 
5.5.8 What this study adds to the existing literature 
The findings of this national survey provides new evidence that physiotherapists 




improving clinical outcomes in people with SpA and that patient adherence to 
prescribed exercise is problematic.  
 
There were high levels of agreement between therapists of a number of new 
factors affecting adherence to exercise in people with SpA. Within healthcare 
related construct good access to physiotherapy and effective medication for 
symptom control improved adherence. Within the disease related construct, 
concurrent mental health problems, high disease symptoms and multiple co-
morbidity reduced adherence. Within the socio-economic domain, support 
increased adherence, while social deprivation reduced adherence. Within the 
patient related construct the belief the exercise would help and being physically 
active improved adherence, whilst lack time, interest or confidence and low 
self-efficacy reduced adherence. Within the treatment related construct, 
individualising the intervention, including goal setting, providing patient 
education, practicing the intervention, discussing barriers and facilitators, 
addressing the general health of the person, monitoring the intervention, 
providing and/or facilitating support, including digital interventions, and 
motivational interviewing could increase adherence.  
 
The survey found that lack of time, contingency of care and poor service 
provision were barriers to implementing interventions to improve adherence.  
 
5.5.9 Limitations 
The main limitations of this study is related to sampling methods. While every 
effort was made to reach a large sample of physiotherapists working with people 
with SpA, no physiotherapists from NI responded. The physiotherapists who 
responded were also mostly experienced practitioners who are likely to have 
specialist insights into adherence and the condition; while this had the 
advantage of capturing expert insights, these views may not be representative of 
younger or more recently qualified physiotherapists. In contrast, the latter may 
have more insights into digital resources or motivational interviewing. 
Furthermore, this survey was limited by snowball sampling in that 
physiotherapists who see people with SpA as part of other services such as MSK 




physiotherapists. The results of this survey are therefore generalizable to those 
physiotherapists’ who are experienced and specialising in SpA. This survey was 
limited by its cross-sectional design, meaning that it was not possible to draw 
causality between any variables from the results or understand how the factor 
interacted.   
 
A further limitation of this study is that respondents answered questions of 
factors affecting adherence that were proposed by the PhD Student. Although 
these factors were informed by the previous literature, this may have prompted 
the respondents to respond to factors which they would not have considered had 
these not been proposed. 
 
Another limitation of this study was that the specific diagnoses within the SpA 
spectrum of conditions that the physiotherapists assessed and treated was not 
collected, so it was not possible to evaluate whether the perceptions of 
physiotherapists differed between those treating mainly axial versus peripheral 
SpA. 
 
5.5.10 Future Research 
This study has identified a number of factors which physiotherapists believe may 
determine adherence. Future studies could investigate these factors in more 
detail, with particular emphasis on determining the most important and the 
weighting of factors in terms of their impact on adherence. This would help 
identify the factors where changes could lead to the greatest impact.  
 
Future research should consider how physiotherapists can easily measure 
adherence within every day practice. 
 
Further research could focus on the extent to which physiotherapists address 
patient adherence to prescribed exercise during routine patient consultations to 
investigate if there is consistency between the perceptions of physiotherapists as 
reported in this study and what physiotherapists actually do in practice. There 
was a high level of agreement of interventions and strategies to aid adherence 




such methods are effective in physiotherapy practice, and whether or not they 
are used routinely by physiotherapists. There is also a need to examine which 
factors are modifiable and which are non-modifiable by physiotherapists.  
 
Future research should determine the training needs for physiotherapists to 
build adherence management into daily practice such as through improved 
communication skills and training in interventions to support adherence and 




The aim of this survey was to explore the beliefs and perceptions of 
physiotherapists specialising in prescribing exercises to people with SpA on 
adherence to exercise programmes, focusing on the five domains in the WHO 
adherence model; the methods of prescribing exercise, the beliefs of the 
importance of patient adherence, the factors which affect adherence, the 
strategies and interventions to increase adherence and the barriers to employing 
these strategies and interventions.  
 
This study identifies multiple factors within the five constructs of the WHO 
adherence model which may interact with each other to determine an 
individual’s adherence to prescribed exercise, highlighting the complexity and 
heterogeneity of this issue. This survey adds that physiotherapists believe that 
adherence to prescribed exercise can be low. 
 
This study identified that time was the commonest barrier for physiotherapists 
to implement strategies to improve adherence.  
 
Physiotherapists should consider the factors potentially affecting each 
individual’s adherence to exercise and aim to implement strategies to 






Future studies should consider how physiotherapist measure adherence within 
every day practice and consider which factors best predict adherence and which 































6 Chapter: General discussion, conclusion and recommendations 
6.1 Study summaries  
The overall aim of this research was to investigate the level of adherence and 
factors affecting adherence to prescribed exercise programmes in people with 
SpA. The aim was formulated after an extensive literature review to address 
important gaps in the literature. To meet the aims of this thesis, three studies 
were conducted.  
The first study in this thesis was a systematic review of 10 studies investigating 
adherence to prescribed physiotherapy exercise programmes in people with SpA. 
The outcome of the systematic review showed that rates of adherence ranged 
from 51% to 95%. There was significant heterogeneity between studies, including 
in how they defined adherence and the types of exercise intervention being 
investigated, making comparisons difficult. Two studies identified that 
adherence improved following educational programmes and one single 
study found higher disease severity and longer diagnostic delays were associated 
with higher adherence. One study indicated supervised group exercise increased 
adherence to HEP whilst another found no difference. Three linked, consecutive 
studies by the same research group reported that adherence reduced over time 
and a further study found adherence reduced after an educational programme. 
From the SLR, it was therefore not possible to reach any definitive conclusions 
about adherence to prescribed physiotherapy programmes in people with SpA. 
No study within the systematic review measured adherence to an online 
physiotherapy programme in SpA.  
The second study within the PhD study evaluated adherence to a 12-month web 
based programme in people with axSpA. As people with this condition are 
required to exercise frequently from diagnosis (commonly in their 20s or 30s) 
over the course of this lifelong chronic condition, online programmes have 
advantages in being flexible and available 24/7, without the need for travel, 
which may potentially benefit long term adherence. The PhD focused in detail 
on adherence levels of participants in the WEBPASS study in terms of: sessions 




adherence to participant choice and physiotherapy prescribed components, 
adherence over time and evaluation of factors which may affect adherence. In 
addition, interview data specifically related to adherence were analysed. This 
study found that the adherence rate in the WEBPASS trial was 27.6% of all 
sessions engaged in overall for the 12-months. It is difficult to compare this 
result directly to the published literature of adherence to exercise interventions 
in SpA due to differences in participant characteristics, length, frequency and 
type of intervention and differing measures of adherence. Seven of the 49 
participants in the WEBPASS trial did not initiate the exercise intervention, 
completing no sessions at all. For those who provided adherence data for the 12-
months (n=38), only seven achieved good adherence according to our pre-
defined cut-off. Finding the link between how adherence affects outcomes may 
help understand the level of adherence required to gain the desired outcomes. 
This study also found that when participants started an exercise session, they 
were very likely to to complete the session. The study also found adherence 
reduced over time but not in a strictly linear fashion, with increases in 
adherence levels around the time of contact with the physiotherapist for study 
visits. Online programmes, have many advantages such as lower costs, more 
flexibility and availability, as well as being able to capture adherence on the 
same system. Individualised online exercise programmes are a viable option for 
some people with axSpA, particularly due to the long term and frequent 
exercises required in this condition, so are an option that physiotherapists 
should consider as part of their management of axSpA. However, it is clear that, 
like all interventions, this is not effective for all and strategies to identify those 
most likely to benefit from these methods are required, as are strategies to 
improve adherence with this programme. The factors which influence adherence 
remain unclear but from the patient view-point, symptoms, getting into a 
routine and support appear to play a role in influencing adherence to this 
intervention. Physiotherapists should encourage service users to build support 
networks, and incorporate exercise into their daily routine, with online exercise 
platforms one option to consider. 
 
The third study within the PhD study explored the beliefs and perceptions of UK 
physiotherapists specialising in prescribing exercises to people with SpA, using 




exercise, the beliefs of the importance of patient adherence, the factors which 
affect adherence, the strategies and interventions to increase adherence and 
the barriers to employing these strategies and interventions. The findings of this 
national survey indicate that almost all physiotherapists believe that adherence 
to prescribed physiotherapy exercise is important in improving clinical outcomes 
in people with SpA, relevant to their practice and that they, as physiotherapists, 
could employ strategies to alter a person’s adherence levels. However, not all 
physiotherapists felt that adherence to exercise was a problem in their patients 
and only two thirds reported that they had sufficient time to assess adherence or 
implement measures to address this. There were high levels of agreement of the 
factors affecting adherence to exercise.  The healthcare related factors found 
were: good access to physiotherapy, effective medication for symptom control 
improved adherence. The disease related factors found were: concurrent mental 
health problems, high disease symptoms and multiple co-morbidity reduced 
adherence. The socio-economic factors found were: support increased 
adherence, while social deprivation reduced adherence. The patient-related 
factors found were: the belief the exercise would help and being physically 
active improved adherence, whilst lack time, interest or confidence and low 
self-efficacy reduced adherence. The treatment-related factors found were, 
individualising the intervention, including goal setting, providing patient 
education, practicing the intervention, discussing barriers and facilitators, 
addressing the general health of the person, monitoring the intervention, 
providing and/or facilitating support, including digital interventions, and 
motivational interviewing could increase adherence. There was some overlap 
between the constructs. 
 
The survey found that lack of time, contingency of care and poor service 
provision were barriers to implementing interventions to improve adherence.  
 
These three studies have contributed to a model of adherence for 
physiotherapists to use and is presented in fig 6-1.
 
 
Figure 6-1. Model of adherence for Physiotherapists to Consider in exercise programmes for People with SpA.  
Adapted from the WHO (2003) with possible factors added from this thesis investigation (R =  














Treatment Related: Interventions that may 
increase adherence:  
• goal setting (S) 
• individualising (S) (C) 
•  education (S) (R) (C) 
• practising exercises, (S) 
•  discussing barriers and facilitators (S) 
•   Support (C) (S) 
•  addressing person’s general health (S) 
•  motivational interviewing (S) 
• supervised group exercise (R)  
• Digital interventions (C) (S) 
Healthcare-related: 
• Good access to physio may increase 
adherence (S) 
• Effective medication may increase 
adherence (S)  
Condition-related: 
• Concurrent mental health problems may 
reduce adherence (S) 
• Conflicting evidence, high disease symptoms 
may reduce adherence or increase 
adherence (S) (R) 
• Delay in diagnosis may increase adherence 
(R) 
• Multiple co-morbidities may reduce 
adherence (S) 
Patient-related: 
• Lack of time (S) 
• Lack of interest, (S) 
• being afraid of exercise, (S) 
• low self-efficacy & low belief exercise will 
help may reduce adherence. (S) 
• Enjoyment, (S) 
• being physically active, (S) 
• believing exercise will help may increase 
adherence (S) 
Socio-Economic: 
• Good support may increase and lack of 
support may reduce adherence (C) (S) 
• High levels of social deprivation may reduce 
adherence (S) 
• Getting into a routine may increase 
adherence (C) 
Consider barriers in implementing interventions;  
• lack of time, (S) 
•  lack of continuity of care, (S) 




















6.2 Contribution to knowledge 
All three studies make an original contribution to knowledge in the field of 
adherence to exercise prescription in people with SpA. The systematic 
review reported in Chapter 3 was the first to assess the available literature 
investigating adherence to prescribed exercise in people with SpA and has 
been published (McDonald et al., 2019). The WEBPASS cohort study 
provided new evidence on the level of adherence to an individualised web-
based physiotherapy programme and added to the limited knowledge of 
adherence to exercises in axSpA and is the first online intervention in 
axSpA. The online survey found new evidence that physiotherapists 
specialising in prescribing exercise in people with SpA knew the importance 
of adherence in achieving clinical outcomes, largely recognised that 
adherence to prescribed exercise is problematic and identified a broad 
range of factors which may contribute to adherence, strategies and 
interventions that may support adherence and barriers to implementing 
them. All three studies contribute to the model of adherence presented in 
fig 6-1 which provides physiotherapists with a suggested model for 
adherence to consider for each person for whom they prescribe exercises. 
6.3 Recommendations for clinicians  
Physiotherapists should be aware that adherence to prescribed exercise in 
people with SpA is variable, can be low and reduces over time, with 
multiple factors in several domains influencing this. Physiotherapists could 
use the model in fig 6-1 with each individual they prescribe exercise to in 
order to consider potential factors affecting adherence and to develop 
strategies and interventions to improve adherence, focusing on those they 
can alter, while being aware of other external factors that may be beyond 
their control, in order to optimise the chances for good adherence, and 





6.4 Public and Patient Involvement in the Thesis 
Patient and public involvement in research is recognised as best practice, 
to ensure that research is relevant to user needs and hence more likely to 
have beneficial impacts (Gray-Burrows et al., 2018). Two patient 
representatives sat on the WEBPASS steering group for the cohort study 
described in Chapter 4, who commented on the process of the study, and 
Debbie Cook who was the current chief executive of NASS was a co-
applicant on the WEBPASS grant. Furthermore, the survey, Chapter 5, was 
piloted with two qualified physiotherapists prior to dissemination. However, 
more patient involvement in the development of research questions within 
the survey and the systematic review within Chapter 3 and how best to link 
the three research studies may have further improved the research ensuring 
the research was relevant to service users.  
 
6.5 Recommendations for future research 
Further research is recommended 
• to find a standardised measure of adherence so meaningful 
comparisons between studies can be formed. 
• to compare adherence across interventions. 
• to better understand the link between adherence and clinical 
outcomes (such as pain, function, disease activity) in people with 
SpA. 
• to confirm the factors affecting adherence as identified by 
physiotherapist within this thesis. 
• to find which factors best predict adherence in people with SpA and 
which are most amenable to intervention. 
• to consider the extent to which physiotherapists address patient 






6.6 Conclusion  
This thesis has provided preliminary data that adherence to prescribed 
exercise in people with SpA can be low, is variable and reduces over time. 
Web-based programmes appear safe and have advantages. Comparing 
adherence rates across different deliveries of programmes is difficult due to 
the heterogeneity of the interventions, participants and measurement of 
adherence. Once a person starts an exercise session more often than not, 
they complete all the exercises within the session, therefore 
physiotherapists should concentrate on strategies to get people started on 
their session. This thesis identified several new factors which possibly 
affect adherence. Physiotherapists could consider and discuss these factors 
with each patient, and problem solve with each individual to modify any 
factors which negatively affect adherence and can change, and maximise 
factors such as support networks which improve adherence. Furthermore, 
physiotherapists could consider several of the strategies and interventions 
such as goal setting and individualising interventions which might improve 
adherence. Overall further research is required to strengthen or confirm 
the findings. As such, the work contained within this thesis should be 
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38 Church Street Glasgow  G11  6NT  
    
Date  27 October 2015  
    
Direct line 0141 211 2102  
 




Study title:  WEB-Based Physiotherapy for People with Axial Spondyloarthritis: A 
Cohort Study (WEB-PASS)  
REC reference:  15/WS/0229  
 
IRAS project ID:  186902  
  
The Research Ethics Committee reviewed the above application at the meeting 
held on 21 October 2015.   Thank you for attending to discuss the application, 
along with Mrs McDonald.   
  
We plan to publish your research summary wording for the above study on the 
HRA website, together with your contact details. Publication will be no earlier 
than three months from the date of this favourable opinion letter.  The 
expectation is that this information will be published for all studies that receive 
an ethical opinion but should you wish to provide a substitute contact point, 
wish to make a request to defer, or require further information, please contact 
the REC Manager Mrs Sharon Macgregor, WoSREC5@ggc.scot.nhs.uk. Under very 
limited circumstances (e.g. for student research which has received an 
unfavourable opinion), it may be possible to grant an exemption to the 
publication of the study.   
  
Ethical opinion  
 The members of the Committee present gave a favourable ethical opinion of the 
above research on the basis described in the application form, protocol and 
supporting documentation, subject to the conditions specified below. .  
  
Conditions of the favourable opinion  
  
The favourable opinion is subject to the following conditions being met prior to 
the start of the study.    
  
Management permission or approval must be obtained from each host 
organisation prior to the start of the study at the site concerned.    
  
Management permission (“R&D approval”) should be sought from all NHS 
organisations involved in the study in accordance with NHS research governance 
arrangements.  
  
Guidance on applying for NHS permission for research is available in the 
Integrated Research Application System or at http://www.rdforum.nhs.uk.   
  
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites (“participant identification centre”), guidance 
should be sought from the R&D office on the information it requires to give 
permission for this activity.  
  
For non-NHS sites, site management permission should be obtained in 
accordance with the procedures of the relevant host organisation.   
  






Registration of Clinical Trials  
  
All clinical trials (defined as the first four categories on the IRAS filter page) 
must be registered on a publically accessible database. This should be before the 
first participant is recruited but no later than 6 weeks after recruitment of the 
first participant.  
   
There is no requirement to separately notify the REC but you should do so at the 
earliest opportunity e.g. when submitting an amendment.  We will audit the 
registration details as part of the annual progress reporting process.  
   
To ensure transparency in research, we strongly recommend that all research is 
registered but for non-clinical trials this is not currently mandatory.  
   
If a sponsor wishes to request a deferral for study registration within the 
required timeframe, they should contact hra.studyregistration@nhs.net. The 
expectation is that all clinical trials will be registered, however, in exceptional 
circumstances non registration may be permissible with prior agreement from 
the HRA. Guidance on where to register is provided on the HRA website.   
  
It is the responsibility of the sponsor to ensure that all the conditions are 
complied with before the start of the study or its initiation at a particular site 
(as applicable).  
  
Ethical review of research sites  
  
NHS Sites  
  
The favourable opinion applies to all NHS sites taking part in the study taking 
part in the study, subject to management permission being obtained from the 
NHS/HSC R&D office prior to the start of the study (see “Conditions of the 
favourable opinion” below).   
  
Summary of discussion at the meeting  
  
Ethical issues raised by the Committee in private discussion, together with 
responses given by the researcher when invited into the meeting  
  
Social or scientific value; scientific design and conduct of the study  
  
The Committee asked what treatment patients would normally receive.  
  
Dr Paul advised that there is no standard usual care.  Patients would see a 
physiotherapist once and be given an exercise programme to do at home.  They 
may or may not see a physiotherapist again.  
   
It was not clear whether the website will record who is using it.  
  
Dr Paul confirmed that patients will log on to the website and tick a box to say that 
they have done the exercises.  They can also add comments (for example – 
whether they are having difficulty with a particular exercise) and the 





Informed consent process and the adequacy and completeness of participant 
information  
  
It was noted in page 2 of the Participant Information Sheet that the section 
explaining what will happen at the first appointment also mentions what will 
happen at three of the visits.  (ie wearing the activPAL). This information is then 
repeated in the “Visits 3 and 4” section and was a little confusing.  
  
The researchers agreed to look at these sections and amend them as appropriate.  
  
However, after the researchers left, the Committee agreed that the Information 
Sheet was satisfactory as this was only a minor point and that no changes are 
required.  
  
Suitability of supporting information  
 It was not clear when the diary would be used and what information will be 
recorded.  The Committee were not sure if compliance would be maintained if 
the diary had to be completed for the duration of the study.  
  
The researchers confirmed that the diary will only be completed while the 
ActivPAL is being worn.  Only the times when the patient goes to bed and gets up 
will need to be recorded.  
  
Other general comments  
 It was noted that there were several places where information had still to be 
added (“ZZZZZZ” and “version x, dated xx.xx.xx”) in the information sheet, 
consent form and interview schedule.  However, it was presumed that this 
information will be completed before the documents are issued.  
  
Approved documents  
  
The documents reviewed and approved at the meeting were:  
  
Document    Version    Date    
Copies of advertisement materials for research participants 
[Poster]   
   14 August 2015   
Covering letter on headed paper [Covering Letter]      29 September 2015  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Insurance letter]   
   12 August 2015   
GP/consultant information sheets or letters [GP letter]   V1   16 July 2015   
Interview schedules or topic guides for participants [Exit 
Telephone Interview]   
1   14 August 2015   
Letter from funder [Letter of Award from ARUK]      20 May 2015   
Letters of invitation to participant [Invitation Letter]   V1   16 July 2015   
Other [Telephone Interview]   1   17 August 2015   
Other [WPAI Questionnaire]         
Other [BASFI Questionnaire]   V1   18 September 2003  
Other [BASDAI Questionnaire]         
Other [EDQ5 Questionnaire]         




Other [Exercise Adherence Questionnaire]         
Other [Activity Diary]   V1   14 August 2015   
Participant consent form [Consent Form]   V1   21 September 2015  
Participant information sheet (PIS)   V1   21 September 2015  
REC Application Form [REC_Form_07102015]      07 October 2015   
Research protocol or project proposal [Protocol]   V1   21 September 2015  
Summary CV for Chief Investigator (CI) [Lorna Paul CV]      23 January 2015   
Validated questionnaire [ASQoL]         
  
Membership of the Committee  
  
The members of the Ethics Committee who were present at the meeting are 
listed on the attached sheet.  
  
The Committee is constituted in accordance with the Governance Arrangements 
for Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.  
  
After ethical review  
  
Reporting requirements  
  
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable 
opinion, including:  
  
Notifying substantial amendments  
Adding new sites and investigators  
Notification of serious breaches of the protocol  
Progress and safety reports  
Notifying the end of the study  
  
The HRA website also provides guidance on these topics, which is updated in the 
light of changes in reporting requirements or procedures.  
  
User Feedback  
  
The Health Research Authority is continually striving to provide a high quality 
service to all applicants and sponsors. You are invited to give your view of the 
service you have received and the application procedure. If you wish to make 
your views known please use the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-thehra/governance/quality-assurance/   
  
HRA Training  
  
We are pleased to welcome researchers and R&D staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/   
  
 15/WS/0229   Please quote this number on all correspondence  
  















Enclosures:           List of names and professions of members who were present 
at the meeting and those who submitted written comments  
  
“After ethical review – guidance for researchers”    
   
Copy to:  Dr Maureen Travers, NHS Greater Glasgow and Clyde    




West of Scotland REC 5  
  
Attendance at Committee meeting on 21 October 2015  
  
   
Committee Members:   
  
Name    Profession    Present    Notes    
Dr Stewart Campbell   Consultant Physician & Gastroenterologist 
(CHAIR)   
Yes       
Dr Roddy Chapman   Consultant Anaesthetist   Yes       
Dr James Curran   GP   Yes       
Dr Gillian Harold   Consultant Radiologist   No       
Mrs Naomi Hickey   Research Nurse   Yes       
Dr Gillian Kerr   Consultant Physician   Yes       
Dr Ahmed Khan   Consultant Psychiatrist   Yes       
Professor Eddie McKenzie   Statistician   Yes       
Canon Matt McManus   Parish Priest (Vice-Chair)   Yes       
Ms Janis Munro   Key Account Manager   Yes       
Mrs June Russell   Retired (Research Chemist)   Yes       
Mr Charles Sargent   Retired   Yes       
Dr Marcel Strauss   Consultant Radiologist   Yes       
Mrs Liz Tregonning   Retired (Special Needs Teacher) (Alternate 
ViceChair)   
Yes       
   
Also in attendance:   
  
Name    Position (or reason for attending)    
Dr Judith Godden   Scientific Officer/Manager   
Mrs Sharon Macgregor   Co-ordinator   













Appendix 2 Patient Information Sheet from Webpass Study 
Participant Information Sheet 
For the study entitled: WEB-based Physiotherapy for People with Axial 
Spondyloarthritis (WEB-PASS) 
Why have I been approached about this study? 
We are inviting you to participate in this study as you have ankylosing spondylitis 
or axial spondyloarthritis (“axial SpA” is used to refer to both from here on) and 
have been identified by your healthcare professional as someone who requires a 
long-term exercise and physiotherapy programme, so would be suitable for 
inclusion in this study. This study is a collaboration between NHS Greater 
Glasgow and Clyde and the School of Medicine at the University of Glasgow; it is 
funded by Arthritis Research UK.  
Before you decide whether or not to take part it is important for you to understand 
why the research is being undertaken and what it will involve.  Please take time to 
read the following information carefully and discuss it with others if you wish.  Ask 
us if there is anything that is not clear or if you would like more information.   
You will need to have internet access to participate in this study. Thank you in 
advance for taking the time to read this information leaflet.  
What is the purpose of the study? 
Regular exercise is a core part of the management of axial SpA, as we know that 
exercise can increase mobility, flexibility, strength, physical activity, pain, mood 
and quality of life in this condition, in addition to the more general health benefits 
of regular activity. However, it is not easy for people to take part in exercise 
regularly over the longer term for a variety of reasons such as work and family 
commitments, motivation, and lack of resources and supervision. There is 
therefore a need to develop and study new ways of delivering exercise for 
conditions such as axial SpA.  The internet offers the potential to deliver 




physiotherapist and has shown potential in a number of other chronic conditions. 
This study will investigate the effectiveness of, and adherence to, a one year web-
based exercise programme specifically developed for axial SpA.  
Do I have to take part? 
No; taking part in research is entirely voluntary; therefore it is up to you to 
decide. You should read this information leaflet and if you are interested in 
taking part you should phone the research team on the contact details at the 
bottom of this information leaflet and we will arrange your 1st appointment. 
When you attend that appointment you will be screened to make sure it is safe 
and suitable for you to take part in the study. If you wish to go ahead you will 
be asked to sign a consent form to show that you agree to take part. You would 
still continue to receive your medications and treatments under the care of 
your rheumatology team as per standard clinical practice.  
If you decide to take part you are still free to withdraw at any time and 
without giving a reason. Your decision will not have any effect on the standard 
of care you receive.  
What will happen to me if I take part? 
There are a total of four study appointments over one year which will take 
place at your local hospital physiotherapy department. The first visit should 
take approximately 90 minutes, while the other 3 visits should take no more 
than 1 hour. 
At your first appointment, you will be asked some questions to ensure you are 
eligible to take part in the study. If you are eligible and wish to take part, you 
will be asked to provide written informed consent and baseline study 
assessments will be completed. This will involve completing a walking test and 
five questionnaires, an assessment of your posture and movement of your spine. 
At 3 of the visits you will also be given a small physical activity monitor to wear 
(attached to one thigh) which will measure your walking activity for one week 





At the second visit (approximately one week after the first visit) your specific  
exercise goals and programme will be devised. Your physical activity monitor 
will be removed and you will be provided with an individualised web-based 
physiotherapy exercise programme. 
Between visits: You will use a computer, laptop or tablet device in your own 
home to access your exercise programme via the internet. You will be asked to 
logon to your exercise programme on the study web-site five times per week in 
order to perform your exercises (approximately 30 minutes at a time) and 
complete the brief online exercise diary. Your physiotherapist will provide you 
with information on how to use the website and how to follow your exercise 
programme. The exercise programme will include the standard exercises 
recommended for axial SpA which will have been tailored to your personal goals 
and ability. Your physiotherapist will phone you once a week for the first 2 
weeks; after this the physiotherapist will review your programme every two 
weeks and will contact you by email with any changes. 
In addition, if you agree to be contacted about this, you may be asked to take 
part in a telephone interview during the project. During this interview we will 
ask you about your adherence to your exercise programme, reasons why you 
complete or find it difficult to complete your online exercise programme and 
what other activities or exercise you do. This telephone call will be recorded, 
anonymised and transcribed by a member of the research team.  
Visits 3 and 4: You will be invited back to repeat the assessments carried out at 
your first assessment after 6 and 12 months. At these assessments you will also 
be given an activity monitor attached to the front of your thigh using a 
waterproof dressing for one week, after which you will remove it and post back 






What are the possible disadvantages or risks of taking part? 
There are no major risks in taking part in this study. Regular exercise is key 
part of the management of axial SpA and is recommended for all people with 
these conditions. Some people may feel breathless while completing the 
exercises and may notice some muscle soreness or tiredness which is generally 
short lasting. A small number of people may find wearing the activity monitor 
causes a minor skin irritation. This is rare but should this be the case, we would 
advise participants to remove the activity monitor and to contact us.  
What are the possible benefits of taking part? 
We hope taking part in the study will improve your health and condition as the 
existing evidence suggests regular exercise is helpful for these, however we 
cannot promise that the study will help you personally. The information 
obtained from this study may help improve the treatment of other people with 
axial SpA.   
What about expenses or payments involved with taking part in the study? 
The exercise programme will be free; however you will be required to have a 
computer, tablet device or smart phone and internet access to take part 
(unfortunately we are unable to cover these costs). You will not be paid for 
participating in the study, but we have funding to help contribute to your 
travelling expenses (£10 per study visit). You will not have to pay postage for 
sending back the activity monitors (pre-paid postage). 
What happens when the research study stops? 
These exercise programmes are designed to give you an individualised exercise 
programme to help you exercise at home along with advice on how to exercise 
in the long term and self-manage your condition. After taking part in this 
research project you should continue exercising on your own independently. You 





Will my taking part in this study be kept confidential? 
Yes, all information collected from you during the study will be kept strictly 
confidential and treated with normal ethical and legal practice for data collection. 
With your permission we will inform your own GP about your involvement in this 
study. In addition representatives of the Sponsor NHS Greater Glasgow and 
Clyde, may access your medical notes where they relate to the study in order to 
monitor that the study is being carried out properly. 
What happens if new information becomes available? 
Sometimes new treatment information becomes available. Although this is unlikely 
for this study, but should this happen during the study the research team will tell 
you and discuss whether you should stay in the study. If you decide not to 
continue, this will not affect your care in any way. If you decide to continue you will 
be asked to sign an updated consent form. 
What will happen if I don’t want to continue in the study? 
You can withdraw at any time without giving us any reason. However, as one of 
the aims of this study is to find out what sorts of things affect the use of this 
programme, we would ask to complete a brief telephone interview with you to 
understand the reasons why you withdrew from the project. This will help us 
understand the difficulties people may have with completing a web-based exercise 
programme over 12 months. If you do withdraw we would also encourage you to 
keep in contact with us and let us know your progress. Any information collected 
prior to your withdrawal will still be used.  
What If there is a problem? 
Should you have a concern about any aspect of the study, in the first instance you 
should contact the research physiotherapist, using the contact details below, who 
will do their best to answer any questions. If this does not resolve the issue, and 
you would like to formally complain you can do this through the NHS Complaints 
Procedure, details can be obtained from the Patients, Relations and Complaints 




Independent advice about the study can be obtained from Jim Woodburn, 
Professor of Rehabilitation, tel: 0141 3318483. 
What happens to the results of the research study? 
It is intended that the results of the study will be published in medical literature 
and/or presented at healthcare conferences. All data will be anonymised before 
this and no-one will be able to identify you. Should you wish to know the results of 
the study then we will send you a summary of the main findings once the research 
is complete.  
Who is organising funding the research?  
This study is funded by Arthritis Research UK.  
Who has reviewed this study? 
All research in the NHS is looked at by the Research Ethics Committee, an 
independent group of people who aim to protect patient safety, rights, well being 
and dignity. This study has been reviewed and given favourable opinion by the 
West of Scotland Research Ethics Committee. 
Participation, further information and contact details. 
Should you wish to take part in this study or if you require any further information 
about this research study please contact:  
Marie Therese McDonald  
Advanced Physiotherapist 
Therapy Department,  
Queen Elizabeth Hospital 












Appendix 3 Interview Schedule for the Qualitative Programme 
Evaluation for Web-pass 





My name is xxxx and I’d like to ask you some questions about 
the web-based physio research study that you have been taking 
part in. This should take about 10-15mins, is that ok? 
 
I would also like to record our conversation, is that ok? 
Section 2: Access 
& exercising at 
home 
 
How do you access the website? Did you use a computer, 
laptop, tablet or phone? 
 
Have you had any issues accessing the website? 
 
What do you think about web-based physio? What is good or 
not good about the website? 
 
Sometimes we are criticised for not exercising in a group or 
the community. What are your thoughts about following an 






How long have you been diagnosed with AS/axial SpA? 
 
Do you think it is important to exercise with your condition? If 
so what do you think the benefits are? 
 
Before participating in the study, had you been advised by your 
doctor or physiotherapist that you should exercise? If so what 
kind of exercise? 
 
What exercise have you done in the past for your AS/axial SpA? 
 
Have you followed exercises on the internet (eg.  YouTube) for 
your AS/axial SpA diagnosis?  
 
Have you followed the exercise programme from NASS? 
 
Have you received an exercise programme from a 
physiotherapist for your AS/axial SpA diagnosis? [If so, what?] 
 
What are your thoughts about following an exercise programme 
over the internet? 
 
How does this web-based physio exercise programme compare 








Roughly how often did you do your web-based exercise 
programme every week? 
 
You said you did your programme X times per week.  How did 
you fit that into your day? 
 
Were there times when it was difficult to exercise X times a 
week?  
If so what circumstances made it difficult? 
So when it was difficult what did you do to try and get your 
programme done?   
 
Could we have done anything to have supported you to 
exercise X times a week more often? 




Do you think being in a research study has affected how often 
you complete your exercise programme? 
 
Have you noticed any benefits since taking part in the exercise 
programme? If so, what? 
 
Have you noticed any increased pain since starting the exercise 
programme? If so, where is the pain? 
 
Throughout the last six months did the amount you did your 
exercises change?  
 
What would help/helps you do regular exercise?  
 
Do you do any other exercises as well as the web-based 
programme? If so, what do you do? [How often/where/with 
who?] 
 
Do you log on to the website each time you do your exercise 
programme? If no, why not? 
 
Do you tick the box to say that you have done your exercises 
each time you do them? If no, why not? 
 
 
12 month time 
point only 
Section 5: Future 
plans 
 
Thanks for your comments; they are really useful to us.   
 
And now that the official period of the project is finished, do 






If you were offered web-based physio again would you take it 
up? 
 
Section 6: Closing  
That is all my questions for you now, is there anything else 
that you would like to feedback to us? 
 
Well thank you very much for taking part in the study and for 
taking the time out to speak to me today as your feedback is 





Appendix 4 Adherence to prescribed Exercise component and 





































1 156 93 59.6 104 58 55.8 Yes 
2 156 72 46.2 104 34 32.7 Yes 
3 156 7 4.5 104 1 1 No 
4 156 88 56.4 104 4 3.8 Yes 
5 156 21 13.5 104 31 29.8 Yes 
6 156 95 60.9 104 50 48.1 Yes 
7 156 79 50.6 104 30 28.8 Yes 
8 156 0 0 104 0 0 Yes 
9 156 9 5.8 104 4 3.8 No 
10 156 35 22.4 104 1 1 Yes 
11 156 70 44.9 104 35 33.6 Yes 
12 156 156 100 104 104 100 Yes 
13 156 8 5.1 104 1 1 Yes 
14 156 22 14.1 104 16 15.4 No 
15 156 0 0 104 0 0 Yes 
16 156 4 2.6 104 0 0 No 
17 156 43 27.6 104 0 0 Yes 
18 156 38 24.4 104 8 7.7 Yes 
19 156 64 41 104 14 13.5 Yes 
20 156 2 1.3 104 0 0 No 
21 156 0 0 104 0 0 No 
22 156 32 20.5 104 14 13.5 No 
23 156 26 16.7 104 20 19.2 No 
24 156 81 51.9 104 27 26 Yes 
25 156 20 12.8 104 8 7.7 Yes 
26 156 102 65.4 104 33 31.7 Yes 
27 156 0 0 104 1 1 Yes 
28 156 36 23.1 104 6 5.8 Yes 
29 156 1 0.6 104 0 0 Yes 
30 156 0 0 104 0 0 No 
31 156 147 94.2 104 78 75 Yes 
32 156 15 9.6 104 2 2 No 
33 156 134 85.9 104 47 45.2 Yes 
34 156 101 64.7 104 68 65.4 Yes 




36 156 0 0 104 0 0 Yes 
37 156 117 75 104 59 56.7 Yes 
38 156 30 19.2 104 3 2.9 Yes 
39 156 0 0 104 0 0 Yes 
40 156 144 92.3 104 83 79.8 Yes 
41 156 118 75.6 104 50 48.1 Yes 







Excluded   
44 156 10 6.4 104 9 8.65 Yes 
45 156 100 64.1 104 34 32.7 Yes 
46 156 83 53.2 104 33 31.7 Yes 
47 156 137 87.8 104 7 6.7 Yes 
48 156 0 0 104 0 0 No 
49 156 86 55.1 104 10 9.6 Yes 











Appendix 5 Prescribed Component Fully Completed or Incomplete 




Were all exercises 




adhered to number 
below sessions 
unfinished) 
1 93 86 
7 
2 72 65 
7 
3 7 7 
0 
4 88 63 
25 
5 21 16 
5 
6 95 22 
73 
7 79 77 
2 
8 0 - 
- 
9 9 0 
9 
10 35 29 
6 
11 70 17 
53 
12 156 150 
6 
13 8 8 
0 
14 22 2 
20 
15 0 - 
- 
16 4 0 
4 
17 43 3 
40 
18 38 17 
21 





20 2 1 
1 
21 0 - 
- 
22 32 29 
3 
23 26 5 
21 
24 81 48 
33 
25 20 9 
11 
26 102 97 
5 
27 0 - 
- 
28 36 33 
3 
29 1 1 
0 
30 0 - 
- 
31 147 147 
0 
32 15 6 
9 
33 134 118 
16 
34 101 93 
8 
35 11 1 
10 
36 0 - 
- 
37 117 98 
19 
38 30 26 
4 
39 0 - 
- 
40 144 78 
66 
41 118 105 
13 
42 8 6 
2 
43 Exclude 0 
0 
44 10 8 
2 
45 100 0 
100 





47 137 133 
4 
48 0 - 
- 
49 86 82 
4 












Appendix 7 Participant Information Sheet at Start of Survey 
Chapter 5 
Dear Physiotherapist, 
You are invited to take part in this study by answering a survey regarding your 
experiences of patient adherence to physiotherapy prescribed exercise in 
spondyloarthritis.  It is up to you to decide whether or not to take part.  There are 
no risks involved in taking part and you will remain anonymous. If you decide to 
start the questionnaire you are free to stop at any point.  Filling in the 
questionnaire completely or in part indicates consent to take part in this study. The 
questionnaire will normally take 10 minutes to complete and we ask you complete 
this only once.  
The results will contribute to a doctoral project with the purpose of finding out if 
physiotherapists believe clinical outcomes can be influenced by adhering to 
prescribed exercises in people with spondyloarthritis, factors which might affect a 
person’s adherence, methods which can be employed by physiotherapists 
specialising in spondyloarthritis to increase patient adherence and what barriers 
physiotherapists may face in employing these methods. 
There are, at this time, no known benefits for you to take part in this survey. 
We would appreciate if you could forward this survey onto any other 
physiotherapists within the UK who regularly see people with spondyloarthritis. 
The researcher will be happy to answer any questions about this study please 








Appendix 8 Copy of Survey Questions used in Electronic Survey of 
Physiotherapist in Chapter 5 
Do you work as a rheumatology physiotherapist seeing patients with spondyloarthritis regularly (at 
least every month)? (Circle your response below). 
 
Yes        
No.   Thank you, you have now completed the survey.   
 
Do adult patients make up more than 80% of your clinical case load? (Circle your response below). 
 
Yes         
No.   Thank you, you have now completed the survey.  
 
Please circle the range that best describes the number of years since you graduated as a 
physiotherapist. 
 
0-2   
3-5   
6-10   
11-15   
16-20   
21-30   
>30  
 





England     
Rest of the world.  Thank you, you have now completed the survey.   
 
 
The following questions relate to patient adherence to physiotherapist prescribed exercises 
in spondyloarthritis. For this study: 
 
 ‘Adherence’ is defined as the extent to which a patient follows the prescribed exercises by 
you, their physiotherapist. This term is often used inter-changeably with ‘compliance’.  
 
Please indicate the extent to which you agree or disagree with the following statements by placing 
a cross within the box which best corresponds to your answer. 
 
 
Treatment outcomes in 
Spondyloarthritis can be positively 









Independent exercise programs (e.g. 
specific exercises you have prescribed 
verbally or in writing) 
     
 
How do you prescribe exercise programmes in SpA. Tick all which apply: 
 
I use digital resources such as apps, or youtube videos  
I give written instructions such as physio tools or exercise sheets  
I provide demonstrations  
I encourage people to exercise in a group.  
I direct people to the NASS website or booklets  





In your experience, in people with spondyloarthritis, do these factors affect adherence to prescribed 



















Being afraid of 
exercise 






      
The person 
believes the 
exercises will not 
the symptoms or 
outcomes 
      
Lack of time       
Lack of interest       
High Motivation       
Multiple Co-
morbidities 
      
Disease 
symptoms such 
as pain, fatigue, 
stiffness, 
frequent flares 
      




      
The belief that 
the exercises will 
help 
      
Support from 
friends, family, 
work or from a 
charity 
      
Lack of support 
from friends, 
family, work or 
from a charity 




as anxiety or 
depression 
















      
Already being 
physically active 
      
Good Access to 
Physiotherapy 
      
 
 
What methods have you found physiotherapists can use to improve patient adherence to 
physiotherapist-prescribed exercise? Please indicate the extent to which you agree or disagree 
with the following statements.                                                                                                










effect on a 
persons 
adherence. 




Individualising the exercise 
programme to the patient (e.g. 
reduction in complexity, tailoring to 
patient lifestyle, modification for pain 
response, individually tailored 
information) 
    
Goal Setting with the patient      
Providing patient education (either 
printed or verbal) of the importance of 
the exercise. 
    
Providing patient education (either 
printed or verbal) on the expected 
outcomes or consequence. 
    
Providing patient education in the form 
of supportive material or links to 
additional material, links to charities 
    
Practicing the exercises within the 
consultation including physiotherapist 
demonstration, patient practice and 
feedback, checking the patient 
understands the instructions 
    
Motivational Interviewing     
Discussing the barriers and facilitators 
to adherence and discussing ways to 
overcome the barriers 
    
Monitoring of patient adherence, 
including use of reminders, follow up 
(face to face or via telephone), use of 
exercise diaries and feedback to the 
patient on their adherence 




Addressing the general health of the 
patient, including referral to GP or 
Allied Health colleague regarding 
issues which may impact on 
adherence such co-morbidities, 
medication or diet 
    
Involvement of the patient’s support 
person, e.g. including them in the 
consultation such as exercising 
alongside the patient 
    
Physiotherapist communication skills, 
including active listening and being 
more empathetic or persuasive with 
the patient 
    
Novel Interventions, such as web-
based interventions exercises 
delivered over internet, or apps, or 
you-tube videos of exercises 
    
Other please specify     
 
 
Do any of the following barriers prevent you from employing methods to improve patient adherence 
to a self-management strategy? Please indicate the extent to which you agree or disagree with the 











I do not have enough time to assess 
patient adherence with prescribed 
strategies 
     
I have limited knowledge/ skills in 
assessing patient adherence 
     
I do not have  enough time to 
provide adherence aiding strategies 
     
I am uncomfortable discussing 
adherence with patients 
     
I have limited knowledge/ skills in 
providing adherence aiding 
strategies 
     
I have limited access to resources 
such as patient educational 
materials 
     
There can be a lack of continuity of 
care; patients often see different 
physiotherapists  
     
I don’t believe that I can alter patient 
adherence-either patients adhere or 
they don’t 
     
I don’t believe that adherence is a 
problem with my patients 
     
I don’t believe that improving patient 
adherence is  relevant to 
physiotherapy practice 
     
Other please specify      
 
Thank you for completing this survey, your time and views are greatly appreciated 
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